CELL ADHESION AND MIGRATION IN SKIN DISEASE
Cell Adhesion and Communication A series of books encompassing monographs...
56 downloads
1158 Views
5MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
CELL ADHESION AND MIGRATION IN SKIN DISEASE
Cell Adhesion and Communication A series of books encompassing monographs on classes of adhesion molecules and monographs giving a broader functional synopsis on adhesion molecules of a particular system. Edited by Steven Pals Volume 1 Cell Adhesion Molecules in Cancer and Inflammation edited by A.A.Epenetos and M.Pignatelli Volume 2 The Laminins edited by P.Ekblom and R.Timpl Volume 3 Tenascin and Counteradhesive Molecules of the Extracellular Matrix edited by K.L.Crossin Volume 4 Adhesion Molecules and Chemokines in Lymphocyte Trafficking edited by A.Hamann Volume 5 Cell Adhesion and Communication Mediated by the CEA Family Basic and Clinical Perspectives edited by C.P.Stanners Volume 6 Ig Superfamily Molecules in the Nervous System edited by P.Sonderegger Volume 7 Epithelial Morphogenesis in Development and Disease edited by W.Birchmeier and C.Birchmeier Volume 8 Cell Adhesion and Migration in Skin Disease edited by J.Barker and J.McGrath This book is part of a series. The publisher will accept continuation orders which may be cancelled at any time and which provide for automatic billing and shipping of each title in the series upon publication. Please write for details.
CELL ADHESION AND MIGRATION IN SKIN DISEASE Edited by
Jonathan Barker and John McGrath St.Thomas’ Hospital, London, UK
harwood academic publishers Australia • Canada • France • Germany • India • Japan Luxembourg • Malaysia • The Netherlands • Russia • Singapore Switzerland
This edition published in the Taylor & Francis e-Library, 2005. “To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.” Copyright © 2001 OPA (Overseas Publishers Association) N.V. Published by license under the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. All rights reserved. No part of this book may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying and recording, or by any information storage or retrieval system, without permission in writing from the publisher. Printed in Singapore. Amsteldijk 166 1st Floor 1079 LH Amsterdam The Netherlands British Library Cataloguing in Publication Data Cell adhesion and migration in skin disease.—(Cell adhesion and commnunication; v. 8) 1. Skin—Diseases—Cytopathology 2. Cell adhesion 3. Cell adhesion— Molecular aspects I.Barker, J. (Jonathan) II. McGrath, John 616.5′07 ISBN 0-203-30459-4 Master e-book ISBN
ISBN 0-203-34336-0 (Adobe eReader Format) ISBN: 90-5823-067-8 (Print Edition) ISSN: 1023–7046
CONTENTS
1.
Preface to the Series
vii
Preface
ix
Contributors
x
Introduction John A.McGrath
1
CELL-CELL ATTACHMENT 2.
The Cornified Cell Envelope Jorge Frank and Angela M.Christiano
8
3.
Keratin and Keratin Disorders Laura D.Corden and W.H.Irwin McLean
26
4.
Desmosomes David R.Garrod, Martyn A.J.Chidgey, Alison J.North, Sarah K.Runswick and Chris Tselepis
56
CELL-MATRIX ATTACHMENT 5.
Protein-Protein Interactions at the Dermal-Epidermal BMZ M.Peter Marinkovich
88
6.
Biology and Pathology of Hemidesmosomes Leena Pulkkinen and jouni Uitto
106
7.
Dermal-Epidermal Adhesion Leena Bruckner-Tuderman
131
LEUKOCYTE TRAFFICKING IN SKIN DISEASES 8.
Introduction Jonathan N.W.N.Barker
164
9.
Skin Homing Lymphocytes Conrad Hauser and René Moser
170
vi
10.
T-cell Accessory Molecules Ralf W.Denfeld and Jan C.Simon
202
11.
Animal Models of Skin Inflammation Benjamin E.Rich and Thomas S.Kupper
221
12.
Langerhans Cell Migration Georg Stingl and Dieter Maurer
241
13.
Leukocyte Adhesion and Accessory Molecules as Therapeutic Targets for Inflammatory Skin Diseases Kimberly E.Foreman and Brian J.Nickoloff
251
Index
264
PREFACE TO THE SERIES
The development and normal functioning of all multicellular organisms is governed to a large part by the interactions cells undergo with neighbouring cells-and with their acellular environment. Many of these interactions are mediated by cell-cell adhesion molecules and by extracellular matrix components and their cellular receptors, that is by molecules which establish direct cell-cell and cell-matrix contacts. These molecules are particularly important for determining whether a cell remains where it is or moves elsewhere and, if a cell moves, where it goes and when it stops migrating. These ness and metastasis. Moreover, recent advances in the field show that most, if are of course key events during normal development, but they play equally crucial roles in adult physiology and pathology, such as the extravasation of white blood cells, inflammatory processes and wound healing, tumour invasive-not all, cell adhesion molecules are capable of triggering intracellular events, in the same way as diffusible growth and differentiation factors and their cellular receptors do. It is thus hardly surprising that clinicians are devoting increasing attention to the molecular mechanisms underlying cell adhesion, and that cell adhesion molecules are not being considered as suitable targets for drug development. This book series is aimed at scientists, both in academia and in industry, at graduate students planning to move into the area, at the clinician, who wants to become familiar with a field with many clinical implications, and at scientists already working in the field, who want to keep abreast with the recent developments outside their own speciality. Hence, each volume of the series reviews a particular segment of the field and provides a critical assessment of recent discoveries and future developments. Each volume has a volume editor, who is an expert in the field and invites contributors to cover the different aspects of the topic. By keeping the number of contributors to each volume small, we hope to avoid overlaps and redundancies, common pitfalls of multi-author volumes. By looking at the previous volumes, I have the impression that we have been successful. Previous volumes of the series addressed the role of cell adhesion in selected physiological and pathological phenomena or concentrated on important structural families. The volumes on Cell Adhesion Molecules in Cancer and Inflammation and on Adhesion Molecules and Chemokines in Lymphocyte Trafficking are examples of the first, those on The Laminins and on the CEA Family are examples of the second kind. Whilst the previous volume, Epithelial Morphogenesis in Development and Disease, focused on the epithelia, whose development and integrity relies heavily on cell adhesion phenomena, this volume addresses this crucial phenomena in an especially important
viii
epithelium, the epidermis of the skin. Together the two books will constitute an invaluable source of information for scientists and clinicians interested in skin biology and diseases.
PREFACE
Cell adhesion and migration play a critical role in many cutaneous diseases. These include blistering disorders both inherited and acquired, and inflammatory conditions, such as eczema and psoriasis. In recent years, considerable advances have been made in our understanding of the molecular basis of cell adhesion and migration in the skin and the precise role of many adhesive proteins have been defined. In this book, we bring together a series of articles written by international experts, describing cell-cell, and cell-matrix adhesion and the biological processes involved in maintaining integrity of the skin and in the orchestration of inflammatory events. In the first part of the book, the molecular mechanisms involved in epidermal cell-cell attachment and keratinocyte structural integrity are discussed in detail. Emphasis is placed on the cornified cell envelope, intermediate filaments and desmosomes. Abnormalities of these structures, for example as a result of genetic mutation or disruption by autoantibodies, lead to specific blistering skin diseases such as epidermolysis bullosa simplex or pemphigus. In the second part of the book, the molecular basis for securing adhesion between the epidermis and the dermis via the intricate network of macromolecules that comprise the cutaneous basement membrane zone is discussed. The importance of perturbations in these adhesion complexes is highlighted by diseases such as junctional epidermolysis bullosa, resulting from inherited abnormalities in genes encoding structural components of hemidesmosomes and anchoring filaments and bullous pemphigoid resulting from autoimmune assault against a hemidesmosomal collagen. In the third part of the book, the molecular events responsible for accumulation of inflammatory cells into skin are discussed. Leukocyte adhesion molecules play a critical role in the control of lymphocyte recruitment into skin and as such are attractive targets for therapeutic intervention in designing new strategies to combat common inflammatory skin diseases including psoriasis and eczema. Indeed, clinical trials are presently under way using biotechnological approaches to anti-leukocyte adhesion molecule therapy and the rationale for such studies is discussed. It is hoped that the high quality chapters from international experts and the layout of this book will appeal to basic scientists and clinicians working in skin biology. Further we believe the book will also be of invaluable assistance to industry by providing information on important molecular targets in bullous and inflammatory skin diseases.
CONTRIBUTORS
Jonathan N.W.N. Barker St. John’s Institute of Dermatology St. Thomas’ Hospital Lambeth Palace Road London SE1 7EH UK Leena Bruckner-Tuderman Department of Dermatology University of Münster Von-Esmarch-Str. 56 48149 Münster Germany Martyn A.J.Chidgey School of Biological Sciences 3.239 Stopford Building University of Manchester Oxford Road Manchester M13 9PT UK Angela M.Christiano Department of Dermatology College of Physicians and Surgeons Columbia University 630 West 168th Street, VC-1526 New York, NY 10032 USA Laura D.Corden Epithelial Genetics Group Department of Molecular and Cellular Pathology Ninewells Medical School University of Dundee
xi
Dundee DD1 9SY UK Ralf W. Denfeld Department of Dermatology Albert-Ludwigs-Universität Freiburg Germany Kimberly E.Foreman Department of Pathology Skin Cancer Research Laboratories Cardinal Bernardin Cancer Center Loyola University Medical Centre Maywood, IL USA Jorge Frank Department of Dermatology College of Physicians and Surgeons Columbia University 630 West 168th Street, VC-1526 New York, NY 10032 USA David R.Garrod School of Biological Sciences 3.239 Stopford Building University of Manchester Oxford Road Manchester M13 9PT UK Conrad Hauser Allergy Unit Division of Immunology and Allergy, and Department of Dermatology (DHURDV) University Hospitals 1211 Geneva 14 Switzerland Thomas S.Kupper Division of Dermatology Harvard Skin Disease Research Center Brigham and Women’s Hospital Boston, MA 02115 USA M.Peter Marinkovich
xii
MSLS Building Rm. p208 Stanford University School of Medicine Stanford, CA 94305 USA Dieter Maurer Division of Immunology, Allergy and Infectious Diseases (DIAID) Department of Dermatology University of Vienna Medical School Vienna Austria John A.McGrath St. John’s Institute of Dermatology St. Thomas’ Hospital Lambeth Palace Road London, SE1 7EH UK W.H.Irwin McLean Epithelial Genetics Group Department of Molecular and Cellular Pathology Ninewells Medical School University of Dundee Dundee DDI 9SY UK René Moser Institute for Biopharmaceutical Research Inc. 9545 Waengi Switzerland Brian J.Nickoloff Department of Pathology Skin Cancer Research Laboratories Cardinal Bernardin Cancer Center Loyola University Medical Centre Maywood, IL USA Alison J.North School of Biological Sciences 3.239 Stopford Building University of Manchester Oxford Road Manchester M13 9PT
xiii
UK Leena Pulkkinen Department of Biochemistry and Molecular Pharmacology Thomas Jefferson University Philadelphia, PA 19107 USA Benjamin E.Rich Division of Dermatology Harvard Skin Disease Research Center Brigham and Women’s Hospital Boston, MA 02115 USA Sarah K.Runswick School of Biological Sciences 3.239 Stopford Building University of Manchester Oxford Road Manchester M13 9PT UK Jan C.Simon Department of Dermatology Albert-Ludwigs-Universität Freiburg Germany Georg Stingl Division of Immunology, Allergy and Infectious Diseases (DIAID) Department of Dermatology University of Vienna Medical School Vienna Austria Chris Tselepis School of Biological Sciences 3.239 Stopford Building University of Manchester Oxford Road Manchester M13 9PT UK Jouni Uitto Department of Dermatology and Cutaneous Biology
xiv
Jefferson Medical College Thomas Jefferson University Philadelphia, PA 19107 USA
1. INTRODUCTION JOHN A.McGRATH
One of the main functions of human skin is to act as a protective barrier against the external environment. Subcutaneous fat and dermal connective tissue help cushion and disperse mechanical trauma, but the actual barrier principally depends on the integrity of the epidermis, including the stratum corneum, as well as a complex network of adhesive junctions that link adjacent keratinocytes to one another as well as basal keratinocytes to the underlying dermis. Cell adhesion in skin involves contributions from several structural proteins, glycoproteins and lipids. Many of these are organised into specific adhesion complexes, the main types of which consist of hemidesmosomes (linking basal keratinocytes to cell matrix) and desmosomes (adhesion between adjacent keratinocytes) (Figure 1.1). Other epithelial anchorage sites include focal contact complexes, adherens junctions, gap junctions and tight junctions. Each of these is composed of a dense network of assorted structural macromolecules specific to each type of junction. Although these junctional components have a predominant role in securing cell adhesion, their function is by no means static. Many proteins or glycoproteins are redistributed or differentially expressed under certain circumstances, such as during cell migration in wound repair or even during the process of normal keratinocyte terminal differentiation. In addition to this dynamic structural modulation, many junctional macromolecules also have roles in cell signalling and cell regulation. Thus, cell adhesion is not a rigid phenomenon. Rather, the adhesive components of these junctional complexes are intricately involved in several aspects of keratinocyte cell biology and physiology. In recent years, considerable information about both the structural composition of cell adhesion junctions and the function of individual components of the various complexes has started to emerge. This influx of information has come from several sources including immunoelectron microscopy studies, clinical observations in patients with acquired or inherited skin fragility disorders, gene targeting experiments, transfection of mutant constructs, and analysis of specific protein-protein interactions, for example using the yeast-two-hybrid system. Studies of human blistering skin diseases have been particularly helpful in providing new data about the biological mechanisms of cell adhesion (Figure 1.2). In the early 1990s, assessment of skin biopsies from patients with the Dowling-Meara form of epidermolysis bullosa simplex revealed that the clumped aggregates within keratinocytes were keratin intermediate filaments, composed of keratin 14 and 5 (Ishida-Yamamoto et al., 1991).
2 JOHN A.MCGRATH
Figure 1.1 Ultrastructural appearances of cell adhesion junctions in human epidermis. (a): hemidesmosomes (arrow) at the dermal-epidermal junction (×40,000); (b): a desmosome (arrow) between adjacent keratinocytes (×70,000).
Subsequently, pathogenetic missense mutations were demonstrated in the corresponding genes, KRT14 and KRT5, in DNA from patients with this autosomal dominant skinfragility syndrome. Thus, epidermolysis bullosa simplex was established as the first keratin gene disorder and the pathological importance of cytoskeletal integrity to cell adhesion was established. In subsequent years, keratin gene defects have been delineated in a large number of other skin diseases, many involving abnormalities of cell adhesion (Irvine and McLean, 1999). To date, mutations have been described in 15 different epithelial keratins as well as two hair keratins. The associated diseases include bullous congenital ichthyosiform erythroderma (epidermolytic hyperkeratosis), ichthyosis bullosa of Siemens, epidermolytic palmoplantar keratoderma, diffuse and focal non-epidermolytic palmoplantar keratoderma, pachyonychia congenita and monilethrix. Further insights into cell adhesion have also been established from studies of diseases affecting keratinocyte terminal differentiation. Specifically, some cases of the autosomal dominant mutilating keratoderma, Vohwinkel’s syndrome, and the disorder, progressive symmetric erythrokeratoderma, have been shown to result from mutations in the gene encoding loricrin, the major component of the cornified cell envelope (Maestrini et al., 1996; Ishida-Yamamoto et al., 1998). Immunoelectron microscopy studies have revealed
INTRODUCTION 3
that the mutant loricrin fails to be incorporated into the cell membrane/envelope but instead has an intranuclear localisation. Desquamation normally involves alterations in cell adhesion through degradation of lamellated lipid and loss of residual desmosomes but this is perturbed by the presence of a dominant-negative loricrin mutation. This process may also be disrupted by abnormalities in keratinocyte transglutaminase, mutations in which may lead to the autosomal recessive disorder, lamellar ichthyosis. Studies of skin diseases involving pathological changes in desmosomes have also provided significant information about keratinocyte adhesion. Desmosomes comprise a collection of transmembranous glycoproteins (desmogleins and desmocollins) and several intracellular proteins that link the cell membrane to the cytoskeleton, including plakoglobin, desmoplakin and plakophilin 1 (Smith and Fuchs, 1998). The acquired blistering skin disease, pemphigus, involves pathogenic autoantibodies directed against conformational epitopes on some of the desmosomal cadherins leading to a loss of cellcell adhesion and acantholysis. Studies of the different subtypes of pemphigus and the distribution of target epitopes in skin and mucosal epithelium have provided further new insights into cell adhesion (Amagai, 1999). For example, patient sera containing antidesmoglein 3 antibodies alone lead to a predominantly mucosal form of pemphigus vulgaris with limited skin involvement. Sera containing both anti-desmoglein 3 and antidesmoglein 1 antibodies may lead to pemphigus vulgaris, with disrupted desmosomal adhesion in both skin and mucosa. In contrast, the presence of desmoglein 1 antibodies alone results in pemphigus foliaceous with skin blisters but no mucosal involvement. Thus, targeting of particular desmosomal cadherins by autoantibodies compromises cell adhesion with different clinical consequences. Naturally occurring mutations in the desmoglein 1 gene have also been described. Specifically, an amino-terminal deletion in desmoglein 1 has been shown to underlie some cases of striate palmoplantar keratoderma, an autosomal dominant genodermatosis (Rickman et al., 1999). This condition does not lead to blistering, but keratinocyte terminal differentiation is affected through perturbed desmosome physiology leading to hyperkeratosis of the palms and soles. This genodermatosis may also result from haploinsufficiency in the desmosomal plaque protein, desmoplakin (Armstrong et al., 1999). In such patients, cell adhesion is disrupted in that electron microscopy reveals that some of the desmosomes are small with widening of intercellular spaces between keratinocytes and disruption of the keratin filament network which is compacted in a perinuclear distribution. Similar ultrastructural features are also seen in patients who have complete ablation of plakophilin 1 (McGrath et al., 1997). In addition to skin fragility with loss of cell-cell adhesion, these patients show features of a hypohidrotic ectodermal dysplasia with abnormalities of hair, nails, teeth and sweating. Such changes arise because plakophilin 1 not only has a role as a structural component of desmosomes but, in addition, as a member of the armadillo gene/protein family, it also contributes to epidermal development and morphogenesis. Components of other epithelial junctions may also have broad biological significance. For example, in gap junctions, mutations in some of the connexin genes (connexins 26 and 31) may either affect keratinocyte terminal differentiation and lead to keratoderma or the mutations may result in non-syndromic deafness, or even clinical overlap between the two depending on the type or combination of connexin mutations (Kelsell et al., 1997; Richard et al., 1998).
4 JOHN A.MCGRATH
Figure 1.2 Inherited and acquired blistering skin diseases provide insights into the mechanisms of epidermal cell adhesion, (a): blisters and erosions in a 40-year-old male with inherited mutations in the type XVII collagen gene (COL17A1) resulting in complete ablation of the protein; (b): extensive conjunctival scarring in a 65-year-old male with acquired autoantibodies to the α3 chain of laminin 5; (c) erosions and scarring on the dorsum of the hand of a 48-year-old male resulting from autoantibodies against the NC-1 domain of type VII collagen; (d) prominent sacral erosions in a 72year-old female with an inherited nonsense/missense combination of mutations in the LAMB3 gene of laminin 5; (e) blisters, erosions, scars and milia on the knees of a 14-year-old girl with an inherited homozygous nonsense mutation in the type VII collagen gene, COL7A1; (f) tense blisters and urticated erythema on the lower leg of a 62-year-old female with acquired autoantibodies against the NC16A domain of type XVII collagen.
INTRODUCTION 5
Cell adhesion between basal keratinocytes and the underlying dermis also involves interactions between multiple structural macromolecules, many of which may be targets for autoantibodies in acquired blistering skin diseases or subjects of inherited mutations in the genes encoding these proteins in genetic blistering skin disorders. Both types of abnormality have offered fresh insights into the structural dynamics of cell adhesion as well as the pathology of certain skin diseases (Borradori and Sonnenberg, 1999). For example, autoantibodies against type XVII collagen (also known as the 180-kDa bullous pemphigoid antigen) lead to blister formation through the lamina lucida and the clinical disorder, bullous pemphigoid. Mutations in the corresponding gene, COL17A1, result in the autosomal recessive genodermatosis, non-Herlitz junctional epidermolysis bullosa. Similar paradigms for acquired-inherited disorders of cell adhesion exist for other hemidesmosome-associated components, including laminin 5 and type VII collagen and, to a lesser extent, plectin and α6β4 integrin (McGrath and Eady, 1998). These diseases provide information about the particular roles of individual structural proteins in cell adhesion. In addition, they offer clues to the relative contributions of specific proteins involved in cell adhesion. For example, total ablation of laminin 5, resulting from inherited nonsense mutations on both alleles of LAMA3, LAMB3 or LAMC2 (the three genes encoding laminin 5), results in the lethal, Herlitz form of junctional epidermolysis bullosa, in contrast to the milder, non-Herlitz phenotype resulting from complete ablation of type XVII collagen (Jonkman, 1999). Just as some components of desmosomes have roles beyond simple mechanical adhesion, the same is true for hemidesmosomes. For example, the α6β4 integrin not only helps secure adhesion between the hemidesmosome and epidermal basement membrane, but it is also able to transduce signals from the extracellular matrix to the cell interior and thereby modulate keratinocyte processes such as differentiation, proliferation and cytoskeletal organisation. The aim of this first section of the book (chapters 2–8) is to examine the mechanics of keratinocyte cell adhesion in more detail. Specifically, the chapters cover the topics of the cornified cell envelope, the keratin intermediate filaments, desmosomes, hemidesmosomes, dermal adhesion, and protein-protein interactions. The goal is to outline the complexity and intricacy of the biology of keratinocyte cell adhesion as well as to demonstrate the rapidly evolving state of knowledge in this field and its relevance to skin scientists and dermatologists. REFERENCES Amagai M. Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20: 92–102, 1999. Armstrong DKB, McKenna KE, Purkis PE et al.Haploinsufficency of desmoplakin causes a striate type of palmoplantar keratoderma. Hum Mol Genet 8:143–148, 1999. Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 112:411–418, 1999. Irvine AD. McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 140:815–828, 1999.
6 JOHN A.MCGRATH
Ishida-Yamamoto A, McGrath JA, Chapman SJ, Leigh IM, Lane EB, Eady RAJ. Epidermolysis bullosa simplex (Dowling-Meara) is a genetic disease characterized by an abnormal keratin filament network involving keratins K5and K14. J Invest Dermatol 97:959–968, 1991. Ishida-Yamamoto A, Takahashi H, lizuka H. Loricrin and human skin diseases: molecular basis of loricrin keratodermas. Histol Histopathol 13:819–826, 1998. Jonkman MF. Hereditary diseases of hemidesmosomes. J Dermatol Sci 20:103–121, 1999. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, Mueller RF, Leigh IM. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387:80–83, 1997. Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, Weeks DE, Lathrop M, Uitto J, Christiano AM. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel’s syndrome. Nat Genet 13: 70–77, 1996. McGrath JA, McMillan JR, Shemanko CS, Runswick SK, Leigh IM, Lane EB, Garrod DR, Eady RAJ. Mutations in plakophilin 1 result in ectodermal dysplasia-skin fragility syndrome. Nat Genet 17:240–244, 1997. McGrath JA, Eady RAJ. Molecular basis of blistering skin diseases. Hosp Med 59:28–32, 1998. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH Jr, DiGiovanna J.J, Compton JG, Bale SJ. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 20:366–369, 1998. Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, Bryant SP, Eady RAJ, Leigh IM, Arnemann J, Magee AI, Kelsell DP, Buxton RS. Amino-terminal deletion in a desmosomal cadherin causes the skin disease striate palmoplantar keratoderma. Hum Mol Genet 8:971–976, 1999. Smith EA, Fuchs E. Defining the interactions between intermediate filaments and desmosomes. J Cell Biol 141:1229–1241, 1998.
CELL—CELL ATTACHMENT
2. THE CORNIFIED CELL ENVELOPE JORGE FRANK AND ANGELA M.CHRISTIANO
SUMMARY The skin is the largest organ of the human body, and is the home of constant cycles of exquisitely regulated cell migration, differentiation, and regeneration. In stratifying squamous epithelia, such as the skin, the cornified cell envelope (CE), a highly insoluble peripheral layer of crosslinked proteins, replaces the plasma membrane in a complex and sequential fashion from precursor proteins initially dispersed in the cytoplasm. The insolubility of the CE is based on the presence of N-ε(γ-glutamyl) lysine isodipeptide cross-links formed by epidermal transglutaminases. Because of its mechanical resilience and impenetrability, the CE provides the human skin with a protective barrier against the environment. Here, we provide an overview of the different components of the CE and their properties and function within this complex scaffolding of cross-linked proteins. INTRODUCTION The human body is continuously exposed to a variety of external environmental aggressors. The first and most important barrier of defense and protection against these hazards is provided by the skin, in particular by the epidermis, the outermost skin layer. The epidermis consists of four different cell layers, the basal layer (stratum basalis), the spinous layer (stratum spinosum), the granular layer (stratum granulosum), and the cornified layer (stratum corneum). Additionally, a transitional cell layer (stratum lucidum) can be differentiated. This stratum lucidum is located between the stratum granulosum and the stratum corneum and, thus, separates the “living” parts of the epidermis from the “dead” epidermal layers. The epidermal network consists of a variety of different cell types, the most important of which is the epidermal keratinocyte, and in recent years, a large number of inherited disorders involving the keratinocyte have been described (Figure 2.1). Through a complex and highly structured cycle of differentiation, keratinocytes are responsible for constructing a protective barrier against the environment. The last step in keratinocyte differentiation is characterized by the formation of cornified cells, so called corneocytes. These corneocytes are enucleated,
THE CORNIFIED CELL ENVELOPE 9
Figure 2.1 A summary of recent progress in the molecular basis of genodermatoses. The inherited skin disorders involving specific skin layers are indicated on the left, and the genes proteins are listed on the right (BPAG1, bullous pemphigoid antigen 1; BPAG2, bullous pemphigoid antigen 2; EB, epidermolysis bullosa; EHK, epidermolytic hyperkeratosis; HD1, plectin; PPK, palmoplantar keratodermas; SPRRs, small proline-rich proteins; VS, Vohwinkel’s syndrome). Reproduced with permission from Ref. 79.
flattened polyhedrons, which consist of a stabilized array of keratin filaments encased within the cornified cell envelope (CE) (1). The CE represents the most insoluble component of stratified squamous epithelial cells and appears as an electron dense and homogeneous band, initially about 15 nm in thickness, replacing the plasma membrane in the uppermost cell layers of squamous epithelia in vertebrates (2, 3). Later, it gradually increases its thickness and rigidity, and in cornified cells, the CE is about 20 nm thick (3). CE formation occurs as a complex but highly structured sequence of events, involving the sequential deposition of distinct proteins (2). These proteins are cross-linked by the formation of Nε-(γ-glutamyl) lysine isodipeptide and disulfide bonds. Nε-(γ-glutamyl) lysine cross-linkage is catalyzed by distinct isoforms of transglutaminases (TG), TG1 and TG 3, and the formation of disulfide bonds is catalyzed by sulfhydryl oxidase (2, 3). Apart from the TGs, the best characterized
10 JORGE FRANK AND ANGELA M.CHRISTIANO
proteins of the CE are loricrin, involucrin and the small proline-rich proteins (SPRRs), which are all encoded by genes localized within a 2 megabase region on human chromosome 1q21, known as the epidermal differentiation complex (EDC) (Figure 2.2) (4, 5). Further components of the CE include elafin (ELA; synonym cysteine-rich protein or skin-derived antileukoproteinase, SKALP), profilaggrin (PFN), trichohyalin (THH), cystatin A (CYA; synonym keratolinin), the S100 protein family (S100A1–S100A11), envoplakin (EPL), periplakin (PPL), and corneodesmosin (CDE) (1–3, 5–9). Here, we discuss the major components of the CE and their properties and function within this complex scaffolding of cross-linked proteins. MAJOR COMPONENTS OF THE CORNIFIED CELL ENVELOPE Transglutaminases The TGs constitute a family of calcium- and thiol-dependent enzymes, catalyzing the formation of Nε-(γ-glutamyl) lysine isodipeptide bonds and N1,N8-bis(γ-glutamyl) spermidine bonds (3). In humans, the TG family consists of six known members, and at least two of these, TG1 and TG3, are believed to play an important role in the formation and maintenance of the CE (10). TG1 is an approximately 92 kDa protein, consisting of 817 amino acids. It is thought to function in a plasma membrane-bound form via its amino terminal region, and also as a soluble form in the cytoplasm (3). The major expression sites are in the upper spinous and granular layers (11), although expression of TG1 can also be detected in undifferentiated epidermal basal cells (12). The gene encoding human TG1 is located on human chromosome 14q 11.2 (13). TG3 is a 77 kDa soluble pro-enzyme, consisting of 692 amino acids. The intact TG3 protein can be subdivided into two globular domains, a 50 kDa amino-terminus containing catalytic regions, and a 27 kDa carboxy-terminus. These two domains are separated by a flexible hinge, corresponding to the cleavage site for conversion to the active protein (14, 15). TG3 is exclusively expressed in the stratum granulosum and the expression is regulated by calcium and the Sp1 and ets transcription factors (16). The gene coding for TG3 has been mapped to human chromosome 20q 11.2 (13, 17). Loricrin Loricrin is a 26 kDa protein that is located in the stratum granulosum of the epidermis and on the inner surface of purified/sonicated CEs (18, 19). The protein consists of 315 amino acids, is rich in glycine (55%), serine (22%), and cysteine (7%), and is highly insoluble. The insolubility is attributed to the high content of glycine residues and the formation of intra- and intermolecular disulfide bonds (1, 3). Loricrin contains repeats of a unique, highly flexible glycine-rich sequence, held in place by aromatic amino acid interactions, and referred to as a “glycine-loop” (1, 3). The amino- and carboxy-terminal ends of loricrin are rich in glutamine and lysine residues (3). Loricrin is the major
THE CORNIFIED CELL ENVELOPE 11
Figure 2.2 The epidermal differentiation complex (EDC). The three gene families residing in the EDC region on human chromosome 1q21 are indicated to the right of the diagram. The loricrin, involucrin and SPRR gene families are shown as purple rectangles, the trichohyalin and filaggrin gene families are shown in green, and the S100 gene family is shown in black. Genomic distances are represented in kilobases (kb). Reproduced with permission from Ref. 79.
component of the CE, comprising about 75% of the total CE mass, or 85–95% of the cytoplasmic two-thirds of the CE (20). Using recombinant loricrin molecules, it was demonstrated that TG1 is involved in establishing inter-molecular cross-links resulting in very large loricrin oligomers, whereas most of the cross-links formed by TG3 are intramolecular bridges (20). Loricrin is mainly expressed in the granular layers of the epidermis, and its expression is upregulated by calcium, cell density, and phorbol ester, and downregulated by retinoids (3). The loricrin gene is a single copy gene and resides within the EDC on human chromosome 1q21 (4,21).
12 JORGE FRANK AND ANGELA M.CHRISTIANO
Involucrin Involucrin is an acidic, water-soluble, rod-shaped protein of 68 kDa and consists of 585 amino acids, rich in glutamine and glutamic acid (3). The protein can be subdivided into amino- and carboxy-terminal flanking domains, showing homology to those of loricrin, and a central domain containing 39 repeats of a consensus decapeptide (22). All 39 repeats contain, on average, 3 glutamine residues, each of them representing a potential cross-linking site (1). Involucrin is ubiquitously synthesized by all stratified squamous epithelia and is expressed in the spinous layer of normal epidermis (3) and in cells of the inner root sheath of the hair follicle (23). Recent studies in transgenic mice demonstrated that over-expression of involucrin in mouse epidermis is associated with a delay in hair ingrowth, alterations in hair appearance, and changes in the appearance of the epidermis (24). Involucrin is believed to act as a major initial component of the CE, functioning as a scaffold onto which other proteins are incorporated (3). However, not all involucrin protein is incorporated into the CE, and it is conceivable that it might exhibit other specific biological functions in the cytoplasm (3). Involucrin expression is positively regulated by phorbol ester, calcium, vitamin D, and hydrocortisone, and negatively regulated by retinoids (3). Involucrin is encoded by a unique gene on human chromosome 1q21 within theEDC (4,21). Small Proline-rich Proteins The SPRRs are small (about 10 to 30 kDa), basic, soluble, proline-rich proteins (3). Members of this family of proteins have also been named pancornulins and cornifin (25, 26). To date, three classes of SPRRs have been distinguished, SPRR1, SPRR2, and SPRR3 (2). They contain a variable number of repeating elements in their central portions with a common sequence motif (XKXPEPXX) and end domains revealing high homology with the amino- and carboxy-terminal domains of loricrin and involucrin (2). Cross-linking occurs at these amino- and carboxy-terminal regions, suggesting that SPRRs may function as molecular cross-bridges connecting two proteins (6, 27). Expression of SPRRs is distinctively regulated in various stratified epithelia (2, 3). In normal human epidermis, SPRR1 is mainly expressed in the skin appendages and SPRR2 is expressed in the stratum granulosum, whereas SPRR3 is absent (3). The expression of SPRR2 and SPRR3 is downregulated by retinoic acid (2). Calcium, interleukin-1 and interleukin-3 upregulate the expression SPRR1, and whereas TGF-β results in downregulation. Human SPRR genes constitute a multigene family clustered within a 300 kb DNA region in the EDC on chromosome 1q21, close to the genes encoding for loricrin and involucrin (4, 28). This gene cluster contains two known SPRR1 genes, eight SPRR2 genes, and a single SPRR3 gene (28). Elafin Elafin is a basic, 6 kDa protein derived from the 12 kDa precursor preproelafin (1,3, 29, 30). Preproelafin consists of 117 amino acids; the initiation methionine, a putative 25-amino
THE CORNIFIED CELL ENVELOPE 13
acid signal peptide (“pre” sequence), a 35-amino acid “pro” sequence, and the 57 amino acids that constitute the mature elafin protein (31). Elafin is a potent inhibitor of elastase and proteinase-3, both derived from polymorphonuclear leukocytes (3). It has a high content of cysteine (14%), glycine (13%), and proline (12%), and its structure suggests the potential to form disulfide bonds (1). Elafin contains an internal segment that is a highly reactive TG substrate. This sequence consists of a series of six amino acids repeated five times (VKGQDP) (32). In normal adult epidermis, there is only little, if any, expression of elafin, but it is highly expressed in differentiated keratinocytes in various pathological conditions, including psoriatic epidermis (3). Further, it is transiently expressed during fetal and neonatal development of the epidermis. The expression of elafin is induced by interleukin Iβ and TNFα (33). The gene encoding elafin has been mapped to chromosome 20q12–q13 (34). In contrast to other CE precursors, the elafin gene contains a signal sequence and proelafin is stored in secretory vesicles and secreted extracellularly (35). Cystatin A Cystatin A is a 12 kDa, lysine-rich protein, belonging to the evolutionarily related family of cystatins which inhibit cysteine proteinases (3, 36). Phosphorylated cystatin A is a natural substrate of epidermal TG and a constituent of the CE (6, 37). It functions as a bacteriostatic barrier (38) and is expressed in the cells of the epidermal spinous layer (39). Cystatin A is upregulated by calcium and forskolin, a cAMP elevating agent (40). The human cystatin A gene is localized on human chromosome 3cen-q21 (41). S100 Protein Family The S100 proteins are a group of small (10–12 kDa), acidic proteins that form homo- and heterodimers and bind calcium via two EF hand motifs (27, 42). They share a common sequence and structure and are expressed in a tissue- and differentiation-specific manner (42). Some of the S100 proteins are expressed in the skin, and S100A10 (calpactin light chain) as well as S100A11 (S100C, calgizzarin) are precursors of the CE (27). Since S100 proteins have no known enzymatic activity, they are thought to function in a calmodulinlike manner to regulate calcium-dependent cell signaling, proliferation, and morphology (27, 42). Recent studies revealed that S100A10 binds to annexin II to form a tetramer, called calpactin 1 (27). S100A11 interacts with annexin I in a calcium-dependent manner, an interaction that requires the 12 first amino acids of the annexin I amino terminus (27). The genes encoding the proteins of the S100 family reside in the EDC on chromosome 1q21 (21). Profilaggrin/Filaggrin Profilaggrin is a highly phosphorylated protein component of the keratohyalin granules of mammalian epidermis in the stratum granulosum (43). It consists of 10 or more tandemly repeated filaggrin units plus an amino- and a carboxy-domain (43, 44). The amino
14 JORGE FRANK AND ANGELA M.CHRISTIANO
terminus of profilaggrin reveals a high degree of homology to the small calcium-binding SI00 proteins in that it contains two alpha-helical EF-hand calcium-binding motifs (43). It is supposed to play an important role in the differentiation of the epidermis by autoregulating its own processing in a calcium-dependent manner or by participation in the transduction of calcium signalling in epidermal cells. Profilaggrin is processed into the intermediate filament-associated filaggrin by specific dephosphorylation and proteolysis during terminal differentiation of epidermal cells (43). Filaggrin is a histidine-rich basic protein that aggregates keratin filaments of terminally differentiating cells of mammalian epidermis (45). The class of filaggrins shows wide species variations and their aberrant expression has been implicated in a number of keratinizing disorders (45). The human filaggrin gene has been mapped to the EDC on chromosome 1q21 and encodes a protein of 324 amino acids (45). The human filaggrin gene repeats show a considerable degree of polymorphism (45). While all repeats are of the same size (324 amino acids), sequences obtained display a high degree of variation (10–15%), in most cases attributable to single base changes (46). Trichohyalin Trichohyalin is a protein that associates in regular arrays with keratin intermediate filaments of the inner root sheath cells of the hair follicle, the medulla layer of the hair follicle, the granular layer of the epidermis, and is a known substrate of transglutaminases (47, 48). It is a high molecular weight (248 kDa) insoluble α-helix-rich constituent of the CE that forms rigid structures as a result of postsynthetic modifications by two Ca2+ dependent enzymes, TGs (protein cross-linking) and peptidyl-arginine deaminase (conversion of arginines to citrullines with loss of organized structure) (47, 48). Trichohyalin contains one of the highest contents of charged residues of any protein. Several defined domains of trichohyalin (domains 2–4, 6, and 8) are almost entirely αhelical, configured as a series of peptide repeats of varying regularity, and are thought to form a single-stranded α-helical rod stabilized by ionic interactions between successive turns of the α-helix (47). The protein is similar in structure to involucrin, although several times longer. Involucrin and trichohyalin may serve as scaffold proteins in the organization of the CE of terminally differentiating cells or even anchor the cell envelope to the keratin intermediate filament network (47, 48). Additionally, trichohyalin possesses a pair of functional calcium-binding domains of the EF hand type at its amino terminus that may be involved in its calcium-dependent postsynthetic processing during terminal differentiation (47). By in situ hybridization, the gene coding for trichohyalin has been localized in the EDC on chromosome 1q21 (49, 50). Envoplakin In 1984, Simon and Green reported the identification of two membrane-associated proteins with molecular masses of 195 and 210 kDa that become incorporated into the CE on TG activation (51). Recently, overlapping cDNA clones encoding the 210 kDa protein were sequenced, and the name “envoplakin” was proposed for this precursor of the CE
THE CORNIFIED CELL ENVELOPE 15
(52). Envoplakin shows homology to the intermediate filament-associated proteins desmoplakin I, bullous pemphigoid antigen I, and plectin (52). All four proteins are characterized by a similar domain structure with an amino-terminal globular domain, a central rod domain, and a carboxy-terminal globular domain. The COOH termini of the plakin family members contain a variable number of tandem repeats that are predicted to be organized into discrete subdomains consisting of α-helices separated by β-turns (52), and first described for desmoplakin I (53). By in situ hybridization, the envoplakin gene was mapped to human chromosome 17q25 (54). Periplakin The second membrane-associated protein identified by Simon and Green in 1984 has a molecular mass of 195 kDa (51). It is expressed in keratinizing and non-keratinizing stratified squamous epithelia and in a number of other epithelia, and was designated “periplakin” (55, 56). Periplakin, like envoplakin, also belongs to the plakin family, whose members are responsible for the maintenance of skin integrity and that of other tissues (57). Like other plakins, periplakin contains a globular amino-terminal domain, consisting of bundled antiparallel -helices, and a central coiled-coil rod domain (55). However, the carboxy-terminal domain of periplakin differs from that of the other plakins in that it lacks any of the sequence-related subdomains (A, B or C) that consist of helices separated by βturns (55). The primary sequences of the amino- and carboxy-termini of periplakin show more than 20% sequence identity to the corresponding regions of desmoplakin I, bullous pemphigoid antigen I, plectin, and envoplakin (55). Periplakin is most closely related to envoplakin, and detailed sequence analyses of the two proteins revealed that in particular their rod domains are more closely related to each other than to those of the other plakin family members (55). This suggested that both proteins could form two-stranded parallel homodimers or heterodimers, which would be stabilized by extensive interchain ion pairing (55). The human periplakin gene consists of 1756 amino acids and was recently mapped to human chromosome 16pl3 (56). Corneodesmosin Corneodesmosin is a basic, phosphorylated and glycosylated protein with a molecular weight of 52–56 kDa (58). In humans, Corneodesmosin is exclusively expressed in cornified squamous epithelia, like the epidermis, hard palate, and the inner root sheath of the hair follicle (58). It is synthesized at the latest stage of keratinocyte differentiation and persists between the cells of the stratum corneum until desquamation occurs (59). By immunofluorescence and immunoelectron microscopy, Corneodesmosin was demonstrated to be bound to the CE (58). Recently, a gene designated “S” (because it was identified in skin) was identified in the class I region of the human major histocompatibility (HLA) complex on chromosome 6p21.3 (60). This gene is expressed at high levels as 2.2 kb- and 2.6 kb mRNAs in human skin, and in situ hybridization revealed that its expression is restricted to the differentiating keratinocytes in the granular layers of the epidermis (60). Later, it became obvious that the product encoded by this gene is, in
16 JORGE FRANK AND ANGELA M.CHRISTIANO
fact, Corneodesmosin (58) and that the protein contains a high percentage of serine, glycine, and proline residues (60). Although there are significant similarities with the proteins encoded by loricrin, keratin 1, and keratin 10, all major components of the stratum granulosum, the S gene is structurally unrelated to other known genes of the HLA complex (60), and, in a study investigating the potential role of the S gene in psoriasis vulgaris, several genetic intragenic polymorphisms have been identified (61). MOLECULAR BASIS OF DISEASES AFFECTING THE CE Lamellar Ichthyosis and Transglutaminase Mutations Lamellar ichthyosis (LI) (OMIM accession numbers 242300 and 601277) is a genetic skin disorder, inherited in an autosomal recessive fashion (62). Clinically, ichthyotic lesions are present at birth and almost always involve the entire skin surface. The children are usually born encased in a collodion membrane that desquamates during the first 10 to 14 days of life. The skin is erythematous and covered with large scales, fissures of the hands and feet, scarring alopecia, dystrophic nails, and ectropion are common symptoms. Because of an obstruction of the eccrine glands, the patients do not sweat normally, which can lead to hyperpyrexia (63). Recently, it was demonstrated that there exist at least three genetically distinct forms of recessively inherited LI characterized by typical pathology of the skin, with direct sequelae of primary cutaneous lesions (for example ectropion, joint contractures, and digital necrosis) and without in volvement of other organ systems (64, 65). The form that maps to chromosome 14q 11 has been designated LI Type 1. This form of LI is characterized by mutations in TG1, one of the major components of the CE (64, 66–74). A second form, LI Type 2, maps to chromosome 2q33–q35 (65); however, no candidate gene for LI Type 2 has been identified so far in this chromosomal region. A third form of LI, LI Type 3, has been mapped to chromosome 20q l l.2 in the region of the TG3 gene (13, 17). A large number of mutations in the TG1 gene in LI have enabled genotype/ phenotype correlation in families with lamellar ichthyosis (73). Linkage analyses using microsatellite markers spanning the region of the TG1 gene confirmed genetic heterogeneity. In patients not linked to the TG1 locus, the second region identified on chromosome 2q33–q35 and the third candidate region on chromosome 20 were excluded, suggesting the existence of at least four loci for lamellar ichthyosis (73). Vohwinkel’s Syndrome and Loricrin Mutations Vohwinkel’s syndrome (OMIM number 124500), first reported in 1929, is an autosomal dominant palmoplantar is keratoderma with pseudoainhum, and sometimes associated with deafness (75, 76) (figure 3). In an extended Vohwinkel’s syndrome family, Maestrini et al. demonstrated linkage to the EDC on chromosome Iq21, the calculated maximum multipoint lod score being 14.3 (75), and a mutation consisting of a 1 bp insertion after nucleotide 730 (730insG) was detected in the loricrin gene (77). This additional G nucleotide was found in an area of six subsequent wild-type G nucleotides (codons 230
THE CORNIFIED CELL ENVELOPE 17
Figure 2.3 Clinical presentation of Vohwinkel’s syndrome, (a) Characteristic honeycomb keratoderma on the palm, (b) Pseudoainhum is present on the third, fourth and fifth digits, (c) Bilateral autoamputation of the fifth toes in an affected individual. Reproduced with permission from Ref. 79.
and 231), introducing a frameshift mutation at codon 232 that altered the terminal 84 amino acids of the encoded protein and resulted in a delayed termination codon, thereby extending the mutant protein by 22 amino acids. Affected individuals were heterozygous for the mutation, which was not found in unaffected members of the family or in unrelated, unaffected control individuals (77). The authors noted that replacement of the fourth glycine-rich domain and the carboxy-terminal glutamine/ lysine-rich domain, which is believed to be involved in normal protein cross-linking would be expected to alter the function of the protein and to impair cross-linking by Tgs (77). Since loricrin monomers become cross-linked to each other as well as to other proteins by isopeptide bonds, the defect would be expected to have a dominant-negative effect, in accordance with the autosomal dominant inheritance of Vohwinkel syndrome (77). The results of immunoelectron microscopy studies suggested that the mutant loricrin protein is abnormally or less efficiently incorporated into the CE and accumulates in intranuclear granules. Detection of this mutation in the loricrin gene was the first evidence for a molecular defect in a gene of the EDC/CE underlying a human disease (75). It was reported for a second time in a seemingly unrelated Vohwinkel’s syndrome family (78). In this study, a lack of linkage to chromosome Iq21 was demonstrated in a third VS family, suggesting genetic heterogeneity within VS (78).
18 JORGE FRANK AND ANGELA M.CHRISTIANO
Progressive Symmetric Erythrokeratoderma and Loricrin Mutations The clinically and genetically heterogeneous group of disorders known collectively as the erythrokeratodermas (EKs) is characterized by widespread erythematous plaques, either stationary or migratory, associated with features that include palmoplantar keratoderma (79). One type, known as progressive symmetric erythrokeratoderma (PSEK; OMIM number 602036), and inherited in an autosomal dominant fashion, shows incomplete penetrance and variable expression (80). The disease is characterized by erythematous and hyperkeratotic plaques, and only approximately 30 cases have been reported since the initial description by Darier in 1911 (80, 81). Non-migratory erythematous plaques develop shortly after birth and are distributed symmetrically over the body surface, in particular on the extremities, the buttocks, and sometimes the face, together with palmoplantar keratoderma. A second major clinical subtype of erythrokeratoderma is EK variabilis (EKV; OMIM number 133200), first described by Mendes da Costa in 1925, and characterized by relatively fixed hyperkeratotic patches on erythematous areas, and by capriciously formed outlines, like the boundary lines of seacoasts on maps (82). Like Vohwinkel syndrome and PSEK, EKV is also inherited as an autosomal dominant trait with incomplete penetrance. The condition is usually evident at birth or within the first year of life, and skin lesions predominantly affect the face, buttocks, and extremities. The erythematous areas move from hour to hour, and palmoplantar keratoderma is generally present. The major feature distinguishing PSEK and EKV is the sharply outlined, geographic regions of migratory erythema in EKV. The questions of whether these two disorders are in fact one disease was raised by MacFarlane et al. in 1991 when they reported studies of two sisters, one of them apparently suffering from EKV and the other one showing clinical symptoms of PSEK (83). The genetic locus for EKV maps to chromosome 1p36.2–p34. In 1997, Ishida-Yamamoto et al. demonstrated one family with PSEK had a mutation in the loricrin gene on chromosome 1q21 (80), suggesting that PSEK and EKV are genetically distinct disorders. They reported a 1-bp insertion of a C following nucleotide 709 (709insC) in the loricrin gene, resulting in a frameshift and a delayed termination codon in the loricrin mRNA (80). The frameshift caused replacement of the carboxyterminal 91 amino acids and extended the coding sequence by an additional 65 nucleotides. The wild-type loricrin polypeptide consists of 315 amino acid, so this mutation replaces the carboxy-terminal third of loricrin with missense amino acids and removes approximately one third of the glutamine and lysine residues involved in isodipeptide cross-link formation (80). The similarities between this disorder and Vohwinkel’s syndrome include palmoplantar hyperkeratosis with a honeycomb appearance, pseudoainhum, and ichthyotic lesions on other body areas, although the PSEK cases revealed significantly more widespread and striking erythematous hyperkeratotic plaques (80). Ishida-Yamamoto et al. noted that the PSEK mutation involves the insertion of a C after a stretch of 4 consecutive C nucleotides and is located only 21-bp upstream of the site of the loricrin mutation causing Vohwinkel syndrome (80), which consists of a 1bp insertion of a G after a stretch of 6 consecutive G nucleotides (78).
THE CORNIFIED CELL ENVELOPE 19
POSSIBILITIES OF FUTURE GENE THERAPY FOR DISORDERS OF THE CE The skin represents an accessible somatic tissue for gene transfer and, depending on therapeutic goals, a variety of cutaneous gene delivery approaches are currently available (84–86). Recently, corrective gene transfer was demonstrated in LI, a disfiguring skin disease characterized by abnormal epidermal differentiation and defective cutaneous barrier function (84). LI is associated with a decreased activity of keratinocyte TG1, the enzyme necessary for normal formation of the cornified epidermal barrier. Using LI as a prototype for therapeutic cutaneous gene delivery, Choate et al. developed a human skin/ immunodeficient mouse xenograft model to correct the molecular, histological and functional abnormalities of skin derived from LI patients in vivo. After retroviral transduction of TG1 into TG1-deficient primary keratinocytes, they regenerated engineered human LI epidermis on immunodeficient mice. The engineered LI epidermis displayed normal TG1 expression in vivo, in contrast to unengineered LI epidermis where TG1 was absent. Epidermal architecture was also normalized by TG1 restoration, as was expression of the epidermal differentiation marker filaggrin. Engineered LI skin demonstrated restoration of cutaneous barrier function to levels seen in epidermis regenerated by keratinocytes from patients with normal skin, indicating functional correction of the proposed primary pathophysiologic defect in LI. These results confirm a major role for TG1 in epidermal differentiation, and demonstrate a potential future approach to therapeutic gene delivery in human skin (84). In 1997, the same group of researchers examined the regeneration of skin from TG1-deficient patients with LI on nude mice by direct injection of naked plasmid DNA (85). Regenerated LI patient skin receiving repeated in vivo injections with a TG1 expression plasmid displayed restoration of TG1 expression in the correct tissue location in the suprabasal epidermis. However, unlike LI skin regenerated from keratinocytes first transduced with a retroviral expression vector for TG1 prior to grafting, directly injected LI skin displayed a non-uniform TG1 gene expression pattern (85). Further, direct injection failed to correct the central histologie and functional abnormalities of the disease. These data demonstrate that partial restoration of gene expression can be achieved via direct injection of naked DNA in human skin, but underscore the need for new advances to achieve efficient and sustained plasmid-based gene delivery to the skin. Recently, another group of researchers has also demonstrated successful corrective gene transfer in the human skin disorder X-linked ichthyosis (XLI) (OMIM number 308100) (86). XLI is characterized by loss of function of the steroid sulfatase arylsulfatase C (STS). Freiberg et al. developed a model of corrective gene delivery to human skin in vivo (86). A retroviral expression vector was produced and utilized for STS gene transfer into primary keratinocytes from XLI patients. Transduction was associated with restoration of full-length STS protein expression as well as steroid sulfatase enzymatic activity in proportion to the number of proviral integrations in XLI cells. Transduced and uncorrected XLI keratinocytes, along with normal controls, were then grafted onto immunodeficient mice to regenerate full thickness human epidermis. Unmodified XLI keratinocytes regenerated a hyperkeratotic epidermis lacking STS expression with
20 JORGE FRANK AND ANGELA M.CHRISTIANO
defective skin barrier function, effectively recapitulating the human disease. Transduced XLI keratinocytes from the same patients, however, regenerated an epidermis histologically indistinguishable from that formed by keratinocytes from patients with normal skin (86). STS expression in transduced XLI epidermis was demonstrated in vivo by immunostaining as well as a normalization of histologie appearance at 5 weeks postgrafting. In addition, transduced XLI epidermis demonstrated a return of barrier function parameters to normal. Thus, these findings demonstrate corrective gene delivery in human XLI patient skin tissue at both molecular and functional levels and provide a model of human cutaneous gene therapy (86). Collectively, these data support the notion that the epidermis is an attractive site for therapeutic gene delivery due to its accessibility and the potential for delivering polypeptides to the systemic circulation. A number of obstacles, however, have emerged in attempts at cutaneous gene delivery, and central among these is the inability to sustain therapeutic gene production. The challenges for the future of gene therapy in the skin have been identified in these early studies, and provide a foundation of knowledge for the growth of this exciting and important field. CONCLUSIONS In recent years, chromosomal mapping and cloning of the genes encoding the different protein components of the CE, as well as the identification of TG1 and loricrin mutations underlying diseases affecting the CE, has greatly enhanced our understanding of the structure and organization of this important structure of the skin. However, more discoveries will be made before the mysteries of this complex protein cross-linked treasury are solved. The number of newly identified precursors of the CE continues to grow, and elucidation of their relevance to the maintenance of skin integrity, inherited skin disorders and approaches to gene therapy is our challenge for the future. REFERENCES 1. 2.
3. 4.
5.
Eckert RL, Crish JF, Robinson NA. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397–424 (1997). Hohl D, de Viragh PA, Amiguet-Barras F, Gibbs S, Backendorf C, Huber M. The small proline-rich proteins constitute a multigene family of differentially regulated cornined cell envelope precursor proteins. J Invest Dermatol 104:902–909 (1995). Ishida-Yamamoto A, lizuka H. Structural organization of cornined cell envelopes and alterations in inherited skin disorders. Exp Dermatol 7:1–10 (1998). Volz A, Korge BP, Compton JG, Ziegler A, Steinert PM, Mischke D. Physical mapping of a functional cluster of epidermal differentiation genes on chromosome Iq21. Genomics 18: 92–99 (1993). Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, Weeks DE, Lathrop M, Uitto J, Christiano AM. A molecular defect in loricrin, the major component of the cornined cell envelope, underlies Vohwinkel’s syndrome. Nature Genet 13:70–77 (1996).
THE CORNIFIED CELL ENVELOPE 21
6.
7.
8.
9.
10.
11.
12. 13.
14.
15.
16.
17.
18.
19.
20.
21.
Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide crosslinked components of the human epidermal cornined cell envelope. J Biol Chem 270: 17702–17711 (1995). Ruhrberg C, Hajibagheri MA, Simon M, Dooley TP, Watt FM. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 134: 715–729(1996). Ruhrberg C, Hajibagheri MA, Parry DA, Watt FM. Periplakin, a novel component of cornined envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. Cell Biol 139:1835–1849 (1997). Simon M, Montezin M, Guerrin M, Durieux JJ, Serre G. Characterization and purification of human corneodesmosin, an epidermal basic glycoprotein associated with corneocyte-specific modified desmosomes. J Biol Chem 272: 31770–31776 (1997). Thacher SM, Rice RH. Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell 40: 685–695 (1985). Michel S, Bernerd F, Jetten AM, Floyd EE, Shroot B, Reichert U. Expression of keratinocyte transglutamine mRNA revealed by in situ hybridization. J Invest Dermatol 98: 364–368 (1992). Kim SY, Chung SI, Yoneda K, Steinert PM. Expression of transglutaminase 1 in human epidermis. J Invest Dermatol 104:211–217 (1995). Yamanishi K, Inazawa J, Liew FM, Nonomura K, Ariyama T, Yasuno H, Abe T, Doi H, HiranoJ, Fukushima S. Structure of the gene for human transglutaminase 1. J Biol Chem 267: 17858–17863 (1992). Kim HC, Lewis MS, Gorman JJ, Park SC, Girard JE, Folk JE, Chung SI. Pro transglutaminase E from guinea pig skin. Isolation and partial characterization. J Biol Chem 265:21971–21978 (1990). Kim IG, Gorman JJ, Park SC, Chung SI, Steinert PM. The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem 268: 12682–12690 (1993). Lee JH, Jang SI, Yang JM, Markova NG, Steinert PM. The proximal promoter of the human transglutaminase 3 gene. Stratified squamous epithelial-specific expression in cultured cells is mediated by binding of Sp1 and ets transcription factors to a proximal promoter element. J Biol Chem 271:4561–4568 (1996). Wang M, Kim IG, Steinert PM, McBride OW. Assignment of the human transglutaminase 2 (TGM2) and transglutaminase 3 (TGM3) genes to chromosome 20q l l.2. Genomics 23: 721–722 (1994). Mehrel T, Hohl D, Rothnagel JA, Longley MA, Bundman D, Cheng C, Lichti U, Bisher ME, Steven AC, Steinert PM, Yuspa SH, Roop DR. Identification of a major keratinocyte cell envelope protein, loricrin. Cell 61:1103–1112 (1990). Steinert PM, Mack JW, Korge BP, Gan SQ, Haynes SR, Steven AC. Glycine loops in proteins: their occurrence in certain intermediate filament chains, loricrins and singlestranded RNA binding proteins. IntJ Biol Macromol 13:130–139 (1991). Candi E, Melino G, Mei G, Tarcsa E, Chung SI, Marekov LN, Steinert PM. Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J Biol Chem 270:26382–26390 (1995). Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and SI00 calcium-binding proteins form a gene complex
22 JORGE FRANK AND ANGELA M.CHRISTIANO
22. 23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
(“epidermal differentiation complex”) on human chromosome Iq21. J Invest Dermatol 106: 989–992 (1996). Eckert RL, Green H. Structure and evolution of the human involucrin gene. Cell 46: 583–589 (1986). Robinson NA, LaCelle PT, Eckert RL. Involucrin is a covalently crosslinked constituent of highly purified epidermal corneocytes: evidence for a common pattern of involucrin crosslinking in vivo and in vitro. J Invest Dermatol 107:101–107 (1996). Crish JF, Howard JM, Zaim TM, Murthy S, Eckert RL. Tissue-specific and differentiationappropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype. Differentiation 53:191–200 (1993). Greco MA, Lorand L, Lane WS, Baden HP, Parameswaran KN, Kvedar JC. The pancornulins: a group of small proline rich-related cornified envelope precursors with bifunctional capabilities in isopeptide bond formation. J Invest Dermatol 104: 204–210 (1995). Marvin KW, George MD, Fujimoto W, Saunders NA, Bernacki SH, Jetten AM. Cornifin, a cross-linked envelope precursor in keratinocytes that is down-regulated by retinoids. Proc Natl Acad Sci U S A 89:11026–11030 (1992). Robinson NA, Lapic S, Welter JF, Eckert RL. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 272:12035–12046 (1997). Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P, Backendorf C. Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics 16:630–637 (1993). Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 265:14791–14795 (1990). SchalkwijkJ, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim Biophys Acta 1096:148–154 (1991). Saheki T, Ito F, Hagiwara H, Saito Y, Kuroki J, Tachibana S, Hirose S. Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem Biophys Res Commun 185:240–245 (1992). Nara K, Ito S, Ito T, Suzuki Y,Ghoneim MA, Tachibana S, Hirose S. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed “cementoin”. J Biochem 115:441–448 (1994). Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 11: 733–741 (1994). Molhuizen HO, Zeeuwen PL, Olde Weghuis D, Geurts van Kessel A, Schalkwijk J. Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20ql2-ql3. Cytogenet Cell Genet 66: 129–131 (1994). Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, FransenJ, Croes H,van Erp PE, SchalkwijkJ. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest 98:1389–1399 (1996).
THE CORNIFIED CELL ENVELOPE 23
36. 37.
38.
39. 40.
41.
42. 43. 44. 45.
46. 47.
48.
49.
50.
51. 52.
Rawlings ND, Barrett AJ. Evolution of proteins of the cystatin superfamily. J Mol Evol 30: 60–71 (1990). Takahashi M, Tezuka T, Katunuma N. Phosphorylated cystatin alpha is a natural substrate of epidermal transglutaminase for formation of skin cornified envelope. FEBS Lett 308:79–82 (1992). Takahashi M, Tezuka T, Katunuma N. Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin alpha in skin cornified envelope. FEBS Lett 355:275–278 (1994). Jarvinen M, Rinne A, Hopsu-Havu VK. Human cystatins in normal and diseased tissues - a review. Acta Histochem 82:5–18 (1987). Takahashi H, Kinouchi M, Wuepper KD, lizuka H. Cloning of human keratolinin cDNA: keratolinin is identical with a cysteine proteinase inhibitor, cystatin A, and is regulated by Ca2+, TPA, and cAMP. J Invest Dermatol 108:843–847 (1997). Hsieh WT, Fong D, Sloane BF, Golembieski W, Smith DI. Mapping of the gene for human cysteine proteinase inhibitor stefin A, STF1, to chromosome 3cen-q21. Genomics 9: 207–209 (1991). Robinson NA, Eckert RL. Identification of transglutaminase-reactive residues in S100A11. J Biol Chem 273:2721–2728 (1998). Markova NG, Marekov LN, Chipev CC, Gan SQ, Idler WW, Steinert PM. Profilaggrin is a major epidermal calcium-binding protein. Mol Cell Biol 13:613–625 (1993). Thulin CD, Taylor JA, Walsh KA. Microheterogeneity of human filaggrin: analysis of a complex peptide mixture using mass spectrometry. Protein Sci 5:1157–1164 (1996). McKinley-Grant LJ, Idler WW, Bernstein IA, Parry DA, Cannizzaro L, Croce CM, Huebner K, Lessin SR, Steinert PM. Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region Iq21. Proc Natl Acad Sci U S A 86:4848–4852 (1989). Gan SQ, McBride OW, Idler WW, Markova N, Steinert PM. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry 29:9432–9440 (1990). Lee SC, Kirn IG, Marekov LN, O’Keefe EJ, Parry DA, Steinert PM. The structure of human trichohyalin. Potential multiple roles as a functional EF-hand-like calcium-binding protein, a cornified cell envelope precursor, and an intermediate filament-associated (cross-linking) protein. J Biol Chem 268:12164–12176 (1993). Tarcsa E, Marekov LN, Andreoli J, Idler WW, Candi E, Chung SI, Steinert PM. The fate of trichohyalin. Sequential post-translational modifications by peptidyl-arginine deiminase and transglutaminases. J Biol Chem 272:27893–27901 (1997). Fietz MJ, Rogers GE, Eyre HJ, Baker E, Callen DF, Sutherland GR. Mapping of the trichohyalin gene: co-localization with the profilaggrin, involucrin, and loricrin genes. J Invest Dermatol 99:542–544 (1992). Lee SC, Wang M, McBride OW, O’Keefe EJ, Kirn IG, Steinert PM. Human trichohyalin gene is clustered with the genes for other epidermal structural proteins and calcium-binding proteins at chromosomal locus Iq21. J Invest Dermatol 100: 65–68 (1993). Simon M, Green H. Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 36:827–834 (1984). Ruhrberg C, Hajibagheri MA, Simon M, Dooley TP, Watt FM. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 134: 715–729 (1996).
24 JORGE FRANK AND ANGELA M.CHRISTIANO
53.
54.
55.
56. 57. 58.
59.
60. 61.
62. 63.
64.
65.
66.
67.
68.
69.
Green KJ, Parry DA, Steinert PM, Virata ML, Wagner RM, Angst BD, Nilles LA. Structure of the human desmoplakins. Implications for function in the desmosomal plaque. J Biol Chem 265:2603–2612 (1990). Ruhrberg C, Williamson JA, Sheer D, Watt FM. Chromosomal localisation of the human envoplakin gene (EVPL) to the region of the tylosis oesophageal cancer gene (TOCG) on 17q25. Genomics 37:381–385 (1996). Ruhrberg C, Hajibagheri MA, Parry DA, Watt FM. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 139:1835–1849 (1997). Aho S, McLean WH, Li K, Uitto J. cDNA cloning, mRNA expression, and chromosomal mapping of human and mouse periplakin genes. Genomics 48:242–247 (1998). Ruhrberg C, Watt FM. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev 7:392–397 (1997). Simon M, Montezin M, Guerrin M, Durieux JJ, Serre G. Characterization and purification of human corneodesmosin, an epidermal basic glycoprotein associated with corneocyte-specific modified desmosomes. J Biol Chem 272:31770–31776 (1997). Haftek M, Simon M, Kanitakis J, Marechal S, Claudy A, Serre G, Schmitt D. Expression of corneodesmosin in the granular layer and stratum corneum of normal and diseased epidermis. Br J Dermatol 137:864–873 (1997). Zhou Y, Chaplin DD. Identification in the HLA class I region of a gene expressed late in keratinocyte differentiation. Proc Natl Acad Sci U S A 90:9470–9474 (1993). Ishihara M, Yamagata N, Ohno S, Naruse T, Ando A, Kawata H, Ozawa A, Ohkido M, Mizuki N, Shiina T, Ando H, Inoko H. Genetic polymorphisms in the keratin-like S gene within the human major histocompatibility complex and association analysis on the susceptibility to psoriasis vulgaris. Tissue Antigens 48:182–186 (1996). Francis JS. Genetic skin diseases. Curr Opin Pediatr 6:447–453 (1994). Phillips SB and Baden HP. Ichthyosiform dermatoses. In fitzpatrick TB, Eisen AZ, Wolff, K, Freedberg, IM, Austen, KF (eds.): “Dermatology in general medicine.”4th edition, pp. 531–544 (1993). Parmentier L, Blanchet-Bardon C, Nguyen S, Prud’homme JF, Dubertret I., Weissenbach J. Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase 1 and evidence for genetic heterogeneity. Hum Molec Genet 4:1391–1395 (1995). Parmentier L, Lakhdar H, Blanchet-Bardon C, Marchand S, Dubertret L, Weissenbach. Mapping of a second locus for lamellar ichthyosis to chromosome 2q33–35. Hum Molec Genet 5:555–559 (1996). Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SP, Ponec M, Bon A, Lautenschlager S, Schorderet DF, Hohl D. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267:525–528 (1995). Russell LJ, DiGiovannaJJ, Rogers GR, Steinert PM, Hashem N, Compton JG, Bale SJ. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nature Genet 9:279–283 (1995). Schorderet DF, Huber M, Laurini RN, Von Moos G, Gianadda B, Deleze G, Hohl D. Prenatal diagnosis of lamellar ichthyosis by direct mutational analysis of the keratinocyte transglutaminase gene. Prenat Diagn 17:483–486 (1997). Laiho E, Ignatius J, Mikkola H, Yee VC, Teller DC, Niemi KM, Saarialho-Kere U, Kere J, Palotie A. Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet 61:529–538 (1997).
THE CORNIFIED CELL ENVELOPE 25
70.
71.
72.
73. 74.
75. 76. 77.
78.
79. 80.
81. 82. 83. 84. 85. 86.
Petit E, Huber M, Rochat A, Bodemer C, Teillac-Hamel D, Muh JP, Revuz J, Barrandon Y, Lathrop M, de Prost Y, Hohl D, Hovnanian A. Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity. Eur J Hum Genet 5:218–228 (1997). Bichakjian CK, Nair RP, Wu WW, Goldberg S, Elder JT. Prenatal exclusion of lamellar ichthyosis based on identification of two new mutations in the transglutaminase 1 gene. J Invest Dermatol 110:179–182 (1998). Hennies HC, Raghunath M, Wiebe V, Vogel M, Velten F, Traupe H, Reis A. Genetic and immunohistochemical detection of mutations inactivating the keratinocyte transglutaminase in patients with lamellar ichthyosis. Hum Genet 102:314–318 (1998). Hennies HC, Kuster W, Wiebe V, Krebsova A, Reis A. Genotype/phenotype correlation in autosomal recessive lamellar ichthyosis. Am J Hum Genet 62:1052–1061 (1998). Candi E, Melino G, Lahm A, Ceci R, Rossi A, Kirn IG, Ciani B, Steinert PM. Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing. J Biol Chem 273:13693–13702 (1998). Vohwinkel KH. Keratoderma hereditaria mutilans. Arch Dermatol Syphil 158: 354–364 (1929). Camisa C, Rossana C. Variant of keratoderma hereditaria mutilans (Vohwinkel’s syndrome). Arch Dermatol 120:1323–1328 (1984). Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, Weeks DE, Lathrop M, Uitto J, Christiano AM. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel’s syndrome. Nature Genet 13:70–77 (1996). Korge BP, Ishida-Yamamoto A, Punter C, Dopping-Hepenstal PJ, lizuka H, Stephenson A, Eady RA, Munro CS. Loricrin mutation in Vohwinkel’s keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 109:604–610 (1997). Christiano AM. Frontiers in keratodermas: pushing the envelope. Trends Genet 13: 227–233 (1997). Ishida-Yamamoto A, McGrath JA, Lam H, lizuka H, Friedman RA, Christiano AM. The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 61: 581–589 (1997). Darier J. Erythro-keratodermie verruqueuse en nappes, symetrique et progressive. Bull Soc Franc Derm Syph 22:252–264 (1911). Mendes da Costa S. Erythro- et keratodermia variabilis in a mother and a daughter. Acta Derm Venerol 6:255–261 (1925). Macfarlane AW, Chapman SJ, Verbov JL. Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings. BritJ Derm 124:487–491 (1991). Choate KA, Medalie DA, Morgan JR, Khavari PA. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nature Med 2:1263–1267 (1996). Choate KA, Khavari PA. Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther 8:1659–1665 (1997). Freiberg RA, Choate KA, Deng H, Alperin ES, Shapiro LJ, Khavari PA. A model of corrective gene transfer in X-linked ichthyosis. Hum Molec Genet 6:927–933 (1997).
3. KERATINS AND KERATIN DISORDERS LAURA D.CORDEN AND W.H.IRWIN MCLEAN
MOLECULAR ASPECTS OF KERATIN INTERMEDIATE FILAMENTS The Intermediate Filament Family of Cytoskeletal Proteins In addition to the actin microfilament and microtuble cytoskeletal systems found in all mammalian cells, there is a third cytoskeletal network comprised of filaments which are intermediate in size between the other two systems and which are therefore termed intermediate filaments (Figure 3.1 & 3.2). Lazarides described five classes of intermediate filament within higher eukaryotic cells, distinguishable biochemically and immunologically: keratin, desmin, vimentin, neurofilaments and glial filaments (Lazarides, 1980). The current classification of the different types of intermediate filament is shown in Table 3.1, below. THE MOLECULAR STRUCTURE OF INTERMEDIATE FILAMENTS All intermediate filaments have a diameter of approximately lOnm (Lazarides, 1980) and share a common structure composed of a central a-helical rod domain of approximately 310 amino acids (Geisler and Weber, 1982; Hanukoglu and Fuchs, 1982; Hanukoglu and Fuchs, 1983; Lewis et al., 1984; Quax et al., 1983; Steinert et al., 1983; Tyner et al., 1985; Weber and Geisler, 1982), corresponding to 46nm in length (reviewed in (Steinert and Bale, 1993; Steinert and Parry, 1985)). The domain structures of type I and II keratins, typical of all intermediate filament types, are shown in Figure 3.3. The rod domain is interspersed by three non α-helical regions which are predicted to take the form of β-turns (Hanukoglu and Fuchs, 1983; Steinert et al., 1983), and divide the rod into four sub-domains termed 1A, 1B, 2A and 2B (Steinert and Parry, 1985) (Figure 3.3). The four helical domains are reasonably constant in size between all intermediate filament types, approximately 30–50, 95, 35 and 95 amino acid residues in length respectively (Hanukoglu and Fuchs, 1983).
KERATINS AND KERATIN DISORDERS 27
Table 3.1 Types of intermediate filament
Figure 3.1 Epithelial cell line PtK2 transfected with a human K17 cDNA clone in eukaryotic expression plasmid pCR3.1, stained with monoclonal antibody F3 against K17 and FITC secondary antibody. This confocal scanning laser microgaph shows the typical dense cytoplasmic meshwork of keratin filaments seen in mammalian epithelial cells. Photograph provided by Drs Frances J.D.Smith and Seana P.Covello, Epithelial Genetics Group, Thomas Jefferson University, Philadelphia.
The non-helical linker regions possess different net charges, implying that ionic interactions between these regions on opposite molecules might play a part in stabilizing the filament (North et al., 1994). The neutral/basic LI linker separates the 1A and 1B subdomains of the rod (Figure 3.3) and consists of between 8–12 residues dependent upon filament type. The acidic linker LI2 separates the rod domain between the IB region and 2A (Figure 3.3). This linker is variable in length (16–22 residues) but shows some degree of sequence conservation between the intermediate filament types. The acidic linker L2, separating the 2A and 2B subdomains of the rod, is the shortest of the three linkers. It is uniform in length, consisting of 8 residues and shows sequence conservation
28 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Figure 3.2 Transmission electron micrograph of human epidermis, showing keratin filament bundles (black arrows) in the cytoplasm of epidermal keratinocytes. Also seen are desmosomes (white arrow), transmembrane complexes which connect the keratin networks of neighbouring cells. Magnification 35,000× approx. figure kindly provided by Dr John A.McGrath, St John’s Institute of Dermatology, St Thomas’s Hospital, London.
(North et al., 1994). The linker regions are thought to impart flexibility on the rod domain (Steinert, 1993). The 2B domain contains a “stutter”, which is a highly conserved discontinuity in the regularity of heptad periodicity in the coiled-coil, of unknown function (North et al., 1994; Steinert and Parry, 1985). The a-helical conformation is slightly distorted in the region of the “stutter”, which could represent a point of weakness within the coiled-coil, enabling it to bend (North et al., 1994). Alternatively, this helix inversion could be necessary to allow filament packing. These hypotheses cannot be formally proven without X-ray crystallographic data. At the amino terminal end of the central rod domain is a region termed the helix initiation motif and at the carboxy terminal end of the rod, the helix termination motif (Steinert, 1993) (red areas, Figure 3.3). These regions show striking sequence conservation among and between intermediate filament types (Conway and Parry, 1988). Conservation of these sequences indicates that they must play an important role in filament assembly (Steinert et al., 1993b; Wilson et al., 1992) (Figure 3.3). This is supported by the identification of mutations in these regions which have dramatic effects on filament assembly and function, as discussed below. The central a-helical region is flanked by a variable domain V1 at the amino-terminus and V2 domain at the carboxy-terminus (Hanukoglu and Fuchs, 1982; Weber and Geisler, 1982) (Figure 3.3). These domains are highly variable both in length and
KERATINS AND KERATIN DISORDERS 29
sequence, accounting for size differences specific for each keratin polypeptide. These domains usually contain tandem peptide repeats and are rich in serines and glycines (Korge et al., 1992; Steinert et al., 1985a). The type II keratins also possess short, complex sequences, H1 and H2 (homology) subdomains, which lie between the rod domain and the V1 and V2 domains, respectively (Steinert et al., 1985a). Mutations in the H1 domain of type II keratins have been shown to cause skin disease, as discussed below. keratins: Protein Domain Structure
Figure 3.3 Schematic diagram showing the protein domain organisation of the type I and type II keratins, a structure which is similar for all intermediate filament types. The a-helical coiled-coil rod domain, which is responsible for heteropolymerisation, consists of 4 subdomains, 1A, 1B, 2A and 2B, separated by non-helical linkers L1, L12 and L2. In helix 2B, is a stutter or discontinuity in the coiled-coil heptad repeats (S). The rod domain is flanked by globular V1 and V2 domains, which vary greatly in size and amino acid composition between keratins compared to the rod domains, which are well conserved in size and sequence. The most highly conserved sequences are the helix boundary motifs (shaded red), at the beginning and end of the rod domain and which are thought to be involved in molecular overlap interactions in filament assembly. Type II keratins have additional conserved features within their variable domains: the homology subdomains H1 and H2, which probably play a role in polymerisation; and the ISIS box, which is thought to be a site of interaction of keratins with other protein complexes.
In contrast to the rod domain, the head and tail regions show great variability not only between individual keratins, but also differ between the intermediate filament types (Geisler and Weber, 1982; Hanukoglu and Fuchs, 1983), reviewed in (Steinert and Parry, 1985; Steinert et al., 1985b). It has been proposed that these differences specify the function of the intermediate filament in which they are found (Steinert et al., 1985b). Experiments carried out to examine filament formation in vitro using the rod domain of desmin, have shown that this domain alone is incapable of forming lOnm filaments, indicating that the head and tail domains are required for polymerisation into mature filaments (Geisler et al., 1982). Studies involving expression of deleted keratin proteins, where either the head or tail domain had been deleted from one or both keratins, have revealed that one member of the heterotypic keratin pair requires an intact head and tail domain for normal filament assembly and elongation to occur (Lu and Lane, 1990). These studies showed that homotypic head/tail interactions of like polypeptides played an
30 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
important role in filament elongation. More recent investigations have pointed to a role for the type II head domain in elongation and lateral alignments/registration of neighbouring molecules, possibly mediated by HI, whereas the tail domains of type I and II keratins have been implicated in filament stabilization (Hatzfeld and Burba, 1994; Steinert and Parry, 1993; Wilson et al., 1992). An evolutionarily conserved nonapeptide motif within the head domain of vimentin (also found in desmin and peripherin) has been shown to be necessary in assembly of soluble tetramers into filaments (Herrmann et al., 1992). The amino acid sequence of the rod domain of an intermediate filament shows over most of its length, a heptad periodicity of hydrophobic residues at positions a and d of every seven (abcdefg). This periodicity is indicative of a protein that forms coiled-coil polymers (Crick, 1953); reviewed in (Cohen and Parry, 1986). A single polypeptide chain, which is predicted to assume a-helical structure is generally unstable in an aqueous environment due to the presence of hydrophobic or apolar residues within the molecule, as reviewed in (Cohen and Parry, 1986; Conway and Parry, 1991). Dimerisation of two a-helical molecules involves twisting of the two polypeptide chains together, placing the hydrophobic residues in a position protected from the aqueous environment, thus forming a stable coiled-coil molecule. Residues in positions e and g are charged and thought to be involved in interchain ionic interactions which stabilize the arrangement of two a-helices within the coiled-coil (Cohen and Parry, 1986). The polar hydrophilic residues b, c and f are located at the periphery of the coiled-coil, in contact with the aqueous environment. The importance of the stability of interations within the coiled-coil has been demonstrated in experiments where head and tail deleted keratin polypeptides were expressed within cultured fibroblasts. Interactions within the heterotypic coiled-coil protected the individual type I or type II keratin from proteolysis which occurs when a single type keratin is expressed alone. Keratins deleted in the head and/or tail regions were capable of resisting proteolysis in combination with a keratin of the opposite type (Lu and Lane, 1990). Keratins: the Type I and Type II Intermediate Filaments Studies on sheep wool proteins suggested that there were two groups of keratins (Parry et al., 1977). Fuchs and colleagues described the existence of two different classes of keratin genes (Fuchs et al., 1981), the type I and II intermediate filaments which constitute the largest fraction of the intermediate filament protein family, with >30 different human keratins described to date (Quinlan et al., 1994). Keratins contribute to the intermediate filament cytoskeleton within epithelial cells, forming a basket-like network around the nucleus in eukaryotic cells extending to the cell periphery, where they contact the plasma membrane through interaction with specific protein junctions, the hemidesmosomes (on the basal cell surface) and the desmosomes (at intercellular membrane sites). It is through interaction with the desmosomes that the intermediate filaments link the cells into a three dimensional structure, increasing mechanical integrity of individual cells and the tissue as a whole.
KERATINS AND KERATIN DISORDERS 31
The desmosomal component desmoplakin has been shown to associate directly through its carboxy terminal tail with the amino terminal head domain of several type II epidermal keratins (Kouklis et al., 1994). This association was not found with the simple epithelial type II keratins, the type I keratins or vimentin (Kouklis et al., 1994). It is the amino terminus of desmoplakin that targets the protein to the desmosome and the carboxy terminus which attaches intermediate filaments to the desmosomal plaque (Stappenbeck et al., 1993; Stappenbeck et al., 1994). Phosphorylation of a serine residue within the carboxy terminus of desmoplakin has been found to be likely to negatively regulate its interaction with keratin intermediate filament networks (Stappenbeck et al., 1994). Keratins are obligate heteropolymers (Hatzfeld and Franke, 1985; Lee and Baden, 1976; Steinert et al., 1976) and the first step in keratin filament assembly has been shown to be the formation of a coiled-coil type I/II heterodimer (Figure 3.4) (Hatzfeld and Weber, 1990; Steinert, 1990). Thus the obligatory heteropolymer step in keratin intermediate filament assembly occurs at the dimer stage and not during tetramer formation (Hatzfeld and Weber, 1990). This heterotypic association appears to be mediated by the α-helical rod domains, as deletions of the head and tail domains do not prevent this association (Lu and Lane, 1990). Within the coiled-coil dimer, the two molecules are parallel and in axial register, as reviewed in (Cohen and Parry, 1990; Steinert, 1993). Chemical cross-linking studies using the rod domain of desmin, capable of homopolymerisation, indicated that intermediate filament structure is based on a tetramer, composed of a dimer of two double stranded coiled-coils (Geisler and Weber, 1982). The tetramer is considered the most stable intermediate filament oligomeric species in vitro (Quinlan et al., 1984). The precise manner in which tetramers associate to form mature 1Onm filaments is not known with certainty, however the free tetramer is composed of two coiledcoil dimers which are thought to exist in an anti-parallel and staggered arrangement (Geisler et al., 1985; Meng et al., 1996; Steinert, 1993; Steinert et al., 1993a; Steinert et al., 1994; Stewart et al., 1989) (see Figures 3.3 & 3.4). This arrangement within the filament raises the possibility of a large number of interactions between adjacent molecules (Figure 3.4). Elongation involves end to end interactions of additional tetramers, with an overlap between the first 10–11 residues of the 1A region of one dimer and the last 10–11 residues of the 2B region of the other (emphasising the importance of the helix initiation and termination motifs) (Steinert, 1993; Steinert et al., 1993a; Steinert et al., 1994) (Figure 3.4). Higher orders of filament assembly have not been conclusively deduced, although protofilaments (2–3nm) and protofibrils are thought to assemble by longitudinal extension of laterally associated tetramers and “half-filaments” by longitudinal extension of oligomers containing 12–20 laterally associated dimers, as reviewed by (Lane, 1993; Quinlan et al., 1994; Steinert, 1993). Accuracy of the type I/II keratin pairing is thought to be important in terms of threedimensional quality of the keratin filament network within the cell (Lu and Lane, 1990). Type I keratins are acidic (K9–K20) and their genes have been found to map to chromosome 17q (Milisavljevic et al., 1996; Rosenberg et al., 1988), except for K18 which maps to the type II (K1–K8) keratin gene cluster (Waseem et al., 1990; Yoon et al., 1994) on chromosome 12q (Rosenberg et al., 1991). The keratins are designated as type I
32 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Figure 3.4 Potential domain alignments within keratin intermediate filaments, adapted from Steinert, 1993a; Steinert et al., 1993b; see also Meng et al., 1996. Cross-linking experiments (Steinert et al., 1993) have established four modes of alignment of two nearest neighbour molecules in the keratin intermediate filament. (A12) the two molecules are aligned antiparallel and in almost axial register. (A11) the two molecules are arranged anti-parallel to each other and staggered, bringing 1B sub-domains into approximate alignment. (A22) the two molecules are again anti-parallel and staggered to bring the 2B sub-domains into close alignment. Alignments A11 and A22 reveal the fourth mode (ACN), here two similarly directed molecules overlap so that the first 10 amino acid residues of 1A overlap with the last 10 amino acid residues of sub-domain 2B on the other molecule (revealing the importance of these conserved regions). Intermediate filament protein domain interactions (vimentin) were studied using the two-hybrid system (Meng et al., 1996). These studies indicated that the 1B sub-domains interact strongly with one another and that the 2B domains also interact strongly with each other. The A11 and A22 modes of alignment were considered to reveal true domain interactions, whereas the A12 and ACN modes may describe adjacent molecules within the filament, but not interacting molecules (as no interaction was found between different constructs containing the 1A or 2B domains).
or II according to their apparent molecular weight and isoelectric point in 2D gel electrophoresis (Moll et al., 1982). The differences in size between the type I and II keratins result from differing lengths of the amino and carboxy terminal regions of the proteins, rather than from significant insertions or deletions within the central rod domain (Hanukoglu and Fuchs, 1983). Keratins are generally expressed in specific pairs depending upon cell type, developmental stage, growth environment and differentiation or disease state of the cell (Lazarides, 1980; Sun et al., 1983; Sun et al., 1985). The tissue-specific expression
KERATINS AND KERATIN DISORDERS 33
Table 3.2 Cytokeratin expression patterns
*indicates that mutations in this keratin have been found to cause human disease.
patterns of human keratins are shown in Table 3.2. For example, keratins K5 and K14 are expressed in the basal cells of the epidermis (Moll et al., 1982; Purkis et al., 1990), although K15 may also be expressed to a lesser extent in these cells (Moll et al., 1982). As cells leave this layer and undergo differentiation, expression of K5 and K14 is downregulated, with increased expression of the keratin pair K1 and K10. In conjunction with K1/K10 expression, K2e (the epidermal form of K2) is expressed in the more superficial suprabasal cells (Collin et al., 1992). The amount of K1 and K10 within the cell increases as it becomes more suprabasal (Coulombe, 1993). In addition to the keratins discussed above, other keratins are also expressed in the epidermis, with the particular keratin expressed being dependent upon tissue location. K9 is a major keratin expressed suprabasally within palmar and plantar skin (Langbein et al., 1993). Keratins K6 and K16 are also found in sole and palm skin and are expressed in regions of the skin which are actively proliferating, for example during wound healing or in psoriasis (Weiss et al., 1984). The anterior corneal epithelium, a non-cornified stratified squamous epithelium, expresses K3 and K12 predominantly, with low levels of K5 and K14 expression within the basal cells (Sun et al., 1984). The non-stratified oesophageal mucosa specifically expresses K4 and K13 (Moll et al., 1982). The expression of two major epidermal keratins in human skin is shown in Figure 3.5.
34 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
MEDICAL ASPECTS OF KERATIN INTERMEDIATE FILAMENTS Mutations in Keratin Genes Cause a Wide Range of Human Diseases Since 1991, mutations have been found in 15 different epithelial keratin genes and two hair keratin genes causing a wide range of human diseases affecting the epidermis and various other epithelia. In each case the phenotype observed has been dependent upon the expression pattern of the defective keratin. All these disorders display keratinocyte fragility, demonstrating that a major function of keratin filaments is to enable epithelial cells to resist physical damage.
Figure 3.5 Indirect immunoperoxidase staining of human epidermis using antibodies against (a) keratin 1 (LH1) and (b) keratin 14 (RCK107). K14 expression is confined to the basal cell compartment (b), whereas K1 expression is found in all other (suprabasal) cell layers of the epidermis. The precise reasons for these striking comparmentalised keratin expression patterns in differentiated epithelia still remain a mystery but are presumed to indicate tissue-specific and/or differentiationspecific functions of the keratin cytoskeleton. Photographs courtesy of Declan P.Lunny, CRC Cell Structure Research Group, Department of Anatomy and Physiology, University of Dundee.
KERATINS AND KERATIN DISORDERS 35
Epidermolysis Bullosa Simplex Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited disorders characterised by skin blistering. There are three main forms of EB: junctional, dystrophic and simplex which were originally classified according to the level within the skin where the blister occurs (Fine et al., 1991). These can now be better classified according to which of the 10 known EB genes are involved, as reviewed by (Uitto et al., 1997). In EB simplex (EBS), the split is intraepidermal and cytolysis occurs within the basal keratinocyte, usually midway between the nucleus and the hemidesmosomes. Mutations in the K5 and K14 genes have been shown to underlie this form of EB. The identification of these mutations confirmed that the primary function of keratin filaments is structural, since these mutations lead to fragility of the tissue in which the mutant keratin is expressed.
Figure 3.6 Clinical appearance of the phenotypes arising from mutations in three major epidermal keratins, (a) The Dowling-Meara form of epidermolysis bullosa simplex (EBS-DM)—widespread epidermal blistering caused by mutations in or near the helix boundary motifs of basal cell keratins K5 or K14. (b) The thickened, hyperkeratotic skin of a patient with bullous congenital ichthyosiform erythroderma (BCIE), which can be caused by mutations in K1 or K10, the keratins expressed in all suprabasal layers of the epidermis. (c) Ichthyosis bullosa of Siemens (IBS), a mild epidermolytic ichthyosis caused by mutations in K2e, a keratin expressed only in high suprabasal layers of the epidermis. Thanks to Dr Alan D.Irvine, Department of Dermatology, Royal Victoria Hospital, Belfast; Dr Marion White, Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen; and Prof Irene M.Leigh, Academic Department of Dermatology, The Royal London School of Medicine and Dentistry, London, for providing these figures.
There are three main forms of EBS (Fine et al., 1991) which generally exhibit autosomal dominant inheritance. The Dowling-Meara form (EBS-DM) is considered to be the most severe, with blisters clustered at any body site as a result of mild physical trauma (Fine et al., 1991). The clinical appearance of EBS-DM is shown in Figure 3.6. A widespread distribution but less severe blistering is associated with the Köbner form of EBS (EBS-K). The mildest variant, Weber-Cockayne EBS (EBS-WC), causes blistering localized to the hands and feet, the major trauma sites of the epidermis (Fine et al., 1991). Electron
36 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Figure 3.7 Transmission electron micrograph of epidermis from a patient with bullous congenital ichthyosiform erythroderma (BCIE), the phenotype due to K1 or K10 mutations shown in Fig. 3.6b. The basal cells at the bottom of the figure, in contact with the basement membrane (arrowheads), do not express K1 or K10 and therefore have normal appearing keratin filaments (compare Fig. 3.2). In contrast, all the upper suprabasal cells can be seen to contain dense filament aggregates due to the mutant keratin expression (arrows) and consequently are undergoing cytolysis. The scale bar represents 5µm. Thanks to Prof Robin A.J.Eady and Dr Akemi IshidaYamamoto, St John’s Institute of Dermatology, St Thomas’s Hospital, London for providing this illustration.
microscopy of biopsy material from EBS-DM patients revealed keratin filament collapse within basal keratinocytes, leading to the formation of electron-dense aggregates within the cytoplasm. Immuno-electron microscopy revealed that these aggregates contained K5 and K14 (Ishida-Yamamoto et al., 1991), suggesting these keratins as candidate genes for EBS. Expression of mutant keratins in cultured cells had been shown to produce similar keratin aggregates (Albers and Fuchs, 1987; Albers and Fuchs, 1989). Filament aggregation can also be seen by EM in many other keratin disorders. Typical tonofilament aggregates are shown in Figure 3.7, in the skin of a patient carrying a K1 mutation. Expression of a truncated K14 gene in the skin of transgenic mice where more than 30% of the rod domain and all of the V2 domain had been replaced by a lacZ fusion protein, led to a phenotype resembling EBS (Vassar et al., 1991). Like EBS-DM, electron
KERATINS AND KERATIN DISORDERS 37
microscopy showed the presence of electron dense aggregates within basal keratinocyte cytoplasm (Vassar et al., 1991). Mice in which only 50 amino acids had been removed from the carboxy terminus of the protein displayed no skin blistering or basal cell cytolysis, although keratin aggregates were seen in some basal cells. This showed that phenotypic severity can depend on the particular mutation involved (Vassar et al., 1991). Further transgenic experiments revealed that different K14 mutations could generate phenotypes of mild and severe blistering in mice (Coulombe et al., 1991b). Linkage analysis provided further support to K5 and K14 as candidate genes for EBS. Genetic linkage mapped the EBS-K gene to the type I keratin gene cluster on chromosome 17q and later, the causative mutation in this family (L384P) was discovered within the 2B segment of the K14 rod domain (Bonifas et al., 1991a; Bonifas et al., 1991b). Mutations encoding different amino acid substitutions within the same codon in K14 (R125H/ R125C) were also identified in EBS-DM cases (Coulombe et al., 1991a). These mutations involved the 125th amino acid, located within the highly conserved helix initiation motif of the K14 polypeptide (Coulombe et al., 1991a). Arginine 125 is the 10th codon within the 1A domain and contains a CpG sequence which is conserved in most type I keratins (McLean and Lane, 1995). Many mutations have now been found to affect analogous residues in different keratins, showing this to be a mutation hot spot. The first mutation in K5 was revealed in a large family with EBS-DM. This mutation was found within the helix termination motif of the K5 helix 2B domain (Lane et al., 1992). Mutations in the K5 and K14 genes associated with EBS-WC soon followed (Chan et al., 1993; Humphries et al., 1993; Rugg et al., 1993). Mutations in the milder forms of EBS have been found to occur outside the highly conserved helix boundary motifs and filaments examined by electron microscopy appear normal (McLean and Lane, 1995). To date, there have been numerous reports of mutations in the K5 and K14 genes in dominant EBS families, reviewed (Corden and McLean, 1996). Pre-natal diagnosis has now been carried out for the Dowling-Meara form of EBS, using PCR amplification and sequencing of genomic DNA (Rugg et al., 1997). More recently a heterozygous point mutation, P25L, was found in the non-helical V1 domain of K5 in individuals from a number of unrelated families with EBS with mottled pigmentation (EBS-MP) (Irvine et al., 1997b; Uttam et al., 1996). Although keratin aggregates are not characteristic of this disorder, organelle distribution was reportedly aberrant in the basal keratinocytes from affected individuals (Uttam et al., 1996). Filament assembly studies carried out in vitro with the mutant K5 revealed subtle effects on the length of the 10nm keratin filaments. Expression of the mutant K5 within transfected PtK2 cells which express K8 and K18, produced keratin filament networks indistinguishable from wild-type (Uttam et al., 1996). How a mutation within this domain acts to weaken the keratin filaments is unknown but it indicates a subtle, previously undetected role for the V1 domain in filament dynamics. It is also unknown how this mutation leads to pigmentary changes, however the slight change in the keratin network within keratinocytes may influence longevity of the melanin granules, or possibly efficiency of melanin transfer from the melanocytes (Uttam et al., 1996).
38 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Recessive Forms of EBS—Nature’s Gene Knockout Experiments Reports of recessive EBS are less common than those exhibiting autosomal dominant inheritance, due to the requirement of two mutant alleles in order for the phenotype to be displayed. One inbred kindred has been described with a very mild recessive form of Weber-Cockayne EBS (Hovnanian et al., 1993). Sequence analysis of affected individuals revealed a homozygous point mutation (E144A) within the 1A domain of K14, outside the helix initiation motif. Heterozygous carriers of this mutation were clinically normal. There has been no other report of a mild recessive form of EBS such as this to date. This may be due to the mild phenotype which may seldom present clinically and/or the rarity of recessive EBS. Following this paper describing a kindred with a mild form of recessive EBS, came two reports of recessive EBS where affected individuals had severe generalised blistering due to complete ablation of K14 expression (Chan et al., 1994; Rugg et al., 1994). In both cases electron microscopy revealed a lack of tonofilament bundles within the basal keratinocyte cytoplasm of affected individuals. K5 was detectable by immunohistochemistry, immuno-electron microscopy and immunoblotting, but K14 expression was completely absent. These patients were clinically described as EBSKöbner, however disease severity was comparable to EBS-DM. In one kindred, the affected individual was the offspring from a consanguineous marriage, with a homozygous 2-nucleotide deletion mutation (313de12). This mutation led to the formation of a premature termination codon, with predicted truncation of K14 within the V1 domain (Rugg et al., 1994). Nonsense-mediated decay of K14 mRNA within the patient’s skin is thought to have rendered the message unde tec table. Simultaneously, there was a report of a child from a consanguineous marriage with a homozygous nonsense mutation (Y204X) in K14 (Chan et al., 1994). This mutation led to a premature termination codon within the 1B domain of K14 and expression of the K14 protein was again undetectable. The phenotype of the affected individual in this second kindred was very similar to the affected individual described by Rugg and colleagues. These two reports described the first “knockouts” of a major epidermal keratin in humans, however, K14 was subsequently ablated in mice by gene targeting. Lack of K14 in homozygous mice was found to be fatal by three months of age. Fatality was not caused by the skin blistering itself which recovered at the time of hair growth, but by oesophageal damage (Lloyd et al., 1995). From these results in K14 “knockout” mice, prognosis for the recessive EBS patients (Chan et al., 1994; Rugg et al., 1994) was expected to be poor. Two other severe recessive EBS families have since been described with the causative mutation again leading to ablation of K14 expression, due to a homozygus splicing mutation (Jonkman et al., 1996) and a homozygous nonsense mutation (Corden et al., 1998). In the family described by Jonkman and colleagues, (Jonkman et al., 1996), there were two elderly affected persons. This showed that the prognosis for K14 knockout in humans is much better than in mice, illustrating that caution should be used in predicting human phenotypes based on mouse models. There have been no recessive mutations published in the K5 gene to date.
KERATINS AND KERATIN DISORDERS 39
In all of the above kindreds affected by severe, generalised recessive EBS, the heterozygous individuals do not display the disease phenotype. This indicates that expression from one normal allele is sufficient for normal keratin function. In terms of gene therapy for such recessive forms of EBS, this implies that introduction of one normal allele into the keratinocytes of the homozygous affected individuals should be sufficient to rescue the disease phenotype. Mutations in K1 and K10 Cause The Skin Thickening Disease BCIE Bullous congenital ichthyosiform erythroderma (BCIE), also known as epidermolytic hyperkeratosis (EH), was the second disease affecting the skin for which mutations in keratin genes were found. BCIE is characterised by blistering and erythroderma, which develop in infancy, and the onset of severe generalised epidermolytic hyperkeratosis in adulthood. The skin of an adult with BCIE is shown in Figure 3.6b. By EM, the basal cells of the epidermis appear normal in comparison to EBS skin, however there is suprabasal cytolysis, as shown in Figure 3.7. Tonofilament aggregates within the suprabasal cells of patients affected by BCIE were found to label with K1 and K10 antibodies (IshidaYamamoto et al., 1992). Transgenic mice were engineered, expressing a mutant K10 gene with a phenotype resembling BCIE/EH (Fuchs et al., 1992) and genetic linkage of this disorder to the type II keratin gene cluster on chromosome 12q was demonstrated (Bonifas et al., 1992; Compton et al., 1992). Subsequently, mutations were found in the K1 and K10 genes (Cheng et al., 1992; Chipev et al., 1992; Rothnagel et al., 1992). Like those found to cause EBS-DM, these mutations clustered in or near the highly conserved helix boundary motifs of K1 and K10. Further mutations have been published within the helix boundary motifs in association with BCIE/EH, reviewed by (Corden and McLean, 1996) and PCR-based prenatal diagnosis has been carried out (Rothnagel et al., 1994a). BCIE can also occur as a nevoid condition, where epidermolytic hyperkeratosis follows the lines of Blaschko. Heterozygous K10 point mutations, similar to other mutations causing classic BCIE, have been detected in the affected skin of several nevoid cases. However no mutation was found within unaffected skin from these individuals, indicating that this condition may be explained by a post-zygotic mutation occurring early in development (Moss et al., 1995; Paller et al., 1994). It is important to note that the offspring of individuals with epidermal nevi may suffer from generalised BCIE/EH, if the cell line containing the keratin mutation contributes to the germline of the parent. It is not yet understood why a defective keratin cytoskeleton should lead to hyperkeratosis (Williams and Elias, 1993), although it is thought that the cytolysis of suprabasal cells leads to cytokine release, which causes over-proliferation of the basal cell layer beneath (Stoof et al., 1994). All of the keratin diseases reported to date involve some degree of hyperkeratosis, although less evident in EBS where the basal cell compartment is destroyed through cytolysis. Nevertheless, palmoplantar hyperkeratosis can accompany EBS-DM (Chan et al., 1996) and epidermolytic hyperkeratosis of other body sites has been seen in recessive EBS (Jonkman et al., 1996). It has previously been reported that a K5/
40 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
K14 network is a pre-requisite for the formation of a normal K1/K10 network, which might explain how mutations in K5/K14 could have a detrimental effect in suprabasal cells (Kartasova et al., 1993). Alternate Phenotypes Caused by K1 Mutation One family with diffuse non-epidermolytic palmoplantar keratoderma (NEPPK) has been reported with a missense mutation outside the K1 rod domain (Kimonis et al., 1994). This mutation occurs within the ISIS box, a 22 amino acid motif conserved within the V1 domain of several type II keratins (Kimonis et al., 1994). The lysine to isoleucine substitution generated by this mutation, occurs in an invariant lysine residue within the ISIS box consensus sequence. This lysine residue in the type II keratins has been found to be frequently involved in the formation of intermolecular cross-links during cornified cell envelope formation (Marekov and Steinert, 1995). The ISIS box sequence within the amino terminal head of type II keratins is thought to be involved in binding of the desmoplakin tail (Kouklis et al., 1994), and so the K73I mutation may act by interfering with the interaction of K1 with other molecules. Ichthyosis Bullosa of Siemens and K2e Mutations Ichthyosis bullosa of Siemens (IBS) is a type of mild epidermolytic ichthyosis localised mainly on the flexures (Siemens, 1937). The outer layers of the epidermis undergo a characteristic moulting/shedding, not seen in patients with EH/BCIE (Siemens, 1937). In a number of kindreds, IBS was found to be linked to the type II keratin gene cluster on chromosome 12q (Steijlen et al., 1994). Tonofilament aggregation and cytolysis are both characteristic of this disorder, but these phenomena are restricted to the upper spinous and granular layers of the epidermis, unlike BCIE (McLean et al., 1994). K2e expression was found to closely mirror the distribution of affected cells in IBS (Collin et al., 1992), which suggested that this was a candidate gene for this disease. Mutations were initially found in the K2e gene in six families affected with IBS, although two of the families were mis-diagnosed as having EH (Rothnagel et al., 1994b). These mutations affected codon 493 within the helix termination motif of K2e (Rothnagel et al., 1994b). Five of the mutations were identical (E493K), and are likely to represent a hot spot for mutations within this gene, involving a CpG dinucleotide. Further cases of this E493K mutation have been found, as well as other mutations in both helix boundary motifs, reviewed by (Corden and McLean, 1996). K9 Mutations Cause EPPK—Fragility of Palm and Sole Skin Epidermolytic palmoplantar keratoderma (EPPK) is an autosomal dominant skin disorder characterised by diffuse thickening of the epidermis on the entire palmar and plantar surfaces, bounded by erythematous margins (Vörner, 1901). The expression of K9 specifically within the suprabasal keratinocytes of the palm and sole led to this gene becoming the candidate for EPPK (Langbein et al., 1993). The gene for EPPK was initially mapped
KERATINS AND KERATIN DISORDERS 41
to the type I keratin gene cluster on 17q12–21 in a large German kindred (Reis et al., 1992). Reis and colleagues then went on to discover three different mutations within the K9 gene, all in the helix initiation motif (Reis et al., 1994). One mutation was found in five unrelated kindreds (R162W), the type I keratin CpG hotspot mutation in the helix initiation motif (McLean and Lane, 1995). Further mutations have been found within the K9 gene, all involving the 1A rod domain, as reviewed (Corden and McLean, 1996). Pachyonychia—Thick Nails due to Mutations in K6a, K6b, K16 & K17 Pachyonychia congenita (PC) is a group of autosomal dominant ectodermal dysplasias characterised by hypertrophie nail dystrophy with various constellations of other ectodermal abnormalitites. There are two main sub-types of PC (McKusick, 1998). The Jadassohn-Lewandowsky variant or type 1 (PC-1) involves pachyonychia in conjunction with severe non-epidermolytic palmoplantar hyperkeratosis, hyperhidrosis, infrequent blistering, oral leucokeratosis and follicular keratoses (Jadassohn and Lewandowsky, 1906). The Jackson-Lawler form or PC-2, has minor oral involvement but displays multiple pilosebaceous cysts (Jackson & Lawler, 1951). This form of the disease may also be associated with pili torti (twisted hairs), natal teeth (some teeth prematurely erupted at birth) and other ectodermal abnormalities (McLean et al., 1995). The fingernails of a patient with PC-1, carrying a mutation in K6a, are shown in Figure 3.8. Genetic linkage to the type I keratin gene cluster was obtained in a large Scottish kindred with PC-2 (Munro et al., 1994). The mutation in this family was found to be a heterozygous missense mutation N92D in the K17 gene (McLean et al., 1995). A missense mutation L130P was simultaneously reported in the K16 gene, in an individual with sporadic PC-1 (McLean et al., 1995). Both of these mutations occur within the highly conserved helix initiation motif of the specific type I keratin. Further K17 mutations have been reported in PC-2 kindreds and also in families diagnosed with steatocystoma multiplex (Covello et al., 1998; Smith et al., 1997). Kl6 mutations have been found in families suffering from focal non-epidermolytic palmoplantar keratoderma (FNEPPK) and extremely subtle nail changes were found in the affected individuals (Shamsher et al., 1995). Mutations were subsequently reported in PC-1 cases in K6a, the type II keratin partner of K16 (Bowden et al., 1995; Smith et al., 1998b). One surprising result has emerged from the study of PC-2. K17 was not known to be specifically expressed in conjunction with any other keratin and was thought to polymerise with K5 in basal cells and K6 or another type II protein, when expressed suprabasally (Lane, 1993). Thus, there was no type II keratin in which mutations could be predicted to produce a PC-2 phenotype and many PC-2 families were shown to have K17 defects, further implying genetic homogeneity. However, a PC-2 family was recently identified where no K17 mutation could be found, but genetic linkage was obtained to markers in the type II keratin cluster and subsequently, a mutation was identified in K6b (Smith et al., 1998a). The PC-2 phenotype in the K6b family was very similar to individuals carrying K17 mutations. K17 and K6b were shown to be co-expressed in many epidermal appendages, confirming that these proteins are expression partners in general,
42 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
although they differed in a few places (Smith et al., 1998a). Thus, the study of this keratin disorder revealed the previously undiscovered role of K6b in epithelial biology. There are at least six highly homologous copies of the K6 gene (K6a–f), at least four of which are expressed (Takahashi et al., 1995). To date, mutations are known in only two of these genes, K6a and K6b. It is not yet known what phenotypes might arise from mutations within the remaining expressed K6 isogenes. K4 and K13 Mutations Cause Fragility of Mucosal Tissues White sponge nevus of Cannon (WSN) is an autosomal dominant disorder which affects non-cornifying stratified squamous epithelia (McKusick, 1998). White “spongy” plaques are found in the mouth, as seen in Figure 3.8, and to a lesser extent in the oesophagus and anogenital mucosa (Jorgenson and Levin, 1981). As K4 and K13 are specifically expressed within these tissues, they became the candidate genes for this disorder (Moll et al., 1982). Two Scottish families were found to carry a mutation in K4 (Rugg et al., 1995) and the complementary mutation in K13 was published simultaneously (Richard et al., 1995). Mutations in these two genes were the first found to affect a tissue other than the epidermis and its appendages. K18 Mutation May Cause Liver Disease Predisposition Expression of K18 carrying a missense mutation in the 1A domain was found to produce filament aggregation (Ku et al., 1995). Transgenic mice expressing mutant K18 developed chronic hepatitis and hepatocyte fragility (Ku et al., 1995). These experiments indicated that liver defects within humans might also be caused by mutations in either of the simple epithelial keratins, K8 or K18. One heterozygous K18 mutation has been published, H127L, which affects the last amino acid of the L1 domain and is believed to predispose towards or be responsible for the development of cryptogenic cirrhosis within the patient (Ku et al., 1997). Mutations in this domain, which is less well conserved at the sequence level and whose function is currently unclear, have not been reported in any other keratin disorder. However, in vitro assembly studies with this K18 mutant showed defective filaments by electron microscopy, giving some indication that this mutation may be pathogenic (Ku et al., 1997). Monilethrix—Beaded Hair Due to Mutations in Hair Keratins Monilethrix is an autosomal dominant hair disorder showing variable phenotype (Winter et al., 1997a; Winter et al., 1997b). Hairs from affected individuals have a characteristic beaded appearance and so trichocyte hair keratins were good candidate genes. The first monilethrix mutations were found in the type II hair cortex keratin, hHb6. Again, these mutations involved amino acid substitution in the helix termination motif (Winter et al., 1997b). A mutation in another type II hair keratin, hHbl, also in the helix termination
KERATINS AND KERATIN DISORDERS 43
Figure 3.8 Clinical appearance of three diverse disorders of differentiation-specific keratins, (a) The hypertrophie nail dystrophy which is a major characteristic of pachyonychia congenita type PC-1 and PC-2, seen here in a PC-1 patient with a K6a mutation. Mutations in four keratins, K6a, K6b, K16 and K17 produce variants of this disease, (b) The buccal hyperkeratosis seen in white sponge nevus syndrome (WSN), due to mutations in mucosal keratins K4 or K13. (c) Retroillumination slit lamp photo-graph of microcysts within the corneal epithelium (arrows) in a patient with Meesmann’s corneal dystrophy (MCD), caused by mutations in keratins K3 or K12. Thanks to Dr Kevin McKenna, Department of Dermatology, Craigavon Area Hospital, Northern Ireland; Dr Colin Munro, Department of Dermatology, Southern General Hospital, Glasgow and Drs Ole and Beate Swensson, Departments of Dermatology and Ophthalmology, Christian-AlbrechtsUniversität, Kiel, Germany for kindly providing these illustrations.
44 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
motif, has been described in a family with monilethrix (Winter et al., 1997a), as well as further mutations in hHb6 (Korge et al., 1998). Focusing on K3 and K12 Mutations in Meesmann’s Corneal Dystrophy The anterior epithelium of the cornea is the outermost protective layer of the eye and consists of about four layers of stratified, non-cornified keratinocytes which predominantly express cornea-specific keratins K3 and K12 (Schermer et al., 1986). Given that mutations in epidermal keratins produce skin fragility disorders, it was logical to think that mutations in K3 or K12 would produce a corneal fragility disease. At the end of 1996, our group considered the corneal dystrophies, of which there are many types (Grayson, 1983), as candidates for K3 and K12 mutations. However, Meesmann’s corneal dystrophy (MCD), a clinically mild disorder characterised by fragility of the anterior corneal epithelium (Meesmann and Wilke, 1939), seemed to be the best candidate for a variety of reasons. Firstly, it is autosomal dominant, like most of the keratin diseases. Secondly, MCD affects only the anterior corneal epithelium, the single tissue where K3 and K12 are specifically expressed. Thirdly, there had been a number of ultrastructural reports of intracellular aggregates of unknown composition in MCD corneocytes (Tremblay and Dube, 1982). Although there had been no suggestion in the literature that these were keratin aggregates, this was nevertheless a valuable clue. The clinical appearance of an MCD cornea, myriads of microcysts seen by slit-lamp examination, is shown in Figure 3.8. Analysis of two Northern Irish families and a large pedigree representing the descendants of Meesmann’s original German family gave positive genetic linkage to the keratin loci on chromosomes 12 and 17 (Irvine et al., 1997a). Mutations were found in the helix boundary motifs of both K3 and K12 in these initial families (Irvine et al., 1997a). Further K12 mutations have also been reported in Japanese MCD kindreds (Nishida et al., 1997). Overall, these results revealed the role of K3 and K12 in maintaining the structural integrity of corneal keratinocytes as well as the underlying molecular pathology in MCD. THE FUTURE OF KERATIN GENETICS RESEARCH More Keratins, More Associated Molecules, More Diseases Since the discovery of the first human keratin mutations at the end of 1991, a large part of the mutation-based research has been focused on the identification of further keratin diseases and in determining the complete range of mutations which are pathogenic in keratins. There are two main outcomes from this research. Firstly, there are now 17 keratins known in human disease and this list will probably continue to grow until there is a genetic disease association for all keratins. Secondly, certain molecular features of keratins have come to light as being structurally important due to the emergence of mutation clusters in these regions, as shown in Figure 3.9. This has been particularly
KERATINS AND KERATIN DISORDERS 45
surprising in some cases, such as the mutations in the linker region L12 of K5 and K14 in mild forms of EBS (Rugg et al., 1993); the discovery of the ISIS motif due to NEPPK mutation in K1 (Kimonis et al., 1994); and mutations at the start of the V1 domain of K5 in EBS-MP (Irvine et al., 1997b; Uttam et al., 1996). Further mutation clusters may emerge with the study of more mutations, particularly in EBS, which might shed light on the structural interactions of intermediate filament molecules. It is interesting to note that outside of K5 and K14 in EBS, most mutations in all other keratins have been found only in or near the helix boundary motifs, reviewed in (Corden and McLean, 1996). One explanation for this anomaly is that subtle mutations in the keratins of basal cells are not tolerable compared to other epithelia, perhaps because other epithelia express more keratin pairs, which might have a dilution effect of the mutant polypeptide. Alternatively, it may well be that mild mutations in other keratins produce more subtle phenotypes which have not yet been identified clinically. Another area for future research in this field is the study of pathogenic mutations in keratin-associated proteins. There are many molecules involved in the anchorage of the intermediate filament cytoskeleton to transmembrane plaques and other subcellular systems, as discussed elsewhere in this book. Of these, only two molecules have so far been shown to have human disease associations, plectin and plakophilin 1 (McGrath et al., 1997; McLean et al., 1996; Smith et al., 1996). In both cases, invaluable information on the biological role of these molecules has been a direct consequence of the disease studies. Although plectin is very widely expressed in both epithelial and non-epithelial tissues, loss of the protein in humans produces only skin blistering and muscle disease, showing that its function is vital only in the context of these tissues. Similarly, through the discovery of plakophilin 1 mutations in a human ectodermal dysplasia, this protein has been shown to be a key player in mediating the connection of keratins to the cytoplasmic side of the desmosomal plaque. Future years will undoubtedly see the discovery of human mutations in further keratin-associated proteins.
Prevention and Therapy of Keratin Diseases Although the study of keratin diseases has been valuable in understanding the basic biology of these protein systems, this work has also enhanced patient care for these disorders through the application of molecular diagnostic techniques. Some keratin diseases, such as MCD or WSN are so mild in their effects that demand for prenatal testing is low. In other disorders with more devastating phenotypes, such as EBS-DM and BCIE, affected families do request prenatal testing. In these cases, knowledge of the mutation in a particular family allows prenatal diagnosis by chorionic villus biopsy to be done at a very early stage of pregnancy. These preventative measures for severe keratin disorders are of no use in prevention of the sporadic mutations which account for many cases of keratin disease and so there will always be a need for improved treatment. Gene therapy is made doubly difficult in the case of keratins since most mutations are dominant-acting, so that gene
Figure 3.9 Clustring of dominant-negative mutations in all keratin diseases within the type I and II protain domain structures. actual numbers of mutations per domain are shown, as of mid-1998. Red bar indicate mutations affecting the helix boundery motif sequences, which can be seen to be mutation hotspots. Mutations outside these highly conserved regions have been shown to result in milder desease phenotypes.
Keratin Dominant-Negative Mutation Clusters
46 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
KERATINS AND KERATIN DISORDERS 47
deactivation rather than replacement therapy must be developed. Despite these difficulties, some research groups are currently engaged in the search for novel gene therapy agents for dominant genetic diseases (Millington-Ward et al., 1997; Montgomery and Dietz, 1997). The increasing body of knowledge of both the genetics and the basic biochemistry of keratins, together with advances in gene therapy for other genetic diseases, should lead to improved treatment for keratin disorders in the new millenium. ACKNOWLEDGEMENTS Thanks to our many friends who provided figures. Original work from this group was supported by grants from The Wellcome Trust (037444/A/93/Z, to E.B. Lane, I.M.Leigh and R.A.J.Eady) ; Cancer Research Campaign (grant SP2060, to E.B.Lane); The Dystrophic Epidermolysis Bullosa Research Associations (DEBRA) of U.K. and America (WHIM); and by the U.S. Public Health Service, National Institutes of Health (grant PO1-AR38923, to J.Uitto). The authors are currently supported by a Wellcome Trust Senior Research Fellowship (to WHIM) and grants from DEBRA UK (WHIM). REFERENCES Albers, K., and Fuchs, E. (1987) The expression of mutant epidermal keratin cDNAs transfected in simple epithelial and squamous cell carcinoma lines. J.Cell BioL, 105, 791–806. Albers, K., and Fuchs, E. (1989) Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments. J. Cell Biol, 108, 1477–1493. Bonifas, J.M., Bare, J.W., Chen, M.A., Lee, M.K., Slater, C.A., Goldsmith, L.W. and Epsteinjnr, E.H. (1992) Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type II keratin gene cluster on chromosome 12. J. Invest. Dermatol, 99, 524–527. Bonifas, J.M., Rothman, A.L. and Epstein, E. (1991a) Linkage of epidermolysis bullosa simplex to probes in the region of keratin gene clusters on chromosomes 12q and 17q. J. Invest. Dermatol., 96, 550a. Bonifas, J.M., Rothman, A.L. and Epstein, E.H. (1991b) Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science, 254, 1202–1205. Bowden, P.E., Haley, J.L., Kansky, A., Rothnagel, J.A. Jones, D.O. and Turner, R.J. (1995) Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat. Genet., 10, 363–365. Chan, Y., Anton-Lamprecht, I., Yu, Q.C., Jäckel, A., Zabel, B., Ernst, J.P. and Fuchs, E. (1994) A human keratin 14 “knockout”: the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev., 8, 2574–2587. Chan, Y.-M., Yu, Q.-C., Fine, J.-D. and Fuchs, E. (1993) The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U.S.A., 90, 7414–7418. Chan, Y.M., Cheng, J., Gedde-Dahl, T., Niemi, K.M. and Fuchs, E. (1996) Genetic analysis of a severe case of Dowling-Meara epidermolysis bullosa simplex. J. Invest. Dermatol., 106, 327–334. Cheng, J., Syder, A.J., Yu, Q.-C., Letai, A., Paller, A. and Fuchs, F. (1992) The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell, 70, 811–819.
48 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Chipev, C.C., Korge, B.P., Markova, N., Bale, S.J., DiGiovanna, J.J., Compton, J.C. and Steinert, P.M. (1992) A leucine-proline mutation in the HI subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell, 70, 821–828. Cohen, C., and Parry, D.A.D. (1986) -helix coiled coils—a widespread motif in proteins. Trends Biochem. Sci., 11, 245–248. Cohen, C., and Parry, D.A.D. (1990) a-helical coiled-coils and bundles: How to design an -helical protein. Proteins, 7, 1–15. Collin, C., Moll, R., Kubicka, S., Ouhayoun, J.-P. and Franke, W.W. (1992) Characterization of human cytokeratin 2, an epidermal cytoskeleton protein synthesized late during differentiation. Exp. CellRes., 202, 132–141. Compton, J.G., DiGiovanna, J.J., Santucci, S.K., Kearns, K.S., Amos, C.I., Abangan, D.L., Korge, B.P., McBride, O.W., Steinert, P.M. and Bale, SJ. (1992) Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q. Nat. Genet., 1, 301–305. Conway, J.F., and Parry, D.A.D. (1988) Intermediate filament structure: 3. Analysis of sequence homologies. Int.J. BioL Macromol, 10, 79–98. Conway, J.F., and Parry, D.A.D. (1991) Three-stranded -fibrous proteins: 3. Analysis of sequence homologies. Int.J. Biol Macromol, 13, 14–16. Corden, L.D., and McLean, W.H.I. (1996) Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp. Dermatol., 5, 297–307. Corden, L.D., Mellerio, J.E., Gratian, M.J., Eady, R.A.J., Harper, J.I., Lacour, M., Magee, G., Lane, E.B., McGrath, J.A. and McLean, W.H.I. (1998) Homozygous nonsense mutation in helix 2 of K14 causes severe recessive epidermolysis bullosa simplex. Hum. Mutation, 11, 279–285. Coulombe, P.A., Hutton, M.E., Letai, A., Hebert, A., Palier, A.S. and Fuchs, E. (1991a) Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analysis. Cell, 66, 1301–1311. Coulombe, P.A., Hutton, M.E., Vassar, R. and Fuchs, E. (1991b) A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J. Cell Biol., 115, 1661–1674. Coulombe, P.E. (1993) The cellular and molecular biology of keratins: beginning of a new era. Curr. Opin. Cell Biol 5, 17–29. Covello, S.P., Smith, F.J.D., Sillevis Smitt, J.H., Paller, A., Munro, C.S., Jonkman, M.F., Uitto, J. and McLean, W.H.I. (1998) Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br.J. Dermatol, 139, 475–480. Crick, F.H.C. (1953) The packing of -helices: simple coiled-coils. Acta Chrystall., 6, 689–697. Fine, J.D., Bauer, E.A., Briggaman, R.A., Carter, D.M., Eady, R.A.J., Esterly, N.B., Holbrook, K.A., Hurwitz, S., Johnson, L., Lin, A., Pearson, R. and Sybert, V.P. (1991) Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: a consensus report by the subcommittee on diagnosis and classification of the national epidermolysis bullosa registry. J. Am. Acad. Dermatol, 24, 119–135. Fuchs, E., Coppock, S.M., Green, H. and Cleveland, D.W. (1981) Two distinct classes of keratin genes and their evolutionary significance. Cell, 27, 75–84. Fuchs, E., Esteves, R.A. and Coulombe, P.A. (1992) Transgenic mice expressing a mutant K10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc. Natl. Acad. Sci. U. S. A., 89, 6906–6910.
KERATINS AND KERATIN DISORDERS 49
Geisler, N., Kaufmann, E. and Weber, K. (1982) Protein chemical characterization of three structurally distinct domains along the protofilament unit of desmin 10 nm filaments. Cell, 30, 277–286. Geisler, N., Kaufmann, E. and Weber, K. (1985) Antiparallel orientation of the two doublestranded coiled coils in the tetrameric protofilament unit of intermediate filaments. J. Molec. Biol, 182, 173–177. Geisler, N., and Weber, K. (1982) The amino acid sequence of chicken muscle desmin provides a common structural model for intermediate filament proteins. EMBO J., 1, 1649–1656. Grayson, M. (1983) Dystrophies, In, Ed.), Diseases of the cornea., The C.V. Mosby Company, St Louis, pp. 237–324. Hanukoglu, I., and Fuchs, E. (1982) The cDNA sequence of a human epidermal keratin: Divergence of sequence but conservation of structure among intermediate filament proteins. Cell, 31, 243–252. Hanukoglu, I, and Fuchs, E. (1983) The cDNA sequence of a type II cytoskeletal keratin reveals constant and variable structural domains among keratins. Cell,33, 915–924. Hatzfeld, M., and Burba, M. (1994) Function of type I and type II keratin head domains: their role in dimer, tetramer and filament formation. J. Cell Sci., 107, 1959–1972. Hatzfeld, M., and Franke, W.W. (1985) Pair formation and promiscuity of cytokeratins: Formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations and purified polypeptides . J Cell Biol., 101, 1826–1841. Hatzfeld, M., and Weber, K. (1990) The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: Use of site-specific mutagenesis and recombinant protein expression. J. Cell Biol., 110, 1199–1210. Herrmann, H., Hofmann, I. and Franke, W.W. (1992) Identification of a nonapeptide motif in the vimentin head domain involved in intermediate filament assembly. J Molec. Biol., 223, 637–650. Hovnanian, A., Pollack, E., Hilal, L., Rochat, A., Prost, C., Barrandon, Y. and Goosens, M. (1993) A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nat. Genet., 3, 327–332. Humphries, M.M., Sheils, D.M., Farrar, G.J., Kumar-Singh, R., Kenna, P.F., Mansergh, F.C., Jordan, S.A., Young, M. and Humphries, P. (1993) A mutation (Met-to-Arg) in the type I keratin (K14) gene responsible for autosomal dominant epidermolysis bullosa simplex. Hum. Mutat., 2, 37–42. Irvine, A.D., Corden, L.D., Swensson, O., Swensson, B., Moore, J.E., Frazer, D.G., Smith, F.J.D., Knowlton, R.G., Christophers, E., Rochels, R., Uitto, J. and McLean, W.H.I. (1997a) Mutations in cornea-specific keratins K3 or K12 cause Meesmann’s corneal dystrophy. Nat. Genet., 16, 184–187. Irvine, A.D., McKenna, K.E., Jenkinson, H. and Hughes, A.E. (1997b) A mutation in the VI domain of keratin 5 causes epidermolysis bullosa simplex with mottled pigmentation. J. Invest. Dermatol, 108, 809–810. Ishida-Yamamoto, A., McGrath, J.A., Chapman, S.J., Leigh, I.M., Lane, E.B. and Eady, R.A.J. (1991) Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin filament network involving keratins K5 and K14. J. Invest. Dermatol., 97, 959–968. Ishida-Yamamoto, A., McGrath, J.A., Judge, M.R., Leigh, I.M., Lane, E.B. and Eady, R.A.J. (1992) Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J. Invest. Dermatol., 99, 19–26.
50 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Jackson, A.D.M. and Lawler, S.D. (1951) Pachyonychia Congenita: a report of six cases in one family. Ann. Eugen. 16, 142–146. Jadassohn, J., and Lewandowsky, F. (1906) Pachyonychia congenita. In, Ed.), Jacobs Ikonographia Dermatologica, Urban and Schwarzenberg, Berlin, pp. 29. Jonkman, M.F., Heeres, K., Pas, H.H., van Luyn, M.J.A., Elema, J.D., Corden, L.D., Smith, F.J.D., McLean, W.H.I., Raemakers, F.C.S., Burton, M. and Scheffer, H. (1996) Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J. Invest. Dermatol., 107, 764–769. Jorgenson, R.J., and Levin, S. (1981) White sponge nevus. Arch. Dermatol., 117, 73–76. Kartasova, T., Roop, D.R., Holbrook, K.A. and Yuspa, S.H. (1993) Mouse differentiation-specific keratins 1 and 10 require a preexisting keratin scaffold to form a filament network. J. Cell Biol, 120, 1251–1261. Kimonis, V., DiGiovanna, J.J., Yang, J.-M., Doyle, S.Z., Bale, SJ. and Compton, J.G. (1994) A mutation in the VI end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J. Invest. Dermatol, 103, 764–769. Korge, B.P., Gan, S.-Q., McBride, O.W., Mischke, D. and Steinert, P.M. (1992) Extensive size polymorphism of the human keratin 10 chain resides in the C-terminal V2 subdomain due to variable numbers and sizes of glycine loops. Proc. Natl. Acad. Sci. USA, 89, 910–914. Korge, B.P., Healy, E., Munro, C.S., Punter, C., Birch-Machin, M., Holmes, S.C., Darlington, S., Hamm, H., Messenger, A.G., Rees, J.L. and Traupe, H. (1998) A mutational hotspot in the 2B domain of human basic hair keratin 6 (hHb6) in monilethrix patients. J. Invest. Dermatol., 111, 896–899. Kouklis, P.D., Hutton, E. and Fuchs, E. (1994) Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. J Cell Biol., 127, 1049–1060. Ku, N.-O., Michie, S., Oshima, R.G. and Omary, M.B. (1995) Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J. Cell Biol., 131, 1303–1314. Ku, N.O., Wright, T.I., Terrault, N.A., Gish, R. and Omary, M.B. (1997) Mutation of human keratin 18 in association with cryptogenic cirrhosis. J. Clin. Invest., 99, 19–23. Lane, E.B. (1993) Keratins. In (Royce, P.M., and Steinmann, B., Ed.), Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects, Wiley-Liss Inc., New York, pp. 237–247. Lane, E.B., Rugg, E.L., Navsaria, H., Leigh, I.M., Heagerty, A.H.M., Ishida-Yamamoto, A. and Eady, R.A.J. (1992) A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature, 356, 244–246. Langbein, L., Heid, H.W., Moll, I. and Franke, W.W. (1993) Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation, 55, 57–71. Lazarides, E. (1980) Intermediate filaments as mechanical integrators of cellular space. Nature, 283, 249–256. Lee, L.D., and Baden, H.P. (1976) Organization of the polypeptide chains in mammalian keratin. ‘Nature, 264, 377–388. Lewis, S.A., Balcarek, J.M., Krek, V., Shelanski, M. and Cowan, N.J. (1984) Sequence of a cDNA encoding mouse glial fibrillary acidic protein: Structural conservation of intermediate filaments. Proc. Natl Acad. Sci. U.S.A., 81, 2743–2746. Lloyd, C., Yu, Q.C., Cheng, J., Turksen, K., Degenstein, L., Mutton, E. and Fuchs, E. (1995) The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. CellBiol, 129, 1329–1344.
KERATINS AND KERATIN DISORDERS 51
Lu, X., and Lane, E.B. (1990) Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: Specific domain functions in keratin stabilization and filament formation. Cell, 62, 681–696. Marekov, L.N., and Steinert, P.M. (1995) The proteins elafin, filaggrin, keratin intermediate filaments, loricrin and small proline rich protein-1 and protein-2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope . J. Biol Chem., 270, 17702–17711. McGrath, J.A., McMillan, J.R., Shemanko, C.S., Runswick, S.K., Leigh, I.M., Lane, E.B., Garrod, D.R. and Eady, R.A.J. (1997) Mutations in the plakophilin 1 gene can result in ectodermal dysplasia/skin fragility syndrome. Nat. Genet., 17, 240–244. McKusick, V.A., 1998 OMIM (On-line Mendelian Inheritance in Man; http://www3. ncbi.nlm.nih.gov/Omim/searchomim.html). Johns Hopkins University, Baltimore. McLean, W.H.I., and Lane, E.B. (1995) Intermediate filaments in disease. Curr. Opin. Cell Biol, 7, 118–125. McLean, W.H.I., Morley, S.M., Lane, E.B., Eady, R.A.J., Griffiths, W.A.D., Paige, D.G., Harper, J.I., Higgins, C. and Leigh, I.M. (1994) Ichthyosis bullosa of Siemens—a disease involving keratin 2e. J. Invest. Dermatol, 103, 277–281. McLean, W.H.I., Pulkkinen, L., Smith, F.J.D., Rugg, E.L., Lane, E.B., Bullrich, F., Burgeson, R.E., Amano, S., Hudson, D.L., Owaribe, K., McGrath, J.A., McMillan, J.R., Eady, R.A.J., Leigh, I.M., Christiano, A.M. and Uitto, J. (1996) Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organisation. Genes Dev., 10, 1724–1735. McLean, W.H.I., Rugg, E.L., Lunny, D.P., Morley, S.M., Lane, E.B., Swensson, O., DoppingHepenstal, P.J.C., Griffiths, W.A.D., Eady, R.A.J., Higgins, C., Navsaria, H., Leigh, I.M., Strachan, T., Kunkeler, L. and Munro, C.S. (1995) Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat. Genet., 9, 273–278. Meesmann, A., and Wilke, F. (1939) Klinische und anatomische Untersuchungen ueber eine bisher unbekannte, dominant vererbte Epitheldystrophie der Hornhaut. Klin. Mbl. Augenheilk., 103, 361–391. Meng, J.-J., Khan, S. and Ip, W. (1996) Intermediate filament protein domain interactions as revealed by two-hybrid screens. J. Biol. Chem., 271, 1599–1604. Milisavljevic, V., Freedberg, I.M. and Blumenberg, M. (1996) Close linkage of two keratin gene clusters in the human genome. Genomics, 34, 134–138. Millington-Ward, S., O’Neill, B., Tuohy, G., AI-Jandal, N., Kiang, A.-S., Kenna, P.F., Palfi, A., Hayden, P., Mansergh, F., Kennan, A., Humphries, P. and Farrar, G.J. (1997) Stratagems in vitro for gene therapies directed to dominant mutations. Hum. Mol Genet., 6, 1415–1426. Moll, R., Franke, W.W., Schiller, D.L., Geiger, B. and Krepler, R. (1982) The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31, 11–24. Montgomery, R.A., and Dietz, H.C. (1997) Inhibition of fibrillin 1 expression using Ul snRNA as a vehicle for the presentation of antisense targeting sequence. Hum. Mol. Gen., 6, 519–525. Moss, C., Jones, D.O., Blight, A. and Bowden, P.E. (1995) Birthmark due to cutaneous mosaicism for keratin 10 mutation. Lancet, 345, 596. Munro, C.S., Carter, S., Bryce, S., Hall, M., Rees, J.L., Kunkeler, L., Stephenson, A. and Strachan, T. (1994) A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12–q21. J. Med. Genet., 31, 675–678. Nishida, K., Honma, Y., Dota, A., Kawasaki, S., Adachi, W., Nakamura, T., Quantock, A.J., Hosotani, H., Yamamoto, S., Okada, M., Shimomura, Y. and Kinoshita, S. (1997) Isolation
52 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy. Am. J. Hum. Genet., 61, 1268–1275. North, A.C., Steinert, P.M. and Parry, D.A. (1994) Coiled-coil stutter and link segments in keratin and other intermediate filament molecules: a computer modeling study. Protins, 20, 174–184. Palier, A.S., Syder, A.J., Chan, Y.M., Button, E., Tadini, G. and Fuchs, E. (1994) Genetic and clinical mosaicism in a type of epidermal nevus. New Eng. J. Med., 331, 1408–1415. Parry, D.A.D., Crewther, W.G., Eraser, R.D.B. and MacRae, T.P. (1977) Structure of -keratin: structural implication of the amino acid sequences of the type 1 and type II chain segments. J. Molec. BioL, 113, 449–454. Purkis, P.E., Steel, J.B., Mackenzie, I.C., Nathrath, W.BJ., Leigh, I.M. and Lane, E.B. (1990) Antibody markers of basal cells in complex epithelia. J. Cell Sci., 97, 39–50. Quax, W., Egberts, W.V., Hendriks, W., Quax-Jeuken, Y. and Bloemendal, H. (1983) The structure of the vimentin gene. Cell, 35, 215–223. Quinlan, R.A., Cohlberg, J.A., Schiller, D.L., Hatzfeld, M. and Franke, W.W. (1984) Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells. J. Molec. Biol, 178, 365–388. Quinlan, R.A., Hutchison, C.J. and Lane, E.B. (1994) Intermediate filaments., Academic Press, London. Reis, A., Hennies, H.-C., Langbein, L., Digweed, M., Mischke, D., Drechsler, M., Schrōck, E., Royker-Pokora, B., Franke, W.W., Sperling, K. and Küster, W. (1994) Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat. Genet., 6, 174–179. Reis, A., Kuster, W., Eckardt, R. and Sperling, K. (1992) Mapping of a gene for epidermolytic palmoplantar keratoderma to the region of acidic keratin gene cluster at 17q12–q21. Hum. Genet., 90, 113–116. Richard, G., DeLaurenzi, V., DiDona, B., Bale, SJ. and Compton, J.G. (1995) Keratin-13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat. Genet., 11, 453–455. Rosenberg, M., Fuchs, E., LeBeau, M.M., Eddy, R.L. and Shows, T.B. (1991) Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. Cytogenet. Cell Genet., 57, 33–38. Rosenberg, M., RayChaudhury, A., Shows, T., Le Beau, M.M. and Fuchs, E. (1988) A group of type I keratin genes on human chromosome 17: characterization and expression. Molec. Cell Biol, 8, 722–736. Rothnagel, J.A., Dominey, A.M., Dempsey, L.D., Longley, M.A., Greenhalg, D.A., Gagne, T.A., Huber, M., Frenk, E., Hohl, D. and Roop, D.R. (1992) Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science, 257, 1128–1130. Rothnagel, J.A., Longley, M.A., Holder, R.A., Küster, W. and Roop, D.R. (1994a) Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing. J. Invest. Dermatol, 102, 13–16. Rothnagel, J.A., Traupe, H., Wojcik, S., Huber, M., Hohl, D., Pittelkow, M.R., Saeki, H., Ishibashi, Y. and Roop, D.R. (1994b) Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat. Genet., 7, 485–490. Rugg, E.L., McLean, W.H.I., Allison, W.E., Lunny, D.P., Macleod, R. L, Felix, D.H., Lane, E.B. and Munro, C.S. (1995) A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat. Genet., 11, 450–452. Rugg, E.L., McLean, W.H.I., Lane, E.B., Pitera, R., McMillan, J.R., Dopping-Hepenstal, P.J.C., Navsaria, H.A., Leigh, I.M. and Eady, R.A.J. (1994) A functional “knock-out” for human keratin 14. Genes Dev., 8, 2563–2573.
KERATINS AND KERATIN DISORDERS 53
Rugg, E.L., Morley, S.M., Smith, F.J.D., Boxer, M., Tidman, M.J., Navsaria, H., Leigh, I.M. and Lane, E.B. (1993) Missing Links: Keratin mutations in Weber-Cockayne EBS families implicate the central LI2 linker domain in effective cytoskeleton function. Nat. Genet., 5, 294–300. Rugg, E.L., Shemanko, G.S., Magee, G.J., Baty, D., Boxer, M. and Lane, E.B. (1997) Taking EBS from mutation analysis to prenatal diagnosis. J. Invest. Dermatol, 108, 597. Schermer, A., Galvin, S. and Sun, T.-T. (1986) Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol, 103, 49–62. Shamsher, M.K., Navsaria, H.A., Stevens, H.P., Ratnavel, R.C., Purkis, P.E., Kelsell, D.P., McLean, W.H.I., Cook, L.J., Griffiths, W.A.D., Gschmeissner, S., Spurr, N. and Leigh, I.M. (1995) Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in 2 families. Hum. Molec. Genet., 4, 1875–1881. Siemens, H.W. (1937) Dichtung und Wahrheit über die die “Ichthyosis bullosa”, mit Bemerkungen zur Systematik der Epidermolysen. Arch. DermatoL Syph. (Berlin), 175, 590–608. Smith, F.J.D., Corden, L.D., Rugg, E.L., Ratnavel, R., Leigh, I.M., Moss, C., Tidman, M.J., Hohl, D., Huber, M., Kunkeler, L., Munro, C.S., Lane, E.B. and McLean, W.H.I. (1997) Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J. Invest. Dermatol, 108, 220–223. Smith, F.J.D., Eady, R.A.J., Leigh, I.M., McMillan, J.R., Rugg, E.L., Kelsell, D.P., Bryant, S.P., Spurr, N.K., Geddes, J.F., Kirtschig, G., Milana, G., de Bono, A.G., Owaribe, K., Wiche, G., Pulkkinen, L., Uitto, J., McLean, W.H.I, and Lane, E.B. (1996) Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat. Genet., 13, 450–457. Smith, F.J.D., Jonkman, M.F., van Goor, H., Coleman, C., Covello, S.P., Uitto, J. and McLean, W.H.I. (1998a) A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2 . Hum. Molec. Genet., 7, 1143–1148. Smith, F.J.D., McKenna, K.E., Irvine, A.D., Bingham, E.A., Coleman, C.M., Uitto, J. and McLean, W.H.I. (1998b) A mutation detection strategy for the human K6A gene and novel mutations in two cases of pachyonychia congenita type 1. Exp. Derm., 8, 109–114. Stappenbeck, T.S., Bornslaeger, E.A., Corcoran, C.M., Luu, H.H., Virata, M.L.A. and Green, K.J. (1993) Functional analysis of desmoplakin domains: specification of the interaction with keratin versus vimentin intermediate filament networks. J. Cell BioL, 123, 691–705. Stappenbeck, T.S., Lamb, J.A., Corcoran, C.M. and Green, K.J. (1994) Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J. Biol Chem., 269, 29351–29354. Steijlen, P., Kremer, H., Vakilzadeh, F., Happle, R., Lavrijsen, A., Ropers, H.-H. and Mariman, E. (1994) Genetic linkage of the keratin type II gene cluster with ichthyosis bullosa of Siemens and with autosomal dominant ichthyosis exfoliativa. J. Invest. Dermatol, 103, 282–285. Steinert, P.M. (1990) The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J. Biol Chem., 265, 8766–8774. Steinert, P.M. (1993) Structure, function and dynamics of keratin intermediate filaments. J. Invest. Dermatol , 100, 729–734. Steinert, P.M., and Bale, S.J. (1993) Genetic skin diseases caused by mutations in keratin intermediate filaments. Trends Genet., 9, 280–284. Steinert, P.M., Idler, W.W. and Zimmerman, S.B. (1976) Self assembly of bovine epidermal keratin filaments in vitro. J. Molec. Biol, 108, 547–567.
54 LAURA D. CORDEN AND W.H. IRWIN MCLEAN
Steinert, P.M., Marekov, L.N., Fraser, R.D.B. and Parry, D.A.D. (1993a) Keratin in termediate filament structure: crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. J. Molec. Biol, 230, 436–452. Steinert, P.M., North, A.C.T. and Parry, D.A.D. (1994) Structural features of keratin intermediate filaments. J. Invest. Dermatol, 103, 19S-24S. Steinert, P.M., and Parry, D.A.D. (1985) Intermediate filaments: conformity and diversity of expression and structure. Ann. Rev. Cell Biol, 1, 41–65. Steinert, P.M., and Parry, D.A.D. (1993) The conserved HI domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbour molecules in mouse and human keratin 1/keratin 10 intermediate filaments at the two- to four-molecule level of structure. J. Biol Chem., 268, 2878–2887. Steinert, P.M., Parry, D.A.D., Idler, W.W.Johnson, L.D., A.C., S. and Roop, D.R. (1985a) Amino acid sequences of mouse and human epidermal type II keratins of Mr 67,000 provide a systematic basis for the structural and fucntional diversity of the end domains of keratin intermediate filament subunits. J. Biol. Chem., 260, 7142–7149. Steinert, P.M., Rice, R.H., Roop, D.R., Trus, B.L. and Steven, A.C. (1983) Complete amino acid sequence of a mouse epidermal keratin subunit and implications for the structure of intermediate filaments. Nature, 302, 794–800. Steinert, P.M., Steven, A.C. and Roop, D.R. (1985b) The molecular biology of intermediate filaments. Cell, 42, 411–419. Steinert, P.M., Yang, J.M., Bale, SJ. and Compton, J.G. (1993b) Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem. Biophys. Res. Commun., 197, 840–848. Stewart, M., Quinlan, R.A. and Moir, R.D. (1989) Molecular interactions in paracrystals of a fragment corresponding to the a-helical coiled-coil rod portion of glial fibrillary acidic protein: evidence for an antiparallel packing of molecules and polymorphism related to intermediate filament structure. J. Cell Biol, 109, 225–234. Stoof, T.J., Boorsma, D.M. and Nickoloff, B J. (1994) Keratinocytes and immunological cytokines. In (Leigh, I.M., Lane, E.B. and Watt, F.M., Ed.), The keratinocyte handbook, Cambridge University Press, Cambridge, pp. 365–399. Sun, T.-T., Eichner, R., Nelson, W.G., Tseng, S.C.G., Weiss, R.A., Jarvinen, M. and WoodcockMitchell, J. (1983) Keratin classes: Molecular markers for different types of epithelial differentiation. J. Invest. Dermatol, 81, 109s-115s. Sun, T.-T., Eichner, R., Schermer, A., Cooper, D., Nelson, W.G. and Weiss, R.A. (1984) Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In (Levine, A.J., Vande Woude, G.F., Topp, W.C. and Watson, J.D., Ed.), The Transformed Phenotype, Cold Spring Harbor Laboratory, New York, pp. 169–176. Sun, T.-T., Tseng, S.C.G., Huang, A.J.-W. and Cooper, D. (1985) Monoclonal antibody studies of mammalian epithelial keratins: A review. Ann. N.Y. Acad. Sci., 455, 307–309. Takahashi, K., Paladini, R.D. and Coulombe, P.A. (1995) Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J. Biol Chem., 270, 18581–18592. Tremblay, M., and Dube, I. (1982) Meesmann’s corneal dystrophy: Ultrastructural features. Canad.J. Opthalmol, 17, 24–28. Tyner, A.L., Eichman, M.J. and Fuchs, E. (1985) The sequence of a type II keratin gene expressed in human skin: Conservation of structure among all intermediate filament genes. Proc. Natl. Acad. Sci. U.S.A., 82, 4683–4687.
KERATINS AND KERATIN DISORDERS 55
Uitto, J., Pulkkinen, L. and McLean, W.H.I. (1997) Epidermolysis bullosa: A spectrum of clinical phenotypes explained by molecular heterogeneity. Mol. Med. Today, 3, 457–465. Uttam, J., Hutton, E., Coulombe, P.A., Anton-Lamprecht, I., Yu, Q.-C., Gedde-Dahl, T., Fine, J.D. and Fuchs, E. (1996) The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc. Natl Acad. Sci. U.S.A., 93, 9079–9084. Vassar, R., Coulombe, P.A., Degenstein, L., Albers, K. and Fuchs, E. (1991) Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell, 64, 365–380. Vorner, H. (1901) Zur Kentniss des Keratoma hereditarium palmare et plantare. Arch. Derm. Syph., 56, 3–31. Waseem, A., Gough, A.C., Spurr, N.K. and Lane, E.B. (1990) Localization of the gene for human simple epithelial keratin 18 to chromosome 12 using polymerase chain reaction. Genomics, 7, 188–194. Weber, K., and Geisler, N. (1982) The structural relation between intermediate filament proteins in living cells and the -keratins of sheep wool. EMBOJ., 1, 1155–1160. Weiss, R.A., Eichner, R. and Sun, T.-T. (1984) Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J. Cell Biol, 98, 1397–1406. Williams, M.L., and Elias, P.M. (1993) From basket weave to barrier. Arch. Dermatol, 129, 626–629. Wilson, A.K., Coulombe, P.A. and Fuchs, E. (1992) The roles of K5 and K14 head, tail and R/ KLLEGE domains in keratin filament assembly in vitro. J. Cell Biol, 119, 401–414. Winter, H., Rogers, M.A., Gebhardt, M., Wollina, U., Boxall, L., Chitayat, D., Babul-Hirji, R., Stevens, H.P., Zlotogorski, A. and Schweizer, J. (1997a) A new mutation in the type II hair cortex keratin hHbl involved in the inherited hair disorder monilethrix. Hum. Genet., 101, 165–169. Winter, H., Rogers, M.A., Langbein, L., Stevens, H.P., Leigh, I.M., Labreze, C., Roul, S., Taieb, A., Kreig, T. and Schweizer, J. (1997b) Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat. Genet., 16, 372–374. Yoon, S.-J., LeBlanc-Straceski, J., Ward, D., Krauter, K. and Kucherlapati, R. (1994) Organization of the human keratin type II gene cluster at 12q 13. Genomics, 24, 502–508.
4. DESMOSOMES DAVID R.GARROD, MARTYN A.J.CHIDGEY, ALISON J.NORTH, SARAH K.RUNSWICK AND CHRIS TSELEPIS
INTRODUCTION Desmosomes are punctate, adhesive intercellular junctions that bind cells together and provide membrane anchoring points for the intermediate filament cytoskeleton. They are circular membrane domains of up to 0.5 µm in diameter. The intercellular material or desmoglea occupies a region of about 30 nm wide between the apposed plasma membranes. It has a highly organised ultrastructure consisting of an electron-dense mid line from which cross-bridges extend to the plasma membranes. Close to the cytoplasmic faces of the plasma membranes are dense outer plaques. These are approximately 20 nm in thickness and are the most consistent and easily-recognisable feature of these junctions. At about 50 nm from the plasma membranes are less dense inner plaques that appear to associate with the intermediate filaments. Thus the total thickness of a desmosome from one inner plaque to the other is approximately 130 nm. Desmosomes may be thought of as the “scaffold couplings” that link the intermediate filament cytoskeleton throughout a tissue. Widely distributed, desmosomes are especially abundant in stratified epithelia where strong intercellular adhesion is required to resist external friction. They are present in almost all epithelia and also in cardiac muscle, the arachnoid and pia of the meninges, and the follicular dendritic cells of the lymphoid system. Desmosomes are macromolecular complexes consisting of at least six interacting proteins (Figure 4.1, Table 4.1). Their adhesion molecules are the desmocollins (Dscs) and desmogleins (Dsgs), members of the cadherin family of calcium-dependent adhesion molecules. These transmembrane proteins have their extracellular domains in the desmoglea and their cytoplasmic domains in the outer dense plaque. The outer plaque contains two proteins that are members of the armadillo family named after the Drosophila segment polarity signalling gene. These are plakoglobin (Pg), also known as γ catenin and present in other intercellular junctions, and plakophilin (Pp). The outer and inner plaques are bridged by the plakin family member desmoplakin (Dp), which mediates interaction between the adhesive domain and the intermediate filaments (reviewed by Schwartz et al., 1990; Buxton and Magee, 1992; Legan et al., 1992; Garrod, 1993; Garrod et al., 1996; Green and Jones, 1996; Chidgey, 1997; Garrod et al., 1998; Burdett, 1998).
D.R.GARROD ET AL. 57
Figure 4.1 Cartoon showing major components of desmosomes. ML=mid-line, PM=plasma membranes OP=outer plaque, IP=inner plaque, IF=intermediate filaments. The numbers at the bottom of the picture indicate distances in nanometres from the plasma membranes of the various plaque components as determined by quantitative measurements from immunogold labelling with domain-specific antibodies. Dsc=desmocollin, a=“a” form, b=“b” form; Dsg=desmoglein; DP=desmoplakin, PG=plakoglobin; PP=plakophilin. N=N-terminus; C=C-terminus. Only one half of the desmosome is shown: it is symmetrical about ML. The intercellular space is not drawn to scale as it would be almost 50% wider if shown at the same magnification as the plaque region.
The most recent additions to the tally of desmosomal components are the two plakin family members, envoplakin and periplakin (Ruhrberg et al., 1996; . Ruhrberg et al., 1997; Ruhrberg and Watt, 1997), which although not exclusively epidermal, appear to be of considerable importance in cornified envelope formation. DESMOSOMAL GLYCOPROTEINS Desmosomal Glycoproteins and Cell Adhesion Desmosomes have long been regarded as points of strong adhesion between cells. Apart from their very “solid” appearance by electron microscopy, this view has been based on their particular abundance in stratified epithelia, such as epidermis, which are subject to substantial frictional forces, and to the loss of adhesion (acantholysis) that occurs in the group of autoimmune epidermal blistering diseases known as pemphigus, where loss of adhesion is caused by antibodies against desmosomal glycoproteins (Stanley, 1993; Stanley and Kárpáti, 1994). Recent experimental demonstrations of the importance of desmosomal adhesion in the epidermis and the heart have been achieved, respectively, by dominant negative and null mutations of the pemphigus vulgaris antigen Dsg3 (Allen et
58 D.R.GARROD ET AL.
al., 1996; Koch et al., 1997) and plakoglobin (Ruiz et al., 1996; Bierkamp et al., 1996). Furthermore, the first human desmosomal mutation, effectively a Pp1 knockout, gives rise to loss of adhesion within the epidermis (McGrath et al., 1997). It has always been assumed that desmosomal adhesion is mediated by the major desmosomal glycoproteins, Dsc and Dsg. Two early pieces of evidence supporting this view were, firstly, that the glycoproteins were greatly enriched in isolates of desmosomal cores (Gorbsky and Steinberg, 1981) and, secondly, that inhibition of desmosome assembly could be obtained in MDBK cells using high concentrations of Fab’ fragments of anti-Dsc antibodies (Cowin et al., 1984). The adhesive roles of these glycoproteins seemed even more likely when it was shown that both were members of the cadherin family of calcium-dependent adhesion molecules (Holton et al., 1990; Koch et al., 1990). Despite all these indications, it has proved extremely difficult to provide experimental proof of the adhesive roles of Dsc and Dsg. Classical cadherins generally participate in homophilic, calcium-dependent cell-cell adhesion (Nose et al., 1990; Shapiro et al., 1996; Nagar et al., 1996). Such homophilic adhesion by Dsc or Dsg is, however, negligible (Amagai et al., 1994a; Chidgey et al., 1996; Kowalcyzk et al., 1996). Recent work by three groups has now provided definitive evidence for mediation of cell-cell adhesion by desmosomal glycoproteins and some indication of how it may operate (Chitaev and Troyanovsky, 1997; Marcozzi et al., 1998; Tselepis et al., 1998). The human fibrosarcoma cell line HT1080 adheres by means of adherens junctions mediated by N-cadherin, but also synthesises Dsg2 (Sacco et al., 1995). Chitaev and Troyanovsky (1997) utilized transfection of these cells with bovine Dscl and human Pg to study desmosomal adhesion. Marcozzi et al., (1998) and Tselepis et al., (1998) used multiple transfection of the non-adhesive L929 mouse fibroblast line to generate adhesion. These studies suggest a number of novel conclusions about desmosomal adhesion, as follows:(i) Both Dsc and Dsg are required for intercellular adhesion. Previous work had shown that expression of single desmosomal glycoproteins in L929 cells did not generate adhesion (Amagai et al., 1994b; Chidgey et al., 1996; Kowalcyzk et al., 1996). Both Marcozzi et al., (1998) and Tselepis et al., (1998) were able to generate extensive aggregation of these cells by simultaneous expression of Dsc, Dsg and Pg. These results suggest that both Dsc and Dsg are required in order to generate adhesion. (ii) Dsc and Dsg can interact heterophilically. Chitaev and Troyanovsky (1997) elegantly demonstrated heterophilic interaction between Dsc and Dsg. They transfected one population of Dsg-expressing HT1080 cells with Dsc which was truncated cytoplasmically to remove the Pg binding domain. Another population of the same cells was transfected with myc-tagged Pg. The two cell populations were co-cultured, then solubilized and immimoprecipitated with anti-Dsc
For further details, other components and references, see text.
Table 4.1 The Principal Components of Desmosomes
D.R.GARROD ET AL. 59
60 D.R.GARROD ET AL.
antibody. It was found that myc-Pg co-precipitated with Dsc, a result explicable only in terms of interaction between Dsc and Dsg on adjacent cells. By contrast, Marcozzi et al. (1998) were unable to precipitate Dsc-Dsg complexes, and Tselepis et al. (1998) found no convincing evidence for adhesive interaction between L cells expressing the different individual glycoproteins. (iii) Cytoplasmic interaction with Pg is required for adhesion Marcozzi et al. (1998) demonstrated that adhesion between L929 cells expressing both desmosomal glycoproteins took place when the cells were further transfected with Pg. Tselepis et al. (1998) demonstrated co-localization of Dsc, Dsg and Pg at the cell surface in transfected L929 cells, but detected no evidence of junction assembly by electron microscopy. (iv) Different glycoprotein isoforms and desmosomal glycoproteins from different species interact Dsc and Dsg each occur as three different isoforms which are the products of different genes. These isoforms are called Dsc1, 2 and 3, and Dsgl, 2 and 3. Dsc2 and Dsg2 are ubiquitous and occur in all desmosome-bearing tissues, but Dscl and 3 and Dsgl and 3 occur principally in stratified epithelia (Legan et al., 1994; Nuber et al., 1995; Schäfer et al., 1994). Marcozzi et al. (1998) used the human Dsgl and Dsc2 isoforms in their transfection experiments showing that these can participate in mutual interaction. Chitaev and Troyanovsky (1997) demonstrated interaction between human Dsg2 and bovine Dscl indicating that not only different isoforms but also proteins from different species can interact. The latter result is consistent with previous studies showing desmosome formation between cells of a variety of different species and phyla including anuran amphibians, birds, and mammals (Overton, 1977; Mattey and Garrod, 1985). North et al. (1996) showed that where different desmocollin isoforms are expressed in the same cells in epidermis, they occur in the same individual desmosomes. It is likely that desmoglein isoforms are similarly distributed (Shimizu et al. 1995). In view of the above experiments, it is probable that different glycoprotein isoforms interact in vivo. (v) Cell adhesion recognition (CAR) sites function in desmosomal glycoprotein interaction E- and N-cadherin possess tripeptide sequences (the CAR sites) in their N-termi nal regions that have been shown to be involved in adhesive binding (Blaschuk et al., 1990). In these molecules the tripeptide sequence is -histidine-alanine-valine- (HAV). The desmosomal cadherins have similarly located, related sequences, which have previously been referred to as putative CAR sites. In bovine Dscl and Dsgl these sites are YAT and
D.R.GARROD ET AL. 61
RAL, respectively. Tselepis et al. (1998) showed that 10mer peptides centred around these putative CAR sites blocked desmosomal adhesion. The peptides were effective at concentration of 0.5 mM. Furthermore, the Dsc peptide and the Dsg peptide were equally effective in inhibiting adhesion, and either peptide alone was as effective as the two together. This demonstrates that the CAR sites are functionally important in adhesion mediated by desmosomal glycoproteins and supports the involvement of heterophilic DscDsg interaction. (vi) The “b” form of Dsc is not essential for adhesion All Dscs occur as two alternatively spliced variants with different sized cytoplasmic domains, that of the “a” form being longer than the “b”. The “a” and “b” forms occur with approximately equal stoichiometry in all desmosome-containing cells and tissue so far examined. Troyanovsky et al. (1993) provided evidence that the cytoplasmic domain of the “a” form contains the signals necessary for plaque assembly. Smith and Fuchs (1998) showed that the three major plaque constituents Pg, Pp and Dp can all interact with “a” form cytoplasmic domain. To obtain adhesion of L cells, Tselepis et al., (1998) expressed both the “a” and “b” forms of bovine Dscl together with Pg and Dsg1. However, Marcozzi et al. (1998) were able to obtain apparently similar adhesion using only the “a” form of Dscs. It therefore appears that the “b” form is not essential for development of adhesion. However, the “b” form is present in all desmosome-containing cells and therefore may have an essential function, possibly in regulating the binding affinity and organisation of desmosomes. (vii) Adhesion between desmosomal glycoproteins is at least partially calcium dependent Both Chitaev and Troyanovsky (1997) and Tselepis et al. (1998) showed that the adhesion generated in their systems was partially abolished by removal of calcium, so that some residual adhesion occurred even in the absence of calcium. Although desmosomal assembly is calcium dependent (Hennings and Holbrook 1983, Watt et al., 1984; Mattey and Garrod, 1986a), desmosomes can also exist in the calcium independent state (Mattey and Garrod, 1986b). It is thus not entirely surprising to find that interaction between desmosomal glycoproteins was not completely abolished by calcium removal. (viii) Clustering of Dsc and Dsg is dependent on the extracellular domains Utilizing Dsc mutants where either the cytoplasmic domain or the N-terminal region of the extracellular domain were deleted, Chitaev and Troyanovsky (1997) showed that mutual clustering of Dsc and Dsg was dependent on the extracellular domain. Thus
62 D.R.GARROD ET AL.
clustering took place after deletion of the entire cytoplasmic domain but was abolished by deletion of the N-terminal region of the extracellular domain. (ix) Classical cadherin-mediated adhesion is not required to initiate adhesive interactions of desmosomal glycoproteins The HT1080 cells used by Chitaev and Troyanovsky (1997) form adherens junctions via Ncadherin. Their results are consistent with previous studies suggesting that cellular interaction via cadherin is essential to general desmosomal adhesion and that there is cross talk between adherens junctions and desmosomes (Wheelock and Jensen, 1992; Amagai et al., 1995a; Lewis et al., 1997). It was possible therefore that adhesive interaction generated by desmosomal glycoproteins in L929 cells was dependent on up-regulation of a cadherin (Tselepis et al., 1998). Two lines of evidence suggest that this is not the case. Firstly, adhesion was blocked by desmosomal glycoprotein CAR pep tides, but not by corresponding conventional cadherin peptides. Furthermore, no up-regulation of expression of cadherin or β-catenin could be detected by immunoblotting in transfected L929 cells exhibiting desmosomal adhesion. Thus, adhesion between desmosomal glycoproteins does not require prior interaction by conventional cadherins or adherens junctions. The results of these studies represent a substantial advance in our understanding of the mechanism of desmosomal adhesion. However, many issues remain to be resolved. Like conventional cadherins, the extracellular domains of the desmosomal cadherins consist of five subdomains (EC1 to 5) each of approximately 100 amino acids. On the basis of binding studies between recombinant proteins of different lengths, Chitaev and Troyanovsky (1997), proposed a model for interaction in which the extracellular domains of the molecules on apposing cells overlap by 3 EC domains. This is different from the results of structural studies of E- and N-cadherins (Shapiro et al., 1996; Naga et al., 1996) where interaction was shown to be between the N-terminal EC1 domains. These are the domains that contain the HAV sites which are located on the faces of the molecules that interact in adhesion (Shapiro et al., 1996). The demonstration that the desmocollin and desmoglein CAR sites are involved in adhesion (Tselepis et al., 1998) suggests that interaction between desmosomal glycoproteins may resemble that seen between conventional cadherins. In addition, the distance between the desmosomal plasma membranes (25 to 35 nm) appears to correspond well with an interaction between the apposed EC1 domains. Furthermore, although our pep tide inhibition studies on transfected cells showed that both Dsc and Dsg peptides were equally effective in inhibiting adhesion, and also as effective as the two peptides combined (Tselepis et al., 1998), provisional experiments with desmosome-forming cells indicate that both peptides are required to block desmosome assembly (Runswick, O’Hare, Streuli and Garrod, unpublished). These results are not entirely consistent with the involvement of heterophilic interaction between Dsc and Dsg in desmosome formation. It may be that the interactions seen in transfected cells, which do not form desmosomes even though they
D.R.GARROD ET AL. 63
adhere to each other (Tselepis et al., 1998), do not mimic precisely the interaction seen in whole desmosomes. Cells in stratified squamous epithelia, transitional epithelia and squamous cells carcinomas possess an additional desmosomal glycoprotein, the E-48 antigen. This 20- to 22 kDa, glycophospatidyl inositol anchored protein has been shown to function in cell-cell adhesion by monoclonal antibody inhibition and transfection studies (Schrijvers et al., 1991; Brakenhoff et al., 1995). Cytoplasmic Interactions of Desmosomal Glycoproteins In in vitro overlay assays Dsc la has been shown to bind to Pp1, Pg and the Dp N-terminus, , while Dsgl binds Pp1 and Pg, the former more weakly and the latter more strongly than Dscla (Smith and Fuchs, 1998). The interactions of Pg with the cytoplasmic tails of the desmosomal glycoproteins have been studied in detail by Troyanovsky and colleagues, using expression studies in epithelial cells (principally A431) with chimeric proteins consisting of the gap junction protein connexin 32 and the cytoplasmic domain of either Dsc1a or Dsg1. These constructs target the desmosomal glycoprotein C-termini to the plasma membrane as part of a gap junction-like structure, and the association of cytoplasmic proteins Dp, Pg and keratin filaments (KF) can be studied by immunofluorescence, immunoprecipitation and electron microscopy. The first use of this technique showed that the Dscla cytoplasmic domain would support Pg, Dp and KF association and plaque formation, and that Dsgl had a dominant negative effect leading to disruption of endogenous desmosomes (Troyanovsky et al., 1993). Deletion mutagenesis of the Dscla tail localised the site for Pg interaction to 37 amino acids at the extreme C-terminus, and this deletion also abolished KF association with the plaque (Troyanovsky et al., 1994a). Dp association was localised to a 10 amino acid region of the Dscla cytoplasmic tail close to the plasma membrane. The dominant negative effect of the Dsgl cytoplasmic domain was not abolished by deletion of 262 amino acids from the extreme C-terminus, but further deletion of 41 amino acids abolished both the dominant negative effect and Pg binding, thus localising the Pg binding domain to this 41 amino acid stretch (Troyanovsky et al., 1994b). This Pg binding region of Dsgl corresponds to a region that is conserved in other cadherins, including Dscla, where it located at the extreme C-terminus (Chitaev et al., 1996). More detailed analysis of Dsg-Pg binding by alanine scanning mutagenesis showed that a series of large hydrophobic amino acids in the conserved region are involved in Pg interaction (Chitaev et al., 1998). Similarly it was shown that nine hydrophobic amino acids within the arm repeats 1–3 of Pg are involved in Dsg-Pg interaction (Chitaev et al., 1998). Chitaev et al. (1998) found a 1:1 stoichiometry of Pg-Dsg binding, in contrast to the suggestion from immunoprecipitation data of a 6:1 Pg:Dsg binding ratio by Kowalczyk et al. (1996). If correct, the latter suggestion might provide an explanation for the dominant negative effect of the Dsgl cytoplasmic domain, since overexpression would be expected to sequester substantial amounts of Pg making insufficient availability for junctional assembly. A further possibility for the dominant negative effect of the Dsgl tail arose from the demonstration that expression in A431 cells of chimeras of E-cadherin extracellular domain and Dsg1 tail resulted in a 3-fold decrease
64 D.R.GARROD ET AL.
inE-cadherin bound to plakoglobin and a 5- to 10-fold reduction in the steady state levels of endogenous desmosomal cadherins, Dsg2 and Dsc2 (Norvell and Green, 1998). Binding of Pp to desmosomal glycoproteins (Smith and Fuchs, 1998) is clearly of functional importance since the human mutations described by McGrath et al. (1997) result in weakened desmosomal adhesion as well as detachment of Dp and KF from the desmosomal plaque. Desmosomal Glycoproteins in Epidermis The different isoforms of the desmosomal glycoproteins have distinct patterns of expression in epidermis and other stratified epithelia (Arnemann et al., 1993; Legan et al., 1994; King et al., 1995; Yue et al., 1995; North et al., 1996). In bovine epidermis, Dsc1 is associated with the upper, terminally-differentiating layers but is absent from the basal layer and the bases of the deep rete ridges. Dsc2 is most strongly expressed in cells immediately above the basal layer that have begun terminal differentiation. This region of greatest Dsc2 expression corresponds with the location in rete ridges of transit amplifying cells, the most rapidly proliferating keratinocyte population (Lavkar and Sun, 1983). Dsc3 is strongly present in the basal layer and gradually fades in the suprabasal layers (Legan et al., 1994; Yue et al., 1995; North et al., 1996). In human epidermis the expression patterns of Dscs are similar (Arnemann et al., 1993; King et al., 1995; 1996). The desmoglein patterns in epidermis are similarly differentiation-related with Dsg3 being most strongly expressed in the basal regions and Dsg1 increasing in expression suprabasally (Arnemann et al., 1993; Shimizu et al., 1995; Amagai et al., 1996). Curiously, Dsg2 appears to be expressed predominantly in the basal layer (Theis et al., 1993). An intriguing pattern of desmosomal glycoprotein expression is also found in mammary epithelium. Here Dsc1 and Dsg1 are not expressed. Dsc2 and Dsg2 are present in both lumenal and myoepithelial cells but Dsc3 and Dsg3 are confined to the latter (Runswick et al., 1996), thus again occupying a basal location. Preliminary studies also reveal interesting Dsc distributions in corneal epithelium. Dscl is absent from this nonkeratinizing epithelium, Dsc2 is expressed throughout, and Dsc3 is confined to the basal and suprabasal limbal region where the corneal stem cells are believed to reside (Messent et al., 2000). Quantification of the distribution of Dscl and Dsc3 isoforms by immunogold labelling of desmosomes at different levels in the epidermis, revealed that they are expressed in a reciprocally graded manner, with Dsc3 decreasing suprabasally from the basal layer and Dsc1 increasing (North et al., 1996). An inversely graded pattern of Dsg3 and Dsg1 expression in human epidermis has also been observed (Shimizu et al., 1995). It may be inferred that different Dsg isoforms are also present in the same junctions, since at intermediate levels of epidermis all desmosomes can be labelled using sera specific for either Dsg1 or Dsg3. These reciprocally-graded expression patterns suggest two conclusions. Firstly, since their molecular composition changes, desmosomes in epidermis are presumably continually turning over as the cells ascend through the layers. At present the functional significance of this is not clear. It may be that changes in cell-cell adhesive properties are
D.R.GARROD ET AL. 65
important in regulating epidermal morphology and differentiation. Secondly, expression of the different glycoprotein isoforms appears to be linked. All six human Dsc and Dsg genes are located at chromosome 18q12, the mouse desmoglein genes are closely linked in the proximal region of chromosome 18 and the bovine desmocollin genes cluster on chromosome 24q21/q22 (King et al., 1995; Arnemann et al., 1992; Wang et al., 1994; Amagai et al., 1995b; Simrak et al., 1995; Buxton et al., 1994; Solinas-Toldo et al., 1995). This clustering may be required for the regulation of desmosomal glycoprotein gene expression. The functional significance of these remarkable desmosomal glycoprotein distributions in epidermis is an important area for future investigation. During development of the mouse embryo three of the six desmosomal cadherin isoforms (Dsc1, Dsc3 and Dsg1) have so far been shown to be first expressed in the developing epidermis. In the mouse embryo, desmosomes first form at the 32-cell stage in a trophectoderm-specific location coincident with the onset of cavitation and blastocoel formation (Fleming et al., 1991). The only Dsc isoform present at this stage is Dsc2. Embryonic Dsc2 gene expression first occurs at the 16-cell stage and is specific to the trophectoderm lineage (Collins et al., 1995). Dsc2 proteins appear immediately after detection of its mRNA and coincides with initial desmosome assembly (Fleming et al., 1991; Collins et al., 1995). Presumably the Dsg isoform present is the ubiquitous Dsg2, though this has not been directly demonstrated. Desmosome formation between trophectoderm cells may be regulated by transcription of the glycoprotein genes although studies on the Dsg genes will be required to confirm this view. The desmocollin isoforms Dsc1 and Dsc3 are not expressed in the early mouse embryo. Dscl is first detected in the epidermis of the external nares at E13.5 (King et al., 1996; Chidgey et al. 1997). Dsc3 is initially expressed 12 hours earlier in nasal epidermis, whisker and the most mature vibrissa follicles (Chidgey et al., 1997). Both genes are upregulated in the general body epidermis at E14.5. At the same time both isoforms are expressed in the suprabasal layers of the newly stratified epidermis. However, by day 18.5 the region of maximum Dsc3 expression becomes basal whilst that of Dscl remains suprabasal (King et al., 1996; Chidgey et al., 1997). Thus the adult pattern of Dsc expression (see North et al., 1996) is established, simultaneously with the onset of the adult pattern of differentiation including the basal location of cell proliferation and the formation of stratum corneum. We have suggested the ratio of Dsc1 to Dsc3 expression at different levels in the epidermis is fundamental to establishing this pattern of differentiation (Chidgey et al., 1997). However, Dsg isoforms are also likely to play a role in this process. It has recently been shown that the Dsgl gene is first expressed at day 13.5 and shows a regional pattern of induction similar to that of Dsc1, being present in the outer cell layers of stratifying epidermis (King et al., 1996). An in situ hybridisation study of desmosomal glycoprotein gene expression during mouse development concluded that the DSC and DSCG genes are transcribed in hierarchical, overlapping temporal and spatial patterns, and that the spatial order in which they are expressed correlates with the physical order of the genes at the desmosomal cadherin locus (King et al., 1997) Denning et al., (1998) investigated the regulation of Dsg isoform expression in cultured human keratinocytes, HaCaT cells and squamous carcinoma cell lines. In particular they showed that down-regulation of PKC by long term treatment with phorbol ester or
66 D.R.GARROD ET AL.
bryostatin 1 led to decreased expression of Dsgl and Dsg3 but not Dsg2. These results are consistent with a role for PKC activation in regulation of the expression of Dsgl and Dsg3 in substantial cells. Adams et al. (1998) expressed a 4.2kb region of the human DSG1 promotor linked to the lacZ reporter gene in transgenic mice. They found that this region does not contain all the regulatory elements necessary for correct expression of the gene but might have elements that regulate activity during hair growth. Desmosomal glycoproteins in the epidermis are the target antigens in the autoimmune blistering disease pemphigus. There are two main forms of the disease, pemphigus foliaceous (PF) and pemphigus vulgaris (PV). Both are associated with formation of epidermal blisters: in PV these tend to be flaccid and fluid-filled, whereas PF the blisters burst readily and become encrusted. PV, but not PF, is also characterised by mucous membrane lesions, particularly of the oral mucosa. Histologically PV blisters show loss of adhesion between keratinocytes or acantholysis immediately above the basal layer while in PF this occurs in the granular layer or directly below it. Thus the blister roof is much thicker in PV than in PF which accounts for the different characteristics of the blisters. Pemphigus is characterised by the presence of circulating autoantibodies to the desmosomal glycoproteins (Dsg1 in PF and Dsg3 in PV) (reviewed by Stanley, 1993; Stanley and Kárpáti, 1994). These autoantibodies, which become bound in the epidermis, have been shown to be pathogenic by a number of criteria: they induce acantholysis of cultured human keratinocytes (Schiltz and Michel, 1976; Hashimoto et al., 1983); they cause epidermal acantholysis when injected into new born mice (Anhalt et al., 1982; Roscoe et al., 1985), even in the absence of complement (Anhalt, et al., 1986); their activity in the new born mouse assay is abrogated by prior incubation with recombinant Dsgl (Amagai et al., 1994a; 1995c). The binding of PV and PF antisera to the extracellular regions of epidermal desmosomes appears to occur in a reciprocally graded fashion; in PV autoantibodies bind more extensively to basal cells whereas in PF autoantibodies bind more extensively to the granular layer (Shumizu et al., 1995). Thus the location of greatest binding corresponds approximately with the level of acantholysis. Because autoantibody binding is clearly not precisely localized to the level of acantholysis we have suggested that acantholysis occurs at the weakest points in the system, where keratinocyte adhesion is most reduced (Domchowski et al., 1995). The mechanism by which acantholysis occurs is not clear. Targeted disruption of the Dsg3 gene in mice produces epidermal and mucosal lesions closely resembling those seen in PV blisters (Koch et al., 1997). This would be consistent with a direct effect on desmosomal adhesion by PV antibodies. However, activation of proteases that cleave adhesion molecules is also a possibility (Hashimoto et al., 1983). It has also been shown that pemphigus sera cause transient changes in cytoplasmic calcium concentration, protein kinase C relocation and activation, and phospholipase C activation in keratinocytes (Esaki et al., 1995; Seishima et al., 1995; Osada et al., 1997). These changes may generate an adhesion-disrupting signal. Further examination of the Dsg3 −/− mouse indicates a role for Dsg3 in anchoring hairs into follicles at the telogen phase of the hair cycle, since young mice lose hair during this phase (Koch et al., 1998). A histochemical study of human hair folicles shows that the
D.R.GARROD ET AL. 67
desmosomal glycoproteins have distinct distribution patterns leading to the conclusion that compositionally different desmosomes are present in various compartments of the follicle (Kruzen et al., 1998). ORGANISATION OF THE DESMOSOMAL PLAQUE The cytoplasmic domains of the Dscs and Dsgs are located in the outer dense cytoplasmic plaque of the desmosome (Figure 4.1, OP) (North et al., 1999). Here they associate with at least three other proteins, Pg, Pp and Dp. Pg and Pp are members of the armadillo family of junctional/signalling molecules, which both participate in the organisation of intercellular junctions and, as complexes with transcription factors, enter the nucleus to regulate gene activity. Pg contributes to the structure of both desmosomes and adherens junctions (Cowin et al., 1986), and has been shown to cause axis duplication in Xenopus development (Karnovsky and Klymkowsky, 1995), while Pp has both junctional and nuclear location (Mertens et al., 1996; Schmidt et al., 1997). The possibility that desmosomal components can also regulate gene expression and cellular differentiation is an important area for current and future investigation. Dp appears to provide a molecular link between the adhesive components of the desmosome and the intermediate filament cytoskeleton (Stappenbeck and Green, 1992; Bornslaegar et al., 1996). Its C-terminus is located in the desmosomal inner plaque (IP, Figure 4.1), into which KF insert (Miller et al., 1987; North et al., 1999). Plakoglobin and Plakophilin Pg and Pp belong to the armadillo family which includes the adherens junction-associated proteins β-catenin and p120cas, and the tumour supressor protein APC (for reviews see Peifer, 1995; Gumbiner, 1995; Klymkowsky and Parr, 1995; Barth et al., 1997; Cowin and Burke, 1996; Huber et al., 1996). Pg occurs as a single isoform, which is a universal component of the cytoplasmic plaques of desmosomes, whereas the two isoforms of Pp have restricted tissue distributions. Members of the armadillo family interact with several different proteins. These interactions appear to be mediated by overlapping regions of a centrally located group of so-called armadillo repeats (arm motifs) (Figure 4.2), each consisting of 42 amino acids (Peifer, 1995; Klymkowsky and Parr, 1995). Pg contains 13 consecutive arm repeats flanked by distinct N-terminal and C-terminal domains (Riggleman et al., 1989). It shares 60–70% sequence identity with armadillo and β-catenin. The Pps consist of 9 arm repeats followed by a C-terminal extension of 13 (Pp 1) or 11 (Pp 2) amino acids and no Nterminal flanking domain (Hatzfeld et al., 1994; Heid et al., 1994; Mertens et al., 1996). The Pps show amino acid identity of 33% to p120 with which they form a sub-group, but less than 25% to Pg, β-catenin and armadillo (Cowin and Burke, 1996). Pg interacts with the cytoplasm domains of Dsc and Dsg, and the classical cadherins (Korman et al., 1989; Kowalczyk et al., 1994; Mathur et al., 1994; Peifer et al., 1992; Roh and Stanley, 1995; Troyanovsky et al., 1994a,b; Butz and Kemler, 1994; Jou et al., 1995; Knudsen and Wheelock, 1992; Piepenhagen and Nelson, 1993). It binds with high affinity
68 D.R.GARROD ET AL.
to Dsg, with lower affinity to Dsc “a” and only weakly to E-cadherin (Chitaev et al., 1996). It also forms cytoplasmic complexes with APC and β-catenin, the latter being a component of the adherens junction (Rubinfeld et al., 1995). Deletion analyses show that the central arm repeats mediate association with classical cadherins, whereas the flanking repeats are essential for desmosomal cadherin binding (Mathur et al., 1994; Troyanovsky et al., 1994a, b; Roh and Stanley, 1995; Chitaev et al., 1996; Troyanovsky et al., 1996; Wahl et al., 1996; Witcher et al., 1996). Competition for binding domains on Pg may determine which complexes it forms. For example, the Dsg binding domain in the first three arm repeats overlaps the β-catenin binding domain (Sacco et al., 1995; Witcher et al., 1996; Chitaev et al., 1996; Wahl et al., 1996; for review see Cowin and Burke, 1996), and may regulate whether Pg associates with desmosomes or with classical cadherins in adherens junctions. Chitaev et al. (1998) have identified, by alanine scanning mutagenesis, nine hydrophobic amino acids in arm repeats 1–3 of Pg that are required for binding to Dsg and Dsc. Human, bovine, murine and rat Pg sequences are available (Franke et al., 1989, Cowin et al., 1986; Butz et al., 1992; Hiipakka, 1996). A variant of Pg from a human transitional carcinoma cell line contains a 120bp deletion corresponding to fourth arm repeat, believed to result from alternative splicing (Ozawa et al., 1995a). This variant binds with lower affinity to E-cadherin, Dsg2 and APC than full-length Pg, but both forms bind acatenin equally (Ozawa et al., 1995b). Where the alternative form is expressed in vivo is not clear. Since Pg is common to both adherens junctions and desmosomes it may have a regulatory function injunction assembly. One such role may be segregating components between these junctions. The defective heart muscle of Pg −/− mice (Ruiz et al., 1996; Bierkamp et al., 1996) has no desmosomes and Dp becomes merged with the components of adherens junctions into extended junctions, while Dsg2 is scattered over the surface of the cells. The force exerted by contraction of heart muscle may cause intermixing of junctional components. Discrete but abnormal desmosomes are present in epithelia of Pg −/− mice. Thus in null mice surviving until birth, abnormal structure of epidermal desmosomes was accompanied by blistering and subcorneal acantholysis (Bierkamp et al., 1996) These desmosomes lacked either the inner or outer plaque, or both, and intermediate filament attachment was impaired. Deletion of Pg and yeast two hybrid analysis suggests that the N-terminus of Dp binds to Pg at a site located in the central arm repeats (Palka and Green, 1997; Kowalczyk et al., 1997). Co-expression of a chimera of the E-cadherin extracellular domain and the Dsgl cytoplasmic domain with Pg and truncated Dp (containing the N-terminus) in L929 and COS cells produced plaque-like junctional structures at points of cell-cell contact (Kowalczyk et al., 1997). Pg, therefore, acts as a link between the cytoplasmic domain of Dsg and Dp. Whether it also links Dsc and Dp is not yet clear. Pg, β-catenin and armadillo share substantial sequence homology in the arm repeats but the N- and C-termini are divergent, possibly conferring specific functions on the different molecules. To address this, mutant Pgs lacking either or both N- and C-termini were expressed in A-431 cells (Palka and Green, 1997). N-terminal deletion did not affect desmosome assembly or morphology but Pg lacking the C-terminus was
Figure 4.2 Comparsion of the domain structures of human plakglobin (adapted from Wahl et al., 1996) and human plakophilins 1a, 1b, 2a & 2b. The imperfect armadilo repeats are shown as nymbered boxes. The domains of plakoglobin necessary for association with desmosomal cadherins, classical cadherins, α-catenin, APC and desmoplakin as determined by deletion analyses are indicated. The fourth armadillo repeat which is lacking in the alternative form of plakoglobin due to a 120bp deletion is shown (hatched box). The plakophilin la mutations (Q304X in arm repeat 1 and 1132ins28 in arm repeat 3) which result in ectodermal dysplasia/skin fragility syndrome are shown. The additional 21 amino acids and 44 amino acids inserts found in the alternative splice forms, plakophilin 1b and 2b, are indicated (solid box). Incomplete carboxyl-terminal armadillo repeats are shown (patterned boxes). Numbers represent amino acid residues. Diagram is not to scale.
D.R.GARROD ET AL. 69
70 D.R.GARROD ET AL.
incorporated into abnormally long desmosomes, possibly indicating that the C-terminus is involved in limiting desmosome length. The C-terminus may mask sites which bind other desmosomal components. Consistent with this a sequence of amino acids in arm repeat 13, which interacts with and masks cadherin binding sites located further upstream (Troyanovsky et al., 1996). The C-terminus may mask cryptic binding sites for Dp, so limiting over-recruitment of components and desmosome length (Palka and Green, 1997). It should be remembered, however, that normal desmosomes appear to fuse when brought together by low calcium medium-induced contraction of MDCK cells (Mattey and Garrod,1986b). Such large desmosomes do not disperse when normal extracellular calcium concentration and cell morphology are restored (unpublished observations). Expression of N-terminally-truncated Pg in both Xenopus and cultured epithelial cells increased the cytosolic levels of endogenous and ectopic Pg (Rubenstein et al., 1997; Palka and Green, 1997). This may reflect enhanced stability of Pg in the non-cadherin associated pool. Stabilisation of β-catenin depends upon dephosphorylation of a serine/threonine glycogen synthase kinase 3β (GSK3β) consensus site in the N-terminus (Peifer et al., 1994b; Rubenstein et al., 1997). GSK3β is the vertebrate homologue of Drosophila Zestewhite-3, a segment polarity gene that is negatively regulated by wingless leading to dephosphorylation, stabilisation and increased cytoplasmic levels of armadillo. Pg also contains a GSK3β consensus site in its N-terminus, deletion of which generates increased cytosolic levels in Xenopus embryos (Rubenstein et al., 1997). Overexpression of β-catenin or Pg suggests that these molecules exert signalling effects. Micro-injection of β-catenin or Pg mRNA into Xenopus embryos causes duplication of the body axis, replicating the effect of Wnt-1 overexpression (Funayama et al., 1995; Karnovsky and Klymkowsky, 1995). The balance between cadherin-bound and unbound pools of β-catenin and Pg may be crucial for signalling during development. The architectural HMG box transcription factor, LEF-1/XTCF-3 interacts with β-catenin (Behrens et al., 1996; Huber et al., 1996; Molenaar et al., 1996) and Pg (Huber et al., 1996). In mammalian cells, β-catenin/LEF-1 or Pg/LEF-1 complexes translocate to the nucleus. The former complex binds to the Ecadherin promoter and may regulate E-cadherin transcription thus affecting assembly of intercellular junctions. Pg also forms complexes with the tumour suppresser protein APC (Rubinfeld et al., 1995). This complex targets proteins for ubiquitination and degradation, thus reducing their levels. APC competes with cadherins for the association with Pg and β-catenin (for review see Polakis, 1995) and may thus regulate the levels of cytosolic Pg. Mutant forms of APC, unable to down-regulate β-catenin and Pg, are associated with colonie hyperplasia. Hence Pg may be a key regulator in cell adhesion, differentiation and proliferation. It is not clear how the diverse functions of Pg are regulated, but modulation of tyrosine phosphorylation may be important. Growth factor-dependent tyrosine phosphorylation of Pg correlates with a more invasive cell state (Shibamoto et al., 1994) and may regulate junction assembly. Additionally, it has been reported that the assembly and formation of adherens junctions precedes desmosome assembly (O’Keefe et al., 1987; Wheelock and Jensen, 1992; Lewis et al., 1997). Studies of the role of Pg injunction assembly suggest that association of Pg with a classical cadherin is necessary before desmosomes can assemble (Lewis et al.,
D.R.GARROD ET AL. 71
1997). However, it has also been shown that Pg preferentially assembles into desmosomes rather than adherens junctions (Näthke et al., 1994; Adams et al., 1996). Furthermore, desmosomal adhesion can form in the absence of classical cadherin-mediated cell interactions (Tselepis et al., 1998). The events leading to junction formation are thus complex with Pg playing an important modulatory role. Steric hindrance between binding partners, molecular conformation, levels of expression and variation in binding kinetics between cadherin cytoplasmic domains may be mechanisms for controlling Pg complex formation. Pp, formerly designated “band 6” in enriched desmosome preparations from bovine nasal epidermis (Skerrow and Matoltsy, 1974), occurs as two isoforms, Pp1 and Pp2. Sequences are available for human and bovine Pp1 (Heid et al., 1994; Hatzfeld et al., 1994). Alternative splicing of exon 7 which encodes 21 amino acids at the beginning of arm repeat 4 of the human Ppl gene results in two variants, 1a (726 amino acids) and 1b (747 amino acids) (Schmidt et al., 1997). Pp2 occurs as two variants, 2a (837 amino acids) and 2b (881 amino acids), through alternative splicing of an exon between the second and third arm repeats. Pp1 and 2 are widely expressed proteins that occur in the nuclei of both epithelial and non-epithelial cells (Mertens et al., 1996; Schmidt et al., 1997). The nuclear function of Pps, if any, is presently unknown. The desmosomal complement of Pps is cell-type specific. Thus, in desmosomes of the suprabasal layers of stratified epithelia, only Pp1 is present, whereas in simple epithelia or myocardial cells only Pp2 can be detected. In other epithelia, both Pp1 and 2 can coexist in desmosomes (Heid et al., 1994; Mertens et al., 1996; Schmidt et al., 1997). Only Pp 1a localises to desmosomes, whereas the 1b variant is restricted to nuclei, probably because the additional sequence in the 1b variant somehow restricts its distribution (Schmidt et al., 1997). Pp1 has a major role in maintaining desmosome function in epidermis. The firstdescribed human desmosomal mutations result in functional knockout of Pp1 (McGrath et al., 1997). In the affected individual, absence of Pp1 results in skin fragility and ectodermal dysplasia, affecting skin, hair and nails. No abnormalities in other organs have been detected. Mutational analysis revealed different nonsense mutations in both of the Pp1 alleles, each causing premature termination of translation. These mutations would result in severely truncated forms of Pp1 and immunostaining was indeed absent from epidermis. Desmosomes in the affected skin are small and greatly reduced in number, lacking inner plaques and IF attachment. Large intercellular spaces indicate weakened desmosomal adhesion. Dp immunostaining was diffuse rather than cell-peripheral, whereas staining for other desmosomal components appeared normal. This suggests that Pp1 links Dp to the desmosomal cadherins and is important for desmosomal adhesion. Desmoplakin DpI and II are major components of the desmosomal plaque, extending across both outer and inner plaque domains (North et al., 1999) (Figure 4.1). Dp is also present in complexus adherentes junctions in vascular endothelial cells (Schmelz and Franke, 1993; Schmeltz et al., 1994; Valiron et al. 1996). Dps are constitutive desmosomal components
72 D.R.GARROD ET AL.
except that DpII is absent from cardiac muscle (Angst et al., 1990). Derived by alternative splicing from a single gene, DpI and DpII have predicted MWs of 332 and 260 kDa, respectively (see Bornslaeger et al., 1994 for review). DpI is a homodimer with a central α-helical coiled-coil rod domain flanked by globular end domains (Bornslaeger et al., 1994). By rotary shadowing, this rod domain is ~130 nm in length, while that of DpII is ~ 43 nm (O’Keefe et al., 1989). However, simultaneous immunogold labelling of both globular end domains in desmosomes of bovine nasal epi dermis showed the length of Dp, measured perpendicular to the plasma membrane, to be only ~40 nm (North et al., 1999). Thus DpI may be folded or coiled in tissue. The rod domain of DpI is characterized by periodic distribution of charged residues indicating that it may aggregate with itself or with similar proteins to form higher order filamentous structures (Stappenbeck and Green, 1992). The Dp C-terminal domain consists of three 176 amino acid subdomains, A, B and C, plus a 68 residue “tail” at the C-terminus. Each subdomain is composed of a 38 residue repeat motif with the same periodicity of acidic and basic residues as the 1B rod domain of IF proteins, suggesting that DP could interact with the latter (Bornslaeger et al., 1994). The N-terminal domain consists of a series of shorter heptad repeats which are predicted to form compact bundles (Virata etal, 1992). By transfection of specific Dp domains into cultured epithelial cells, Green and colleagues have demonstrated that the C-terminus mediates interactions with IF (Stappenbeck and Green, 1992; Stappenbeck et al., 1993; see also below). At least two Cterminal subdomains are involved in this binding. An additional 48–68 residue region at the C-terminus is critical for keratin, but not vimentin, association (Stappenbeck et al., 1993). The rod domain apparently mediates aggregation of desmoplakin molecules, thus contributing to desmosomal plaque architecture (Stappenbeck and Green, 1992; Bornslaeger et al., 1996): yeast two-hybrid studies indicate that the carboxyl portion of the rod contains a site essential for dimerization (Meng et al., 1997). The N-terminal domain targets Dp to the outer plaque (Stappenbeck et al., 1993; Bornslaeger et al., 1996) and clusters plakoglobin-desmosomal cadherin complexes into discrete plasma membrane domains (Kowalczyk et al., 1997). Consistent with this, immunogold labelling shows the Dp N-terminus to lie in the outer plaque and the C-terminus in the zone of IF attachment (North et al., 1999) (Figure 4.1). Smith and Fuchs (1998) have shown that targeting of Dp to desmosomes is disrupted by deletion of only about 10% of its N-terminal sequence, and that only 86 residues of the N-terminal residues are sufficient for desmosomal targeting. Transfection of cells with Dp lacking the C-terminus (Bornslaeger et al., 1996), causes formation of abnormal junctions in which desmosomal (Dp, desmosomal cadherins) and adherens junction (E-cadherin, α- and β-catenin) components merge, suggesting that the C-terminal domain may be involved in segregating desmosomes from other junctions. In endothelial cells, molecular interactions and junctional associations of Dp differ from those in epithelial cells. Kowalczyk et al. (1998) have shown that a Dp amino terminal peptide is recruited into cell junctions in association with VE-cadherin, plakoglobin and βcatenin, suggesting the formation of junctional complexes which associate with both the actin and intermediate filament cytoskeletons.
D.R.GARROD ET AL. 73
Desmoplakin Homologues: Envoplakin, Periplakin and Plectin Dp belongs to a protein family, recently termed the plakin family (Uitto et al., 1996; Ruhrberg and Watt, 1997), which includes plectin, envoplakin, periplakin and BPAG1 (bullous pemphigoid antigen 1 or BP230), which is a component of hemidesmosomes. All have predicted structures consisting of a rod domain of variable length flanked by globular end domains (reviewed by Green and Jones, 1996; Ruhrberg and Watt, 1997). The Cterminal domains have different numbers of conserved subdomains, which may be involved in binding to different types of IFs (Stappenbeck et al., 1993). The plakins are predicted to form homodimers or heterodimers via the heptad repeats of the central rod. Envoplakin (Ruhrberg et al., 1996), a precursor of the cornified envelope of epidermis, is expressed in stratified squamous epithelia, but not in simple epithelia or in nonepithelial cells. With a molecular mass of 210 kDa, it is derived from a 6.5 kb mRNA transcribed from a single copy gene. Its up regulation during terminal differentiation and its colocalisation with Dp at desmosomes and on keratin filaments suggests a role in linking the cornified envelope to the desmosome-IF network. Periplakin (Ruhrberg et al., 1997), a 195 kDa protein, associates with the desmosomal plaque and with keratin filaments in the differentiated layers of the epidermis. Like envoplakin it was originally identified as a cornified envelope precursor (Simon and Green, 1984). Periplakin and envoplakin co-immunoprecipitate and immunolocalisation indicates that they form a network radiating out from desmosomes (Ruhrberg et al., 1996; Ruhrberg et al., 1997). Together the proteins may provide a scaffolding onto which the cornified envelope is assembled (Ruhrberg et al., 1997). Plectin is a 300 kDa multifunctional IF-associated protein which is widely distributed among tissues, and which forms homotetramers up to 200 nm long and 2–3 nm wide (Foisner and Wiche, 1987, 1991; Svitkina et al., 1996). Believed to be a versatile cytoplasmic cross-linker, it interacts with multiple proteins, crosslinking IFs and connecting them to microtubules, actin microfilaments and membrane adhesion sites including desmosomes and hemidesmosomes (Foisner and Wiche, 1991; Svitkina et al., 1996; Eger et al., 1997). Plectin binding to DP has been demonstrated in vitro (Eger et al., 1997) and a cytokeratin binding site has been identified in the C-terminus (Nikolic et al., 1996). A number of alternatively spliced plectin variants may be involved in these diverse interactions (McLean et al., 1996; Elliott et al., 1997). The disease muscular dystrophy associated with epidermolysis bullosa simplex (MD-EBS) has been linked to plectin mutations (Gache et al., 1996; McLean et al., 1996; Pulkinnen et al., 1996; Smith et al., 1996). Electron microscopy of patients epidermis showed disruption of the inner plaques of hemidesmosomes and keratin filament detachment. However, no disruption of desmosomes was observed and desmosomes were unaffected in plectin-deficient mice (Andrä et al., 1997) suggesting that plectin is not indispensable in desmosomes.
74 D.R.GARROD ET AL.
Intermediate Filament Attachment and Accessory Plaque Proteins The principal desmosomal component involved in mediating interactions between IFs and the desmosomal plaque is Dp. Cell transfection experiments using mutant desmoplakin constructs have shown that the C-terminus of desmoplakin can interact with both keratin and vimentin IFs (Stappenbeck and Green, 1992; Stappenbeck et al., 1993) in a phosphorylation-dependent manner (Stappenbeck et al., 1994). Direct interactions between Dp and IF proteins have also been demonstrated in vitro (Kouklis et al., 1994; Meng et al., 1997). Specific IF types interact with DP via distinct sequences in different IF domains (Meng et al., 1997). Thus type II epidermal keratins bind to the Dp C-terminus via sequences in the N-terminal head domain of a single keratin polypeptide chain, while the interaction of Dp with simple epithelial keratins requires the presence of both type I and type II partner proteins, indicating the importance of the tertiary structure of the αhelical coiled coil (Meng et al., 1997). The interactions of the Dp C-terminus with type III IF proteins (e.g. vimentin) is weaker than with epidermal keratins (Meng et al., 1997), but may be strengthened in vivo by the formation of coiled-coil Dp dimers, since strong alignment of Dp with vimentin IF in transient transfections has been shown to require the Dp rod domain (Stappenbeck and Green, 1992; Stappenbeck et al., 1993). The physiological relevance of Dp-IF binding has been confirmed by the expression of Dp Nterminal polypeptides in stably transfected cell lines: these polypeptides act in a dominant negative manner to produce disrupted Junetional structures which lack associated keratin filaments (Bornslaeger et al., 1996). Further members of the plakin family are strong candidates for a role in IF-desmosome attachment, both by their localisation to the region where IF insert into the plaque and by their homology to Dp. Plectin has been reported to bind both Dp and IF and by immunoelectron microscopy lies further from the desmosomal membrane than Dp: it could thus function as a linker between them (Eger et al., 1997). Intermediate filament Associated Protein (IFAP) 300, a vimentin IF-binding protein, localises to desmosomes and hemidesmosomes at the region where IF attach to the inner plaque and has been demonstrated to bind keratins in vitro (Skalli et al., 1994): the relationship of this protein to plectin remains unclear. The sequence similarity of envoplakin and periplakin to Dp, together with their localisation to desmosomes and along keratin IF, may also indicate an involvement in anchoring filaments to desmosomes (Ruhrberg et al., 1997). Alternatively these proteins may mediate cross-linking and stabilisation of desmosome-associated IF, rather than themselves anchoring the filaments. A further component which may be particularly important in this latter role, namely the organisation and/or stabilisation of a mature desmosome-IF network is pinin (originally known as the O8L antigen; Ouyang and Sugrue, 1992). This 140kDa desmosomal accessory protein is located at the periphery of the plaque of only mature desmosomes of epithelia, its temporal appearance here apparently correlating with the establishment of a highly-organised desmosome- IF complex (Ouyang and Sugrue, 1996). However, reservations about a desmosomal role for pinin have recently been expressed (Brandner et al., 1997).
D.R.GARROD ET AL. 75
A number of other desmosomal components located nearer to the plasma membrane may also be involved in IF attachment. Visualisation of isolated Dsg1 tails by rotary shadowing has revealed a head portion of ~ 4 nm diameter, presumed to reside near to the membrane, and a thin tail some 19 nm long (Rutman et al., 1994). It has been proposed that this long tail portion, which contains basic residues, could stretch across the plaque and thus be favourably located to bind IF (Nilles et al., 1991). Such binding has not been demonstrated. Pp1 has been demonstrated to bind cytokeratins in vitro (Kapprell et al., 1988; Hatzfeld et al, 1994; Smith and Fuchs, 1998) yet by immunogold labelling lies within the outer, rather than inner, plaque domain (North et al., 1999, Figure 4.1). Desmocalmin (bovine form; the human form is known as keratocalmin (Fairley et al., 1991) is a 240 kDa calmodulin-binding plaque protein which is expressed only in stratified epithelia (Tsukita and Tsukita, 1985). Like Pp1, desmocalmin is localised immediately subjacent to the plasma membrane yet binds to polymerised keratin IF in vitro (Tsukita and Tsukita, 1985). How can the in vitro binding results be reconciled with apparent physical separation of Pp1 and desmocalmin from the inserting IF? Two possible explanations are either that the in vitro binding to keratin IF of some of the above proteins is not physiologically relevant, or that the keratins may actually approach nearer to the membrane than previously supposed. Leloup et al. (1979) suggested that the traversing filaments were unraveled protofilaments from terminating IF. Recent expression studies have shown that DP proteins containing both the rod and C-terminal domains aggregate with IF proteins to form structures that resemble the 4–5 nm traversing filaments of the inner plaque (Stappenbeck and Green, 1992). This meshwork is not seen with Dp alone, suggesting that IF may be present in the plaque as an anastomosing network of fine filaments associated with Dp (Bornslaeger et al., 1994). CONCLUSION Experimental confirmation of the adhesive role of desmosomal glycoproteins and recent discoveries on the interactions between molecules in the desmosomal plaque have greatly increased our understanding of these junctions. However, much more detailed knowledge is required, as well as a clearer insight into how they relate to desmosome structure. Further important issues are the process of desmosome assembly and breakdown, and the dynamic regulation of desmosomal adhesion. These topics have been reviewed recently (Garrod et al., 1996; 1998; Burdett, 1998). These reviews indicate the likelihood that both “inside-out” and “outside-in” signalling are involved in the regulation of desmosomal adhesion. A much greater understanding of the function of desmosomes in the epidermis is required. An important question relates to the function of the differential expression of desmosomal glycoproteins and plakophilins in epidermis. Do the patterns represent differential adhesion in different epidermal layers and, if so, how is this important in relation to epidermal structure and morphogenesis? Alternatively, could these patterns somehow generate signals that provide positional information to regulate epidermal differentiation?
76 D.R.GARROD ET AL.
REFERENCES Adams, C.L., Nelson, W.J., & Smith, SJ. (1996). Quantitative analysis of cadherin-cateninactin reorganization during development of cell-cell adhesion. J. Cell Biol. 135:1899–1911. Adams, MJ., Reichel, MB., King, LA, Marsden, M.D., Greenwood, M.D., Thirlwell, H., Arnemann, J., Buxton, R.S. and Ali, R.R. (1998). Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens. Biochem. J. 329:165–174. Allen, E., Yu, Q-C BeFuchs, E. (1996). Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J. Cell Biol. 133: 1367–1382. Amagai, M., Hashimoto, T., Shimizu, N. & Nishikawa, T. (1994a). Absorption of pathogenic antibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:59–67. Amagai, M., Karpati, S., Klaus-Kovtun, V., Udey, M.C. & Stanley, J.R. (1994b). The extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J. Invest. Dermatol. 102:402–408. Amagai, M., Fujimori, T., Masunaga, T., Shimizu, N., Takeichi, M. and Hashimoto, T. (1995a). Delayed assembly of desmosomes in keratinocytes with disrupted classic-cadherin-medicated cell adhesion by a dominant negative mutant. J. Invest. Dermatol. 104:27–32. Amagai, M., Hashimoto, T., Green, K.J., Shimizu, N. & Nishikawa, T. (1995b). Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104:895–901. Amagai, M., Wang, Y., Minoshima, S., Kawamura, K., Green, K.J., Nishikawa, T. & Shimizu, N. (1995c). Assignment of the human genes for desmocollin 3 (DSC3) and desmocollin 4 (DSC4) to chromosome 18q12. Genomics 25:330–332. Amagai, M., Koch, P.J., Nishikawa, T. & Stanley, J.R. (1996). Pemphigus vulgaris antigen (desmoglein 3) is localised in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106:351–355. Andrā,K., Lassmann,H., Bittner,R., Shorny,S., Fāssler,R., Propst,F. & Wiche,G. (1997). Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev. 11:3143–3156. Angst, B.D., Nilles, L.A. & Green, K.J. (1990). Desmoplakin II expression is not restricted to stratified epithelia. J. Cell Sci. 97:247–257. Anhalt, G.J., Labib, R.S., Voorhees, J.J., Beals, T.F. & Diaz, L.A. (1982). Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Eng.J.Med. 306: 1189–1196. Anhalt, G.J., Till, G.O., Diaz, L.A., Labib, R.S., Patel, H.P. & Eaglstein, N.F. (1986). Defining the role of complement in experimental pemphigus vulgaris in mice. J. Immunol. 137: 2835–2840. Arnemann, J., Spurr, N.K., Magee, A.I. & Buxton, R.S. (1992). The human gene (DSG2) coding for HDGC, a second member of the desmoglein subfamily of the desmosomal cadherins, is, like DSG1 coding for DG1, assigned to chromosome 18. Genomics 13:484–486. Arnemann,J., Sullivan, K.H., Magee, A.I., King, L.A. & Buxton, R.S. (1993). Stratification-related expression of isoforms of the desmosomal cadherins in human epidermis. J. Cell Sci. 104: 741–750.
D.R.GARROD ET AL. 77
Barth, A.I.M., Näthe, I.S. & Nelson, W.J. (1997). Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Current Opinion in Cell Biology 9: 683–690. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedle, R. & Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638–642. Bierkamp, C., McLaughlin, K.J., Schwartz, H., Huber O. & Kemler, R. (1996). Embryonic heart and skin defects in mice lacking plakoglobin. Dev. Biol. 180:780–785. Blaschuk, O.W., Sullivan, R., David, S. & Pouliot, Y. (1990). Indentification of a cadherin cell adhesion recognition sequence. Dev. Biol. 139:227–229. Bornslaeger, E.A., Stappenbeck, T.S., Kowalczyk, A.P., Palka, H.L. & Green, K.J. (1994). Molecular genetic analysis of desmosomal proteins. In Molecular biology of desmosomes and hemidesmosomes. Collins, J.E. & Garrod, D.R. (eds). RG Landes Company, Austin, pp. 35–52. Bornslaeger, E.A., Corcoran, C.M., Stappenbeck, T.S. & Green, K.J. (1996). Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J. Cell Biol. 134:985–1001. Brakenhoff, R.H., Gerretsen, M., Ellen, M.C., Knippels., van Dijk, M., van Essen, H., Weghuis, D.O., Sinke, R.J., Snow, G.B. & van Dongen, G.A.M.S. (1995). The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparantly involved in keratinocyte cell-cell adhesion. J. Cell Biol. 129:1677–1689. Brandner, J.M., Reidenbach, S. & Franke, W.W. (1997). Evidence that “pinin”, reportedly a differentiation-specific desmosomal protein, is actually a widespread nuclear protein. Differentiation 62:119–127. Burdett, I.D. (1998). Aspects of the structure and assembly of desmosomes. Micron 29:309–328. Butz, S., Stappert, J., Weissig, H. & Kemler, R. (1992). Plakoglobin and -catenin: distinct but closely related. Science. 257:1142–1144. Butz, S. & Kemler, R. (1994). Distinct cadherin-catenin complexes in Ca2+-dependent cell-cell adhesion. FEBS Lett. 355:195–200. Buxton, R.S. &Magee, A.I. (1992). Structure and interactions of desmosomal and other cadherins. Seminars in Cell Biology, 3:157–167. Buxton, R.S., Wheeler, G.N., Pidsley, S.C., Marsden, M.D., Adams M.J., Jenkins N.A., Gilbert, DJ. & Copeland N.G. (1994). Mouse desmocollin (DSC3) and desmoglein (DSG1) genes are closely linked in the proximal region of chromosome 18 . Genomics 21:510–516. Chidgey, M.A.J. (1997). Desmosomes and disease. Histol. Histopath. 12, 1159–1168. Chidgey, M.A.J., Clarke, J.P. & Garrod, D.R. (1996). Expression of full length desmosomal glycoproteins (desmocollins) is not sufficient to confer strong adhesion in transfected L929 cells. J. Invest. Dermatol. 106:689–695. Chidgey, M.A.J., Vue, K.K.M., Gould, S., Byrne, C., & Garrod, D.R. (1997). Changing pattern of desmocollin 3 expression accompanies epidermal organisation during skin development. Dev. Dyn. 210:315–327. Chitaev, N.A., Leube,. E., Troyanovsky, Eshkind, L.G., & Franke, W.W. (1996). The binding of plakoglobin to desmosomal cadherins: Patterns of binding sites and topogenic potential. J. Cell Biol. 133:359–369. Chitaev, N.A. & Troyanovsky, S.M. (1997). Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J. Cell Biol. 138:193–201.
78 D.R.GARROD ET AL.
Chitaev, N.I., Averbakh, A.Z., Troyanovsky, R.B. & Troyanovski, S.M. (1998). Molecular organization of the desmoglein-plakoglobin complex. J. Cell Sci. 111:1941–1949. Collins J.E., Lorimer, J.E.,Garrod, D.R., Pidsley, S.C., Buxton, R.S. & fleming, T.P. (1995). Regulation of desmocollin transcription in mouse preimplantation embryos. Development 121:743–752. Cowin, P. & Burke, B. (1996). Cytoskeleton-membrane interaction. Curr. Opin. Cell Biol. 8: 56–65. Cowin, P., Kapprell, H.-P., Frank, W.W., TamkunJ. & Hynes, R.O. (1986). Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell. 46:1063–1073. Cowin, P., Mattey, D.L. & Garrod, D.R. (1984). Identification of desmosomal surface components (desmocollins) and inhibition of desmosome formation by specific Fab’. J. Cell Sci. 70:41–60. Denning, M.F., Guy, S., Ellerbroek, S.M., Norvell, S.M., Kowalczyk, A.P. & Green, K.J. (1998). The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. Experimental Cell Research. 239:50–59. Dmochowski, M., Hashimoto, T., Chidgey, M.A.J., Yue, Y.Y.M., Wilkinson, R.W., Nishikawa, T. & Garrod, D.R. (1995). Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera. Brit. J. Dermatol. 133:519–525. Eger, A., Stockinger, A., Wiche, G. & Foisner, R. (1997). Polarization dependent association of plectin with desmoplakin and the lateral submembrane skeleton in MDCK cells. J.Cell Sci. 110:1307–1316. Elliott, C.E., Becker, B., Oehler, S., Castanon, M.J., Hauptman, R. & Wiche, G. (1997). Plectin transcript diversity: Identification and tissue distribution of variants with distinct first coding exons and rodless isoforms. Genomics 42:115–125. Esaki, C., Sheshima, M., Yamanda, T., Osanda, K. & Kitajima, Y. (1995). Pharmacologie evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4, 5-triphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma cell line. J.Invest. Dermatol. 105:329–333. Fairley, J.A., Scott, G.A., Jensen, K.D., Goldsmith, L.A. & Diaz, L.A. (1991). Characterization of keratocalmin, a calmodulin-binding protein from human epidermis. J. Clin. Invest. 88: 315–22.’ Fleming, T.P., Garrod, D.R. & Elsmore, AJ. (1991). Desmosome biogenesis in the mouse preimplantation embryo. Development 112:527–539. Foisner, R. & Wiche, G. (1987). Structure and hydrodynamic properties of plectin molecules. J. Mol. Biol. 198:515–31. Foisner, R. & Wiche, G. (1991). Intermediate filament-associated proteins. Curr. Opin. Cell Biol. 3:75–81. Franke, W.W., Goldschmidt, M.D., Zimbelmann, R., Mueller, H.M., Schiller, D.L. & Cowin, P. (1989). Molecular cloning and amino acid sequence of human plakoglobin, the common junctional plaque protein. Proc. Nat. Acad. Sci. USA. 86:4027–4031. Funayama, N., Fagotto, F., McCrea, P. & Gumbiner, B.M. (1995). Embryonic axis induction by the armadillo repeat domain of -catenin: evidence for intracellular signalling. J. Cell Biol. 128: 959–968. Cache, Y., Chavanas, S., Lacour, J.P., Wiche, G., Owaribe, K., Meneguzzi, G. & Ortonne, J.P. (1996). Defective expression of plectin/HDl in epidermolysis bullosa simplex with muscular dystrophy. J. Clin. Invest. 97:2289–2298. Garrod, D.R. (1993). Desmosomes and hemidesmosomes. Current Opinion in Cell Biology 5: 30–40.
D.R.GARROD ET AL. 79
Garrod, D., Chidgey, M. & North, A. (1996). Desmosomes; differentiation, development, dynamics and disease. Curr. Opin. Cell Biol. 8:670–678. Garrod, D.R., Tselepis, C., Runswick, S.K., North, A.J., Wallis, S.R. & Chidgey, M.A.J. (1998). Desmosomal adhesion. In “The Adhesive Interactions of Cells” Ed. D. Garrod, M.A.J. Chidgey and A.J. North.28:165–202. Gorbsky, G. & Steinberg, M.S. (1981). Isolation of the intercellular glycoproteins of desmosomes. J. Cell Biol. 90:243–248. Green, K.J. & Jones, J.C.R. (1996). Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB Journal 10:871–881. Gumbiner, B.M. (1995). Signal transduction by -catenin. Curr. Opin. Cell Biol. 7:634–640. Hashimoto, K., Safran, K.M., Webber, P.S., Lazarus, G.S. & Singer, K.H. (1983). Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J. Exp. Med. 157:259–272. Hashimoto, T., Amagai, M., Parry, D.A., Dixon, T.W., Tsukita, S., Tsukita, S., Miki, K., Sakai, K., Inokuchi, Y. & Kudoh, J. (1993). Desmoyokin, a 680 kDa keratinocyte plasma membraneassociated protein, is homologous to the protein encoded by human gene AHNAK. J. Cell Sci. 105:275–286. Hatzfeld, M., Kristjansson, G.I., Plessmann, U. & Weber, K. (1994). Band 6 protein, a major constituent of desmosomes from stratified epithelia, is a novel member of the armadillo multigene family. J. Cell Sci. 107:2259–2270. Heid, H.W., Schmidt, A., Zimbelmann, R., Schäfer, S., Winter-Simanowski, S., Stumpp, S., Keith, M., Figge, U., Schnölzer, M. & Franke, W.W. (1994). Cell-type specific desmosomal plaque proteins of the plakoglobin family: plakophilin (band 6 protein). Differentiation 58: 113–131. Hennings, H. & Holbrook, K.A. (1983). Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. Exp. Cell Res. 143:127–142. Hiipakka, R.A. (1996). Molecular cloning and sequencing of the rat plakoglobin cDNA. GenBank Data library (accession no. U58858). Holton, J.L., Kenny, T.P., Legan, P.K., Collins, J.E., Keen, J.N., Sharma, R. & Garrod, D.R. (1990). Desmosomal glycoproteins 2 and 3 (desmocollins) show N-terminal similarity to calcium-dependent cell-cell adhesion molecules. J. Cell Sci. 97:239–246. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, E.G. & Kemler, R. (1996). Nuclear localization of -catenin by interaction with transcription factor LEF-1. Mech. Dev. 59:3–10. Jou, T.S., Stewart, D.B., Stappert, J., Nelson, W.J., & Marrs, J.A. (1995). Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc. Nat. Acad. Sci. USA. 92:5067–5071. Kapprell, H.-P., Owaribe, K. & Franke,W.W. (1988). Identification of a basic protein of Mr 75, 000 as an accessory desmosomal plaque protein in stratified and complex epithelia. J. Cell Biol. 106:1679–1691. Karnovsky, A., & Klymkowsky, M.W. (1995). Anterior duplication in Xenopus induced by the overexpression of the cadherin-binding protein plakoglobin. Proc. Natl. Acad. Sci. USA. 92: 4522–4526. King, LA., Sullivan, K.H., Bennett, R. & Buxton, R.S. (1995). The desmocollins of human foreskin epidermis: identification and chromosomal assignment of a third gene and expression patterns of the three isoforms. J. Invest. Dermatol. 105:314–321.
80 D.R.GARROD ET AL.
King, LA., O’Brien, T.J. & Buxton, R.S. (1996). Expression of the “skin-type” desmosomal cadherin DSC1 is closely linked to the keratinization of epithelial tissues during mouse development. J. Invest. Dermatol. 107:531–538. King, L.A., Angst, B.D., Hunt, D.M., Krugar, M., Arnemann, J. & Buxton, R.S. (1997). Hierarchical expression of desmosomal cadherins during stratified epithelial morphogenesis in the mouse. Differentiation. 62:83–96. Klymkowsky, M.W. & Parr, B. (1995). The body language of cells: the intimate connection between cell adhesion and behaviour. Cell 83:5–8. Knudsen, K.A. & Wheelock, MJ. (1992). Plakoglobin, or an 83 kD homologue distinct from -catenin interacts with E-cadherin and N-cadherin. J. Cell Biol. 118:671–679. Koch, P.J., Walsh, M.J., Schmelz, M., Goldschmidt, M.D., Zimbelmann, R., & Franke W.W. (1990). Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur. J. Cell. Biol. 53:1–12. Koch, P.J., Mahoney, M.G., Ishikawa, H., Pulkkinen, L., Uitto, J., Shultz, L., Murphy, G.F., Whitaker-Menezes, D. & Stanley, J.R. (1997). Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes a loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J.Cell Biol. 137:1091–1102. Koch, P.J., Mahoney, M.G., Cotsarelis, G., Rothenberger, K, Lavker, R.M. & Stanley, J.R. (1998). Desmoglein 3 anchors telogen hair in the folicle. J. Cell Sci. 111:2529–2537. Korman N.J., Eyre R.W., Klaus-Kovtum V. & Stanley J.R. (1989). Demonstration of an adheringjunction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. New Eng. J. Med. 321:631–635. Kouklis, P.D., Hutton, E. & Fuchs, E. (1994). Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. J. Cell Biol. 127:1049–1060. Kowalczyk A.P., Palka H., Luu H.N., Milles L.A., Anderson J.E., Wheelock M.J. & Green K.J. (1994). Posttranslational regulation of plakoglobin expression: influence of the desmosomal cadherins on plakoglobin metabolic stability . J. Biol. Chem. 269:31214–31223. Kowalczyk, A.P., Borgwardt, J.E. & Green, K.J. (1996). Analysis of desmosomal cadherinadhesive function and stoichiometry of desmosomal cadherin-plakoglobin complexes. J.Invest. Dermatol. 107:293–300. Kowalczyk A.P., Bornslaeger E.A., Borgwardt J.E., Palka H.L., Dhaliwal A.S., Corcoran C.M., Denning M.F. & Green K.J. (1997). The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J. Cell Biol. 139: 773–784. Kowalczyk, A.P., Navarro, P., Dejana, E., Bornslaeger, E.A., Green, K.J., Kopp, D.S. & Borgwardt, J.E. (1998). VE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plako-globin in the recruitment of desmoplakin to intercellular junctions. J.Cell Sci. 111:3045–3057. Kurzen, J., Moll, I., Moll, M., Schäfer, S., Simics, E., Amagai, M., Wheelock, MJ. & Franke, W.W.(1998).Compositionally different desmosomes in the various compartments of the human hair follicle. Differentiation 63:295–304. Lavker, R.M. & Sun, T.T. (1983). Epidermal stem cells. J. Invest. Dermatol. 81:121s-127s. Legan, P.K., Collins, J.E. & Garrod, D.R. (1992). The molecular biology of desmosomes and hemidesmosomes: “What’s in a name?”BioEssays 14:385–393. Legan, P.K., Yue, K.K.M., Chidgey, M.A.J., Holton, J.L., Wilkinson, R.W. & Garrod, D.R. (1994). The bovine desmocollin family: a new gene and expression patterns reflecting epithelial cell proliferation and differentiation. J Cell Biol. 126:507–518.
D.R.GARROD ET AL. 81
Leloup, P., Laurent, L., Ronveaux, M., Drochmans, P. & Wanson, J.-C. (1979). Desmosomes and desmogenesis in the epidermis of calf muzzle. Biol. Cellulaire 34:137–152. Lewis, J.E., Wahl III, J.K., Sass, K.M., Jensen, P.J., Johnson, K.R. & Wheelock, M.J. (1997). Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J. Cell Biol. 136:919–934. Marcozzi, C., Burdett, I.D., Buxton, R.S. & Magee, A.I. (1998). Co-expression of both types if desmosomal cadherin and plakoglobin confers strong intercellular adhesion. J. Cell Sci. 111: 495–509. Mathur, M., Goodwin, L. & Cowin, P. (1994). Interactions of the cytoplasmic domain of the desmosomal cadherin Dsgl with plakoglobin. J. Biol. Chem. 269:14075–14080. Mattey, D.L. & Garrod. D.R. (1985). Mutual desmosome formation between all binary combinations of human, bovine, canine, avian and amphibian cells: desmosome formation is not tissue- or species-specific. J. Cell Sci. 75:377–399. Mattey, D.L. & Garrod, D.R. (1986a). Calcium-induced desmosome formation in cultured kidney epithelial cells. J. Cell Sci. 85:95–111. Mattey, D.L. & Garrod, D.R. (1986b). Splitting and internalisation of the desmosomes of cultured kidney epithelial cells by reduction in calcium concentration. J. Cell Sci. 85:113–124. McGrath, J.A., McMillan, J.R., Shemanko, C.S., Runswick, S.K., Leigh, I.M., Lane, E.B., Garrod, D.R. & Eady, A.J. (1997). Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nature Gen. 17:240–244. McLean, W.H., Pulkkinen, L., Smith, F.J., Rugg, E.L., Lane, E.B., Bullrich, F., Burgeson, R.E., Amano, S., Hudson, D.L. & Owaribe, K., et al. (1996). Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organisation. Genes Dev. 10: 1724–1735. Meng, J.-J., Bornslaeger, E.A., Green, K.J., Steinert, P.M. &Ip, W. (1997). Twohybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell typespecific intermediate filaments. J. Biol. Chem. 272:21495–21503. Messent, A.J., Blissett, M.J., Smith, G.L., North, A.L., Magee, A., Foreman, D., Garrod, D.R. & M. Boulton (2000). Expression of a single pair of desmosomal glycoproteins renders the corneal epithelium unique amongst stratified epithelia. Invest. Ophathal. Vis. Sci. 41:8–15. Mertens, C., Kahn, C. & Frank, W.W. (1996). Plakophilins 2a & 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque. J. Cell Biol. 135:1009–1025. Miller, K., Mattey, D., Measures, H., Hopkins, C. & Garrod, D. (1987). Localization of the protein and glycoprotein components of bovine nasal epithelial desmosomes by immunoelectron microscopy. EMBO J. 6:885–889. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek., V., Roose, J., Destree, O. & Clevers, H. (1996). XTcf-3 transcription factor mediates -catenin-induced axis formation in xenopus embryos. Cell 86:391–399. Nagar, B., Overduin, M., Ikura, M. & Rini, J.M. (1996). Structural basis of calcium-induced Ecadherin rigidifiction and dimerization. Nature 380:360–364. Näthke, I.S., Hinck, L., Swedlow, J.R., Papkoff, J. & Nelson, J.W. (1994). Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J. Cell Biol. 125:1341–1352. Nikolic, B., MacNulty, E., Mir, B. & Wiche, G. (1996). Basic amino acid residue cluster within nuclear targeting sequence motif is essential for cytoplasmic plectin-vimentin network junctions. J. Cell Biol. 134:1455–1467.
82 D.R.GARROD ET AL.
Nilles, L.A., Parry, D.A.D., Powers, E.E., Angst, B.D., Wagner, R.M. & Green, K.J. (1991). Structural analysis and expression of human desmoglein: a cadherin-like component of the desmosome. J. Cell Sci. 99:809–821. North, A.J., Chidgey, M.A.J., Clarke, J.P., Bardsley, W.G. &Garrod, D.R. (1996). Distinct desmocollin isoforms occur in the same desmosomes and show reciprocally graded distributions in bovine nasal epidermis. Proc. Natl. Acad. Sci. USA 93:7701–7705. North, A.J., Bardsley, W.G., Hyam, J., Bornslaeger, E.A., Cordingley, H.C., Trinnaman, B., Hatzfeld, M., Green, K.J., Magee, A.I. & D.R. Garrod (1999). Molecular map of the desmosomal plaque. J. Cell Science. 112:4325–4336. Norvell, S.M. and Green, K.J. (1998). Contributions of extracellular and intracellular domains of full length and chimeric cadherin molecules to junctiona assembly in epithelial cells. J. Cell Sci. 111:1305–1318. Nose, A., Tsuji, K. & Takeichi, M. (1990). Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 61:147–155. Nuber, U.A., Schäfer, S., Schmidt, A., Koch, PJ. & Franke, W.W. (1995). The widespread human desmocollin Dsc2 and tissue-specific patterns of synthesis of various desmocollin subtypes. Eur. J. Cell Biol. 66:69–74. O’Keefe, E.J., Briggaman, R.A. & Herman, B. (1987). Calcium-induced assembly of adherens junctions in keratinocytes. J. Cell Biol. 105:807–817. Osada, K, Seishima, M. & Kitajima, Y. (1997). Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J. Invest. Dermatol. 108:482–487. Ouyang, P. & Sugrue, S.P. (1992). Identification of an epithelial protein related to the desmosome and intermediate filament network. J. Cell Biol. 118:1477–1488. Ouyang, P. & Sugrue, S.P. (1996). Characterisation of pinin, a novel protein associated with the desmosome-intermediate filament complex. J. Cell Biol. 135:1027–1042. Overton, J. (1977). Formation of junctions and cell sorting in aggregates of chick and mouse cells. Dev. Biol. 55:103–116. Ozawa, M., Nuruki, K, Toyoyama, H. & Ohi Y. (1995a). Cloning of an alternative form of plakoglobin ( -catenin) lacking the fourth armadillo repeat. J. Biochem. 118:836–840. Ozawa, M., Terada, H. & Pedraza, C. (1995b). The fourth armadillo repeat of plakoglobin (catenin) is required for its high affinity binding to the cytoplasmic domains of E-cadherin and desmosomal cadherin Dsg2, and the tumor suppressor APC protein. J. Biochem. 118: 1077–1082. O’Keefe, E.J., Erickson, H.P. & Bennett, V. (1989). Desmoplakin I and desmoplakin II. Purification and characterisation. J. Biol. Chem. 264:8310–8318. Palka, H.L., & Green, K.J. (1997). Roles of plakoglobin end domains in desmosome assembly. J. Cell Sci. 110:2359–2371. Peifer, M., McCrea, P.D., Green, K.J., Wieschaus, E. & Gumbiner, B.M. (1992). The vertebrate adhesive junction proteins -catenin and plakoglobin and the segment polarity gene armadillo form a multigene family with similar properties. J. Cell Biol. 118:681–691. Peifer, M., Pai, L.M. & Casey, M. (1994). Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and Zeste-white 3 kinase. Dev. Biol. 166: 543–556. Peifer, M. (1995). Cell adhesion and signal transduction: the Armadillo connection. Trends in Cell Biology 5:224–229.
D.R.GARROD ET AL. 83
Piepenhagen, P.A. & Nelson, W.J. (1993). Defining E-cadherin-associated protein complexes in epithelial cells: plakoglobin, beta- and gamma-catenin are distinct components. J. Cell. Sci. 104:751–762. Polakis, P. (1995). Mutations in the APC gene and their implications for protein structure and function. Curr. Opin. Genet. Dev. 5:66–71. Pulkkinen, L., Smith, F.J.D., Shimizu, H., Murata, S., Yaoita, H., Hachisuka, H., Nishikawa, T., McLean, W.H.I. &Uitto J. (1996). Hum. Mol. Genet. 5:1539–1546. Riggleman, B., Wieschaus, E. & Schedl, P. (1989). Molecular analysis of the armadillo locus: uniformly distributed transcripts and a protein with novel internal repeats are associated with a Drosophila segment polarity gene. Genes Dev. 3:96–113. Roh, J.-Y. & Stanley, J.R. (1995). Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen) in keratinocytes requires the cadherin-like intracytoplasmic segment. J. Invest. Dermatol. 104:720–724. Roscoe, J.T., Diaz, L., Sampaio, S.A.P., Castro, R.M., Labib, R.S., Takahashi, Y., Patel, H., & Anhalt, G.J. (1985). Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J. Invest. Dermatol. 85:538–541. Rubenstein, A., Merriam, J. & Klymkowsky, M.W. (1997). Localizing the adhesive and signaling functions of plakoglobin. Dev. Genet. 20:91–102. Rubinfeld, B., Souza, B., Albert, I., Munemitsu, S. & Polakis, P. (1995). The APC protein and Ecadherin form similar but independent complexes with -catenin, -catenin and plakoglobin. J. Biol. Chem. 270:5549–5555. Ruhrberg, C. & Watt, F.M. (1997). The plakin family: versatile organizers of cytoskeletal architecture. Curr. Opin. Genet. Dev. 7:392–397. Ruhrberg, C., Hajibagheri, M.A.N., Parry, D.A.D. & Watt, F.M. (1997). Periplakin, a novel component of cornified envelopes and desmosomes that belong to the plakin family and forms complexes with envoplakin. J. Cell Biol. 139:1835–1849. Ruhrberg, C., Hajibagheri, M.A.N., Simon, M., Dooley, T.P. & Watt, F.M. (1996). Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J. Cell Biol. 134:715–729. Ruiz, P., Brinkmann, V., Ledermann, B., Behrend, M., Grund, C., Thalhammer, C., Vogel, F., Birchmeier, C., Gunthert, U., Franke, W.W. & Birchmeier, W. (1996). Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J. Cell Biol. 135:215–225. Runswick S.K., Garrod, D.R. & Streuli C.H. (1996). The differential expression of desmocollin isoforms in mammary epithelia. Biochem. Soc. Trans. 346S. Rutman, A.J., Buxton, R.S. & Burdett, I.D.J. (1994). Visualisation by electron microscopy of the unique part of the cytoplasmic domain of a desmoglein, a cadherin-like protein of the desmosome type of cell junction. FEBS Lett. 352:194–196. Sacco, P.A., McGranahan, T.M., Wheelock, M.J. & Johnson, K.R. (1995). Identification of plakoglobin domains required for association with N-cadherin and a-catenin. J. Biol. Chem. 270:20201–20206. Schäfer, S., Koch, P.J. & Franke, W.W. (1994). Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins. Exp. Cell Res. 211:391–399. Schiltz, J.R. & Michel, B. (1976). Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J. Invest. Dermatol. 67:254–260.
84 D.R.GARROD ET AL.
Schmelz, M., Moll, R., Kuhn, C. & Franke, W.W. (1994). Complexus adhaerentes, new group of desmoplakin-containing junctions in endothelial cells: II. Different types of lymphatic vessels. Differentiation 57:97–117. Schmelz, M., Moll, R., Kuhn, C. & Franke, W.W. (1994). Complexus adhaerentes, a new group of desmoplakin-containing junctions in endothelial cells: II. Different types of lymphatic vessels. Differentiation 57:97–117. Schmidt, A., Langbein, L., Rode, M., Prätzel, S., Zimbelmann, R. &: Franke, W.W. (1997). Plakophilins 1a and 1b: widespread nuclear proteins recruited in specific epithelial cells as desmosomal plaque components. Cell Tissue Res. 290:481–499. Schrijvers, A.H., Gerretsen, M., Fritz, J.M., van Walsum, M., Quak, J.J., Snow, G.B. & van Dongen, G.A. (1991). Evidence for the role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Exp. Cell Res. 196:264–269. Schwartz, M.A., Orawibe, K., Kartenbeck, J. & Franke, W.W. (1990). Desmosomes and hemidesmosomes: constitutive molecular components. Ann. Rev. Cell Biol. 6:461–491. Seishima, M., Esakai, C., Osada, K., Mori, S., Hashimoto, T. & Kitajima, Y. (1995). Pemphigus IgG, but not bullous pemphigoid IgG, causes transient increase in intracellular calcium and inositol 1, 4, 5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J. Invest. Dermatol. 104:33–37. Shapiro, L., Fannon, A.M., Kwong, P.D., Thompson, A., Lehmann, M.S., Grübel, G., Legrand, J.-F., Als-Nielsen, J., Colman, D.R. & Hendrickson, W.A. (1995). Structural basis of cellcell adhesion by cadherins. Nature 374:327–337. Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oka, N., Miyazawa, K., Kitamura, M., Takeichi, M. & Ito, F. (1994). Tyrosine phosphorylation of -catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhesion Commun. 1:295–305. Shimizu, H., Masunaga, T., Ishiko, A., Hashimoto, T. & Nishikawa, T. (1995). Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to extracellular regions of desmosomes in different layers of human epidermis . J. Invest. Dermatol. 105:153–159. Simon, M. & Green, H. (1984). Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 36:827–834. Simrak, D., Cowley, C.M.E., Buxton, R.S. & Arnemann, J. (1995). Tandem arrangement of the closely linked desmoglein genes on human chromosome 18. Genomics 25:591–594. Skalli, O., Jones, J.C.R., Gagescu, R. & Goldman, R.D. (1994). IFAP 300 is common to desmosomes and hemidesmosomes and is a possible linker of intermediate filaments to these junctions. J. Cell Biol. 125:159–170. Skerrow, C.J. & Matoltsy, A.G. (1974). Chemical characterization of isolated epidermal desmosomes. J. Cell Biol. 63:524–531. Smith, F.J.D., Eady, R.A.J., Leigh, I.M., McMillan, J.R., Rugg, E.L., Kelsell, D.P., Bryant, S.P., Spurr, N.K., Geddes, J.F., Kirtschig, G., Milana, G., de Bono, A.G., Owaribe, K., Wiche, G., Pulkkinen, L., Ditto, J., McLean, W.H.I. & Lane, E.B. (1996). Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nature Genet. 13:450–457. Smith, E.A. & Fuchs, E. (1998). Defining the interactions between intermediate filaments and desmosomes. J. Cell Biol. 141:1229–1241. Solinas-Toldo, S., Troyanovsky, R., Weitz, S., Lichter, P., Franke, W.W. &Freis, R. (1995). Bovine desmocollin genes (DSC1, DSC2, DSC3) cluster on chromosome 24q21/q22. Mamm. Genome. 6:484–486.
D.R.GARROD ET AL. 85
Stanley, J.R. (1993). Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Advances in Immunology, 53:291–325. Stanley, J.R. & KárpáZti, S. (1994). Desmosome, hemidesmosome and disease. In: Molecular biology of desmosomes and hemidesmosomes. Collins, J.E. and Garrod, D.R. (eds). R.G. Landes Company, Austin, pp. 107–125. Stappenbeck, T.S. & Green, K.J. (1992). The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filaments networks when expressed in cultured cells. J. Cell Biol. 116:1197–1209. Stappenbeck, T.S., Bornslaeger, E.A., Corcoran, C.M., Luu, H.H., Virata, M.L.A. & Green, K.J. (1993). Functional analysis of desmoplakin domains: specification of the interaction with keratin versus vimentin intermediate filament networks. J. Cell Biol. 123:691–705. Stappenbeck T.S., Lamb, J.A., Corcoran, C.M. & Green, K.J. (1994). Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J. Biol. Chem. 269:29351–29354. Svitkina, T.M., Verkhovsky, A.B. & Borisy, G.G. (1996). Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol. 135:991–1007. Theis, D.G., Koch, P.J. &Franke, W.W. (1993). Differential synthesis of type 1 and type 2 desmocollin mRNAs in human stratified epithelia. Int. J. Dev. Biol. 37:101–110. Troyanovsky, S.M., Eshkind, L.G., Troyanovsky, R.B., Leube, R.E. & Franke, W.W. (1993). Contributions of cytoplasmic domains of desmosomal cadherins to desmosome assembly and intermediate filament anchorage. Cell 72:561–574. Troyanovsky, S.M., Troyanovsky, R.B., Eshkind, L.G., Leube, R.E. & Franke, W.W. (1994a). Identification of amino acid sequence motifs in desmocollin, a desmosomal glycoprotein that are required for plakoglobin binding and plaque formation. Proc. Natl. Acad. Sci. USA 91: 10790–10794. Troyanovsky, S.M., Troyanovsky, R.B., Eshkind, L.G., Leube, R.E. & Franke, W.W. (1994b). Identification of the plakoglobin- binding domain in desmoglein and its role in plaque assembly and intermediate filament storage. J. Cell Biol. 127:151–160. Troyanovsky, R.B., Chitaev, N.A. &: Troyanovsky, S.M. (1996). Cadherin binding sites of plakoglobin : localization, specificity and role in targeting to adherens junctions. J. Cell Sci. 109:3069–3078. Tselepis, C., Chidgey, M.A.J., North, A. & Garrod, D.R. (1998). Desmosomal adhesion inhibits invasive behaviour. Proc. Natl. Acad. Sci. USA. 95:8064–8069. Tsukita, S. & Tsukita, S. (1985). Desmocalmin: a calmodulin binding high molecular weight protein isolated from desmosomes. J. Cell Biol. 101:2070–2080. Uitto, J., Pulkkinen, L., Smith, F.J.H. & McLean, W.H.I. (1996). Plectin and human genetic disorders of the skin and muscle. Exp. Dermatol. 5:237–246. Valiron, O., Chevrier, V., Usson, Y., Breviario, F., Job, D. & Dejana, E. (1996). Desmoplakin expression and organisation at human umbilical vein endothelial cell-to-cell junctions. J. Cell Sci. 109:2141–2149. Virata, M.L.A., Wagner, R.M., Parry, D.A.D. & Green, K.J. (1992). Molecular structure of the human desmoplakin I and II amino terminus. Proc. Natl. Acad. Sci. USA 89:544–548. Wahl, J.K., Sacco, P.A., McGranahan-Sadler, T.M., Sauppe, L.M., Wheelock, M.J., & Johnson K.R. (1996). Plakoglobin domains that define its association with the desmosomal cadherins and the classical cadherins: identification of unique and shared domains. J. Cell Sci. 109: 1143–1154.
86 D.R.GARROD ET AL.
Wang, Y.M., Amagai, M., Minoshimia, S., Sakai, K., Green, K.J., Nishikawa, T. & Shimizu, N. (1994). The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18ql2. Genomics 20:492–495. Watt, F.M., Mattey, D.L. & Garrod, D.R. (1984). Calcium-induced reorganization of desmosomal components in cultured human keratinocytes. J. Biol. 99:2211–2215. Wheelock, M.J. &Jensen, P.J. (1992). Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J. Cell Biol. 117:415–425. Witcher, L.L., Collins, R., Puttagunta, S., Mechanic, S.E., Munson, M., Gumbiner, B. & Cowin, P. (1996). Desmosomal cadherin binding domains of plakoglobin. J. Biol. Chem. 271: 10904–10909. Yue, K.K.M., Holton, J.L., Clarke, J.P., Hyam, J.L.M., Hashimoto, T., Chidgey, M.A.J. & Garrod, D.R. (1995). Characterisation of a desmocollin isoform (bovine DSC3) exclusively expressed in lower layers of stratified epithelia. J. Cell Sci. 108:2163–2173.
CELL—MATRIX ATTACHMENT
5. PROTEIN-PROTEIN INTERACTIONS AT THE DERMAL-EPIDERMAL BMZ M.PETER MARINKOVICH
Specific protein-protein interactions are required for the assembly and continued integrity of all basement membranes. In the highly specialized dermal-epidermal basement membrane zone (BMZ) an intricate and precise organization of multiple components is required to maintain dermal-epidermal cohesion. Disruption of this organized array of components, either by inherited (epidermolysis bullosa) (Marinkovich et al., 1999) or acquired (autoimmune bullous) disease (Lin et al., 1997), can result in extensive skin and mucosal blistering. ULTRASTRUCTURAL ORGANIZATION OF THE DERMALEPIDERMAL BMZ BMZ ultrastructure has traditionally been visualized by standard transmission electron microscopy (Figure 5.1a). Through this technique, it can be appreciated that at the superior end of the dermal-epidermal BMZ, intermediate filaments insert upon electron dense condensations of the keratinocyte plasma membrane termed hemidesmosomes. Anchoring filaments appear as thin threadlike structures (Ellison and Garrod, 1984) which extend from the extracellular surface of hemidesmosomes, span the electron lucent space in the BMZ termed the lamina lucida, and appear to connect hemidesmosomes to the electron dense portion of the extracellular BMZ termed the lamina densa. Anchoring fibrils are banded structures which extend perpendicularly from the lamina densa into the adjacent superficial papillary dermis. Anchoring fibrils either extend back to reinsert onto the lamina densa or connect with electron dense structures of the papillary dermis termed anchoring plaques (Keene et al., 1987). In connecting to these structures, anchoring fibrils entrap interstitial collagen and other dermal molecules and help to firmly attach the lamina densa onto the papillary dermis. Newer techniques in the analysis of tissues by electron microscopy combine high pressure, cryopreservation and freeze substitution to yield improved preservation of tissue architecture (Hippe-Sanwald, 1993). During the initial cryopreservation step, water in tissues is converted to noncrystaline ice, through the combined application of very low temperature and very high pressure. Subsequently, absolute acetone or methanol with aldehyde or osmium is substituted for the ice, and crosslinking occurs at very low
PROTEIN-PROTEIN INTERACTIONS AT THE DERMAL-EPIDERMAL BMZ 89
Figure 5.1 Ultrastructural appearance of the dermal-epidermal basement membrane. Human neonatal foreskin was examined by transmission electron microscopy using standard fixation (A), or high pressure freeze substitution (B). Note absence of anchoring fibrils and lamina lucida structures in B. Magnification: A, 72, 660; B, 55,650. Micrographs provided by Douglas Keene, Shriners Hospital, Portland Oregon.
temperatures. This technique greatly reduces the loss of soluble substances such as proteoglycans. Recent studies with high-pressure freeze substitution electron microscopy have demonstrated that dermal-epidermal BMZ ultrastructure seen with conventional fixation may be artifactual (Keene and McDonald, 1993) (Keene et al., 1997). While hemidesmosomes and intermediate filaments are clearly visible with these techniques, anchoring fibrils and the lamina lucida appear absent (Figure 5.1b). Instead, a continuous felt-like matrix extends from the basal keratinocyte plasma membrane into the papillary dermis. These studies suggest that the lamina lucida seen after conventional fixation may arise as a dehydration artifact caused by a shrinking away of the basal cell plasma membrane from the underlying dermis after water removal. Likewise, the lamina densa, anchoring filaments and anchoring fibrils may appear due to artifactual precipitation resulting from removal of proteoglycans and other soluble substances during conventional fixation methods. These studies provide additional insight into BMZ organization. INTERMEDIATE FILAMENT-HEMIDESMOSOME INTERACTIONS Basal keratinocyte intermediate filaments contain the acidic keratin 14 and the basic keratin 5. Initially these keratins combine together as polar coiled-coil dimers. The dimers go on to form staggered anti-parallel tetramers and then undergo additional lateral and end to end associations to form 2 to 3 nm diameter apolar protofilaments and 4 to 5 nm
90 M.PETER MARINKOVICH
diameter protofibrils. finally two to four protofilaments associate into a coiled coil lattice to form 10 nm diameter intermediate filaments (Fuchs and Cleveland, 1998). Recent studies have suggested that the nonhelical keratin 5 head domain may be important in the anchoring of intermediate filaments to other structures (Smith and Fuchs, 1998). The desmosomal components desmoplakin, plakophilin 1 and plakoglobin, all appear to interact with this domain. Intermediate filaments through the keratin 5 head domain may also associate with hemidesmosomal components although this remains to be proven. The keratin 5 head domain is also suspected to be involved with the binding of intermediate filaments to melanosomes (Uttam et al., 1996) as mutations which affect this domain are associated with epidermolysis bullosa simplex with mottled pigmentation. BPAG1 Hemidesmosomes contain two plaque proteins, including BPAG1 (BP230) and plectin (HD1). BPAG1 is a 230 kD protein which consists of a central rod flanked by carboxyl (C) and amino (N) terminal globular domains (Tanaka et al., 1991) (Sawamura et al., 1991) (Tamai et al., 1995) (Tang et al., 1996). BPAG1 has significant homology both to desmoplakin as well as to plectin in its two C terminal repeating globular domains. This homologous region contains the keratin binding region. BPAG1 localizes to the inner plaque on the cytoplasmic surface of the hemidesmosome and functions in the connection between hemidesmosomes and intermediate filaments. BPAG1 negative transgenic mice lack a hemidesmosomal inner plaque and the connection between hemidesmosomes and intermediate filaments is severed, creating a cytoplasmic zone of mechanical fragility just above the hemidesmosomes, which results in intraepidermal blistering (Guo et al., 1995). In these mice neither hemidesmosome stability or cell substratum adhesion appear to be weakened. Thus BPAG1 does not appear vital for hemidesmosome or BMZ assembly. BPAG1 also exists as an alternatively spliced neural isoform termed BPAG1n (dystonin). As a result of the ablation of the domains common for both BPAG1 and BPAGln, BPAG1 knockout mice also develop severe dystonia and sensory nerve degeneration typical of dystonia musculorum (dt/dt) mice (Bowling et al., 1997). BPAG1 is also a major autoantigen targeted by sera of most patients with the blistering disease, bullous pemphigoid (Stanley, 1991). PLECTIN Plectin is a 500 kD cytoskeletal linker protein (Liu et al., 1996). Plectin associates with a variety of types of cytoskeletal structures including keratin, vimentin, neurofilaments, microfilaments, and microtubules. It shows a very widespread expression in the majority of tissues and cell types studied. In stratified epithelial cells, plectin promotes cell-cell adhesion by linking keratin containing intermediate filaments and desmosomes, while plectin’s role in promoting dermal-epidermal cohesion lies in its ability to link keratin into the hemidesmosomal plaque.
PROTEIN-PROTEIN INTERACTIONS AT THE DERMAL-EPIDERMAL BMZ 91
Figure 5.2 Anchoring filaments: central organizers of specialized basement membrane assembly. Four anchoring filament proteins, α6β4 integrin, collagen XVII, laminin 5 and laminin 6 are depicted schematically on the left. Important structural domains and proposed functions are listed to the right.
92 M.PETER MARINKOVICH
Rotary shadowing electron microscopic studies have shown that plectin, like many BMZ proteins, assumes a dumbbell shape and contains a central 200 nm helical coiled-coil rod, which is flanked at either end by large globular domains (Wiche, 1998). Gel permeation studies which predicts plectin’s molecular weight to be 1100 kD, suggest that plectin exists as a dimer in solution. Immuno-gold electron microscopy studies have demonstrated localization of plectin with intermediate filaments (Foisner et al., 1995). The C terminal globular domain of plectin contains 6 repeating domains containing approximately 300 amino acids each. Each domain contain multiple copies of a tandemly repeated 19 amino acid motif. A 50 amino acid segment bridging repeat domains 5 and 6 contains a basic amino acid residue cluster located in a bipartite nuclear localization sequence that functions as the intermediate filament binding site (Nikolic et al., 1996). Near this site of domain 6 is a phophorylation site for p34cdc2 protein kinase that may be involved with dissociation of plectin from intermediate filaments (Malecz et al., 1996). Plectin’s interaction with hemidesmosomes studied by immuno-gold electron microscopy with domain specific antibodies (Foisner et al., 1994) reveal a lack of orientation of plectin’s association between intermediate filaments and hemidesmosomal plaque. In this study, the same domains were seen to insert both into keratin filaments as well as hemidesmosomal plaque. These studies suggest that two binding sites of plectin exist which each are capable of interacting with other hemidesmosomal elements. These findings are consistent with direct ligand binding studies (Rezniczek et al., 1998) which demonstrate that both the N and C terminal globular domains of plectin are capable of binding to β4 integrin. Furthermore, plectin is capable of associating with two different regions of the β4 integrin cytoplasmic domain. The significance of these multiple interactions remains to be elucidated. Plectin has been recently shown to exist in multiple isoforms generated by alternative splicing of the amino termini (Elliott et al., 1997). At least eight isoforms have been detected thus far. Isoform expression levels as shown by RNAase protection assays, demonstrate a diversity of different isoform expression in individual tissues. The splicing diversity affects both coding and noncoding regions and may affect plectin function and/ or expression. Other molecules, including HD1 (Heida et al., 1992) and IFAP 300 (Skalli et al., 1994), which show similarities as well as differences with plectin in terms of tissue distribution as well as other parameters may represent some of these alternatively spliced plectin isoforms, however this remains to be determined. Plectin deficient patients show a blistering phenotype with separation of the skin occurring above the level of the hemidesmosome (Smith et al., 1996) (Gache et al., 1996) (McLean et al., 1996) (Chavanas et al., 1996). Hemidesmosomes are intac suggesting that plectin is not essential for hemidesmosome formation. Plectin deficient patients have been shown to have an associated muscular dystrophy, which accounts for the name, epidermolysis bullosa simplex with muscular dystrophy. Premature stop codon mutations of the plectin gene were found to be associated with the majority of these patients, although in one case, a three amino acid deletion was found in the N terminal globular region. This region, which is involved with the interaction of plectin with β4 integrin, is likely to be important in plectin function. The mechanism as to how a lack of plectin in
PROTEIN-PROTEIN INTERACTIONS AT THE DERMAL-EPIDERMAL BMZ 93
muscle leads to muscular dystrophy remains to be determined. Plectin knockout mice (Andrä et al., 1997) also demonstrate a blistering phenotype similar to epidermolysis bullosa patients described above, but show more extensive muscle pathology.
α6β4 INTEGRIN Hemidesmosomes also contain the transmembrane proteins collagen XVII and α6β4 integrin (Figure 5.2). The cytoplasmic portions of these molecules make up part of the hemidesmosome dense plaque whereas the extracellular portions of these molecules make up portions of the anchoring filament and may contribute to the structure known as the subbasal dense plate which underlies hemidesmosomes in the lamina lucida region. α6β4 integrin is an essential and central component of the hemidesmosome (Sonnenberg et al., 1991). Like all of the members of the family of molecules known as integrins (Hynes, 1992), it consists of two transmembrane subunits assembled together in a noncovalent fashion (Tamura et al., 1990) (Sonnenberg et al., 1990). The extracellular domains of these subunits combine together to form a ligand binding site, whereas the intracellular domains interact with other hemidesmosomal components. β4 integrin is only known to combine with the α6 subunit, whereas the α6 subunit can combine with β4 or β1 subunits. The α6β1 or α6β4 integrin combinations have been shown to act as receptors for laminin, and α6β4 integrin has been shown to act as a receptor for laminin 5. β4 integrin contains an especially large approximately 1000 amino acid cytoplasmic domain, which consists of two pairs of fibronectin repeats separated by a connecting segment. Replacement of β4 integrin deletion constructs in β4 integrin negative EB-PA keratinocytes revealed a 27 amino acid region of the connecting segment was required for hemidesmosome assembly (Niessen et al., 1997). This region of β4 integrin is critical in localizing plectin to hemidesmosomes, and a direct interaction between β4 integrin cytoplasmic domain and plectin has been demonstrated (Rezniczek et al, 1998). β4 integrin directly interacts with collagen XVII (Schaapveld et al., 1998) (Borradori et al., 1997) and influences its localization to hemidesmosomes. The sequences on β4 integrin which appear to mediate this interaction lie on the C terminal section of the connecting segment and the third fibronectin repeat. In addition to binding collagen XVII and plectin, β4 integrin cytoplasmic domain, under some circumstances may fold over and bind to itself. Ligand binding studies show that the C terminal 85 amino acids of β4 integrin can interact with and bind the connecting segment and regions N terminal to it. This folding appears to influence the affinity of β4 integrin for plectin and may be involved in hemidesmosome assembly/disassembly. β4 integrin contains a tyrosine activation motif (TAM) in its connecting segment. Mutations involving the tyrosines in this motif have been shown to have variable effects. In one study, these mutations appeared to prevent the incorporation of β4 integrin into hemidesmosomes (Mainiero et al., 1995).In another study, TAM mutations appeared to have only a minor effect on the localization of collagen XVII to hemidesmosomes (Borradori et al., 1997). As mentioned above, α6β4 integrin appears to play a central role in hemidesmosome formation in that transgenic mice lacking the β4 integrin show skin devoid of
94 M.PETER MARINKOVICH
hemidesmosomes as well as blistering and severe deficits in cell adhesion (Bowling et al., 1996). Patients with absence of the β4 (Vidal et al., 1995) or 6 integrin (Ruzzi et al., 1997) due to underlying gene mutations demonstrate very rudimentary hemidesmosome formation at best, widespread blistering and pyloric atresia (epidermolysis bullosa with pyloric atresia, EB-PA). COLLAGEN XVII Collagen XVII (BP180/BPAG2) is another transmembrane component of hemidesmosomes. It is collagenous protein with a type II transmembrane orientation (Giudice et al., 1992). Based on electron microscopy and crosslinking studies, collagen XVII appears to assemble into a homotrimer (Schumann and Bruckner-Tuderman, 1996) and contains three main regions; an intracellular N terminal globular head, a central rod and an extracellular flexible tail (Hirako et al., 1996). The C terminal portion of the molecule appears to be involved with polarization of the collagen XVII molecule to the basal surface of keratinocytes. As mentioned above the cytoplasmic domain of collagen XVII colocalizes and binds with the β4 integrin in the hemidesmosome (Borradori et al., 1998) (Aho and Uitto, 1998). A subset of epidermolysis bullosa patients who lack collagen XVII expression also show a lack of localization of BPAG1 into hemidesmosomes. Analysis of deleted collagen XVII cDNA constructs suggests that the C terminal half of the collagen XVII cytoplasmic domain is required for BPAG1 localization into hemidesmosomes. Thus the collagen XVII endodomain has two important functions: ligation of BPAG1 (which links intermediate filaments to the hemidesmosome) and ligation of the β4 integrin endodomain (which serves to correctly localize collagen XVII to the hemidesmosome). Collagen XVII assists in promoting epidermal adhesion, as evidenced by the widespread blistering that occurs in patients with generalized atrophie benign epidermolysis bullosa (GABEB) who lack this molecule. Interestingly, retrovirally mediated collagen XVII gene replacement in primary GABEB keratinocytes corrected adhesion defects in vitro and corrected blistering defects in vivo after grafting of these cells onto immunodeficient mice (Seitz et al., 1999). The large non-collagenous region of collagen XVII near the transmembrane region, termed the NC16A domain may be involved with association of collagen XVII with 6 integrin in keratinocytes in vitro, indicating that this portion of the molecule may be necessary for binding to α6β4 integrin (Hopkinson et al., 1995). This portion of the molecule also contains the epitopes recognized by bullous pemphigoid autoantibodies (Liu et al., 1995). The central rod and flexible tail region of collagen XVII contains a number of interrupted collagenous domains which assemble into a triple helix. The most distal extracellular portion of this molecule contains epitopes recognized by autoantibodies from some patients with cicatricial pemphigoid (Balding et al., 1996). Based on rotary shadowed electron microscopic measurements, the extracellular portions of collagen XVII may extend up to 193 nm. It is therefore likely that collagen XVII extends the full length of the lamina lucida and inserts into the lamina densa. This is consistent with the
PROTEIN-PROTEIN INTERACTIONS AT THE DERMAL-EPIDERMAL BMZ 95
observation that cicatricial pemphigoid autoantibodies recognize autoepitopes in the lamina densa region of the BMZ (Bedane etal, 1997). The anchoring filament component, LAD-1 is a 120 kD protein expressed by keratinocytes (Marinkovich et al., 1996) which represents the nondegraded form of the previously identified 97 kDa linear IgA bullous dermatosis autoantigen (Zone et al., 1990). The mAb 123 which recognizes LAD-1, induces deepithelialization of human skin in situ, suggesting that LAD-1 plays an important cohesive role in the dermal-epidermal BMZ (Marinkovich et al., 1996). A previously described 125 kD component of anchoring filaments which appears to be the bovine analog of LAD-1, was found to be the first protein to be expressed during the earliest phases of wound healing in an organ culture model (Klatte et al., 1989). Recent evidence implicates LAD-1 as a proteolytic fragment of the collagen XVII exodomain. Linear IgA bullous dermatosis autoantibodies, as well a group of monoclonal antibodies have been shown to react with LAD-1 extracted from skin and keratinocyte medium, but do not show significant reaction with full length collagen XVII (Klatte et al., 1989) (Marinkovich et al., 1996) (Pas et al., 1997) (Zone et al., 1998). These observations were the main evidence which supported LAD-1 being a novel protein. Recent peptide sequencing studies has shown that LAD-1 contains homologous sequences with collagen XVII (Zone et al., 1998). Northern blot analysis has failed to confirm any alternatively spliced variants of collagen XVII (Schacke et al., 1998) and an absence of both LAD-1 and collagen XVII in patients with generalized atrophie benign epidermolysis bullosa (Marinkovich et al., 1997) suggests that LAD-1 probably is not a separate gene product. With these possibilities ruled out, the most likely hypothesis appears to be that LAD-1 may indeed be a proteolytic fragment of collagen XVII, with proteolysis inducing a group of neoepitopes. As these neoepitopes include those recognized by linear IgA bullous dermatosis autoantibodies, and by mAb 123 which induces skin de-epidermalization in situ, the proteolysis of collagen XVII appears to be an important event from a disease standpoint. N terminal sequencing of processed collagen XVII isolated from skin suggests that the cleavage occurs in the NC16A domain (Zone et al., 1998). Processed collagen XVII appears to exist as a triple helix (Balding et al., 1997), and contains domains which are collagenase sensitive but pepsin resistant (Schacke et al., 1998). In one study, proteolytic cleavage of a bacterial fusion protein containing the NC16a and its proximal collagenous domain was demonstrated using purified gelatinase B (Stahle-Backdahl et al., 1994), however cleavage of native collagen XVII has not been demonstrated with this enzyme. In another study, inhibition of furin served to inhibit collagen XVII processing (Schacke et al., 1998). A furin consensus site is present in the NC16a region of collagen XVII and it is possible that this enzyme in a membrane associated form may be involved in collagen XVII processing. Alternatively, it is known that furin proteolytically activates membrane type metalloproteinase 1 and that this enzyme activates gelatinase A. Thus it is also possible that either of these two enzymes may be responsible for collagen XVII processing.
96 M.PETER MARINKOVICH
LAMININS OF THE DERMAL-EPIDERMAL BMZ In addition to α6β4 integrin and collagen XVII, anchoring filaments contain the molecules laminin 5 (Verrando et al., 1988) (Rousselle et al., 1991) (Carter et al., 1991) and laminin 6 (Marinkovich et al., 1992a) (Figure 5.2). Laminins are family of hetero trimeric BMZ proteins which contain a, β and γ chains (Burgeson et al., 1994). Laminin 5 contains α3, β3, and γ2 chains. All previously described laminins were shown to have three short arms and one long arm, forming a cross shape as shown by rotary shadowing analysis. In contrast, laminin 5 appears as a dumbbell shape which is the result of severe truncations of the short arms. Each of these short arm reductions occur primarily as a result of truncations of the genes coding for these subunits, however some of this reduction occurs post-translationally as extracellular processing events on the α3 and γ2 short arms (Marinkovich et al., 1992b). Because of these short arm truncations, laminin 5 cannot polymerize or bind to nidogen. Instead laminin 5 forms a disulfide bonded complex with laminin 6 (Champliaud et al., 1996). The importance of laminin 5 in mediating epithelial adhesion is best illustrated by the widespread blistering, mucosal erosions and extracutaneous epithelial adhesion defects that occur in patients with Herlitz junctional epidermolysis bullosa, where laminin 5 expression is absent (Meneguzzi et al., 1992) (Marinkovich et al., 1993) due to underlying gene mutations (Uitto et al., 1995). Laminin 5 is initially synthesized and secreted by keratinocytes in an unprocessed form with an α3 chain of 200 kD, a β3 chain of 140 kD, and the γ2 chain of 155 kD (Marinkovich et al., 1992b). The domains I and II in all three chains are believed to adopt a helical coil conformation, account for the rod-like central portion of the laminin molecule, and are essential for laminin assembly, βγ dimers accumulate intracellularly and assembly of these dimers with the α chain appears to be the rate limiting step in laminin assembly (Matsui et al., 1995). Shortly after secretion, the α3 chain becomes processed from 200 to 165 kD. In addition, the γ2 chain is processed from 155 to 105 kD by the enzyme BMP-1 (Lee et al., 1997). These processing steps occur both in vitro in cultured keratinocytes, as well in vivo in human tissues. An additional processing step predominantly occurs in vivo, which results in the conversion of the a three chain from 165 to 145 kD (Marinkovich et al., 1992b). Analysis of laminin 5 extracted from human tissue shows that the former two steps occur to completion while the latter processing step occurs in approximately half of the laminin 5 molecules. In addition, further processing via MMP-2, of the γ2 chain from 105 kD to 80 kD, at the boundary of domains III and II; occurs in certain proliferative states, such as squamous cell carcinoma and the developing mammary gland (Giannelli et al., 1997). This processing which has only been demonstrated in rat tissues, appears to facilitate a promigratory epithelial phenotype. It remains to be shown whether this processing step occurs in human tissues. The laminin 3 chain contains an especially large C terminal globular domain which consists of five repeating EGF-like segments. The G domain of laminin 5 α3 chain contains the major cell binding activity, which provides laminin 5 the ability to serve as the major attachment ligand for a number of epithelial cell types including keratinocytes and squamous carcinoma cells. Processing of the α3 chain from 200 to 165 kD appears to
PROTEIN-PROTEIN INTERACTIONS AT THE DERMAL-EPIDERMAL BMZ 97
occur near the junction of the G3 and G4 domains, and laminin 5 containing processed 165 kD α3 chain supports cell attachment (Rousselle and Aumailley, 1994) (Rousselle et al., 1995). These observations make it clear that the cell binding activity and the binding sites for integrins α3β1 and α6β4 are located somewhere in the G1 to G3 domains. Further confirming this, an antibody, termed BM165, which recognizes the G1 domain, has been shown to inhibit the attachment of keratinocytes to underlying culture substrate and to interfere with the attachment of epidermis to dermis (Rousselle et al., 1991). Laminin 5 additionally has heparin binding properties contained within the G4 and 5 domains (Sung et al., 1997). The significance of the heparin binding is as yet unclear. It is possible that, prior to processing and insertion into the BMZ, laminin 5 may bind to BMZ heparan sulfate proteoglycan, also known as perlecan, or alternatively cell surface heparan sulfate proteoglycan, synd